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Abstract 
UK ethnic minority patients are reported to be under-represented in clinical trials. 
Under-representation of any patient group within an Randomised Clinical Trial can 
bias trial results and subsequent extrapolation into the general population. 
However, the true extent of ethnic minority representation in RCTs is masked by 
the poor quality of ethnicity data. This thesis investigates ethnicity data collection in 
healthcare and the representation of ethnic minority patients in RCTs in the UK.  
A systematic literature review of ethnicity data collection identified a paucity of 
published evidence. Self-reported ethnicity was recognised as the optimal method 
of data collection but training is needed to raise awareness of the importance of 
such data. Reasons for the gaps in ethnicity data were explored through a 
healthcare professional survey and focus groups with lay South Asian volunteers. 
The majority of healthcare professionals agreed it was important to collect ethnicity 
and emphasised the need for training. The focus groups revealed a willingness to 
provide these data, subject to being given information regarding their use.  
A second systematic literature review of interventions to improve recruitment and 
retention of ethnic minorities to RCTs found a dearth of literature from the UK. US 
studies reported financial incentives, government grants and the involvement of 
community representatives to be effective.  
Census data, hospital episode statistics data, clinical trials recruitment and reasons 
for non-participation, collected in one cancer research network, were used to 
assess the local representation of ethnic minorities within RCTs. The results did not 
show ethnic minorities to be under-represented, but there was insufficient 
evidence to rule out under-representation as a problem.  
Reducing inequalities in participation in clinical trials is dependent upon having 
accurate and complete ethnicity data. A change in policy to mandate the collection 
of ethnicity data in primary care and linked through to other healthcare service 
providers is required.   
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Chapter 1 Introduction 
1.1 Rationale for research topic 
Participation of ethnic minorities has been reported to be under-represented in 
clinical trials (Hussain-Gambles 2004, Godden et al, 2010). As a South Asian working 
in cancer clinical trials for over a decade, I was aware of evidence suggesting 
patients entering clinical trials had better outcomes even when randomised to 
standard care, also referred to as a ‘trial effect’ (Karjalainen and Palva, 1989, 
Braunholtz et al, 2001). It is suggested that patients benefit from active follow-up 
and closer monitoring and management of their disease. As the daughter of parents 
speaking little English, I played a pivotal role when my father was invited to 
participate in a phase III diabetes Randomised Controlled Trial (RCT). Patients like 
my father who do not have an English speaking family member to accompany them 
to appointments and act as an interpreter are still likely to miss the opportunity to 
participate in a trial.  
The true extent of ethnic minority representation in RCTs is masked by the poor 
quality of ethnicity data in healthcare. Through this thesis, I investigate ethnicity 
data collection in healthcare, review the literature using interventions to improve 
ethnic minority participation in RCTs, investigate the representativeness of ethnic 
minorities in RCTs and explore barriers to participation.  
2 
 
I started my career as a statistical reviewer on a systematic literature review looking 
at barriers and attitudes to participation in clinical trials from the patient and 
healthcare professional perspectives (Ward et al, 2000). The review revealed the 
patients participating in clinical trials to be mainly White, English speaking, middle-
class men. Barriers to trial participation identified included: distrust of healthcare 
professionals, lack of time and resources and language issues. Language was 
important as most patient information sheets and consent forms were only 
available in English. This automatically excluded all non-English speakers from 
clinical trials unless interpreters were readily available. However, patient 
information sheets were translated into two languages (Urdu and Gujarati) in a 
cancer trial using prophylactic anti-coagulants for which I was the statistician. 
Unfortunately, they did not improve uptake which may have been due to poor staff 
preparedness or poor literacy levels in certain ethnic minorities (Department of 
Health, 1999, Szczepura et al, 2005). 
I went on to analyse a West Midlands Occupational Urothelial Tumour Unit study 
exploring survival and delay times in the diagnosis and treatment of bladder cancer 
(from onset of first symptoms to treatment). The results of the study showed delays 
affected overall survival, with shorter GP and hospital delays resulting in poorer 
survival, this was as expected, with patients with severe symptoms rushed through 
quickly (Wallace et al, 2002). It was suspected that delay times may vary by 
geographical area, otherwise known as the ‘postcode lottery’. All patients with a 
valid postcode were assigned a Townsend Material Deprivation Score. The analysis 
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confirmed material deprivation as a significant prognostic variable along with other 
patient and tumour characteristics. However, the analysis also showed that delay 
times did not significantly vary across geographical area (Begum et al, 2004). 
Feedback from presentation of the results suggested ethnicity may be a 
contributing factor believing it to be a proxy for deprivation and vice versa (Begum 
et al, 2002). Unfortunately, ethnicity data were not available for this study. 
However, it was around this time that I first developed an interest in inequalities in 
cancer.  
Subsequently, my speciality became the analysis and reporting of haematological 
trials, which included the Medical Research Council Multiple Myeloma trials and 
studies of leukaemia. I also became aware of the increased risk of developing 
multiple myeloma in the African and Caribbean communities (Smith et al, 2005). I 
was then involved in a study examining the occurrence of acute Graft versus Host 
Disease and transplant-related mortality by ethnic group in patients undergoing 
standard sibling allogeneic stem cell transplantation. Indications of an increased risk 
in the non-Caucasian group were found which may have been attributable to 
differences in tumour biology, socioeconomic factors like nutrition, or post-
transplant care (Karanth et al, 2006).  
Given the paucity of ethnicity data and the heavy consequences of not identifying 
and facilitating patients from ethnic minority groups into clinical trials described 
above, the research topic for this thesis was formed.  
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The thesis investigates ethnicity data collection and the issue of ethnic minority 
under-representation in RCTs, the consequences of which are clouded by the poor 
collection of ethnicity data in healthcare. This research was started by a nine month 
grant from Cancer Research UK (CRUK) who commissioned the Cancer Ethnicity 
(CanEth) feasibility study to identify methods of collecting accurate data on 
ethnicity and recognised this as being essential to inform policy makers, funders 
and public health experts on the cancer incidence, prevalence and outcomes. 
1.2 Ethnic minorities in the UK 
1.2.1 UK migration 
The British Nationality Act (1948) passed due to a shortage of labourers, allowed 
people born in British territory to enter and work in the UK without the need for a 
visa. The 22nd June 1948 saw the first arrivals from the West Indies and marked the 
start of mass immigration into the UK, until 1972 when new legislation restricting 
immigration to those with work permits or with family born in the UK was 
introduced. Immigration from the former British Empire colonies of India, Pakistan, 
Bangladesh, the Caribbean, South Africa, Kenya and Hong Kong was vast, and saw 
the ethnic minority population of the UK rise from a few thousand in 1948 to 1.4 
million in 1970. Further to this, political changes in Africa led to a stream of 
migration of African Indians between the 1960s and early 1970s (Gill et al, 2007). 
Later immigrants originated from Pakistan and Bangladesh or were the families of 
the earlier arrivals. In recent years, we have seen the arrival of new migrants from 
5 
 
Eastern Europe following the enlargement of the European Union in 2004. Numbers 
of asylum seekers and refugees of Somali and Middle-Eastern origin have also 
increased (The Migration Observatory, 2013).  
1.3 Ethnicity data collection 
1.3.1 Census 
Ethnicity data collection first commenced in the UK in the form of country of birth 
collected in the census from 1841 to 1991. In 1991, the ethnicity question was 
introduced providing ten categories based upon immigration routes. This was 
expanded to 16 categories in 2001 and 18 for the 2011 census. These changes were 
accompanied by free text boxes to capture free text. The expansions were a result 
of large numbers of the population selecting ‘other’ and entering free text because 
they did not identify with the choice of categories available, and also to capture the 
growing mixed population.  
1.3.2 Health 
Ethnicity data collection was also initiated in other areas besides the census. It 
became a requirement to collect ethnicity data as part of the Hospital Episode 
Statistics (HES) data in 1995 but was poorly implemented. The levels of missing data 
and invalid codes rendered the data unusable (Aspinall, 2000). However, some 
improvement has been reported in Finished Consultant Episodes with a reduction 
in ‘not known’ and ‘not stated’ codes from 23.9% in 2004/05 to 8.6% in 2009/10 
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(HES online, 2011). In 2004, a single Quality and Outcomes Framework (QOF) point 
out of a possible thousand was offered for collection of ethnicity data for all new 
registrations in primary care, and again this was a weak incentive which did not 
have much impact. The system could also be cheated by selecting ‘other’, or ‘not 
known’ which would mean the field was complete but did not provide any useful 
information, the incentive was recognised to be ineffective and abandoned 
(Johnson, 2012).  
1.4 Ethnicity 
The term ‘ethnicity’ is derived from the Greek word ‘Ethnos’ meaning ‘tribe of 
people’. Ethnicity is a multi-dimensional and subjective concept, which means that 
self-reporting is the most accurate method of capturing this information. Ethnic 
groups can be broadly defined as people from the same geographical location or 
those who have a common language, religion or culture. There is no hard or fast 
definition of ethnicity and the area is subject to great debate with researchers using 
a diverse range of terminology, which has meant that publications relating to ethnic 
minorities are not easy to find. Bhopal (2004) attempted to define the concept and 
measures of ethnicity in the form of a glossary style article with the hope that it 
might lead to an internationally applicable glossary and provide a basis for indexing 
terms. The essential components of ethnicity can be said to comprise of the 
following items but this list is by no means exhaustive:  
 Country of birth 
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 Country of origin 
 Parents country of origin 
 Religion 
 Language 
 Diet 
 Nationality 
 Race 
 Culture 
 Dress 
Race is an out of date term and is considered unacceptable in the UK (Gill et al, 
2007). Historically, race was used prior to ethnicity and is still collected in some 
countries such as the USA today. Race refers to physical attributes such as, skin 
colour, facial features, hair colour and texture. Skin colour is an inaccurate indicator 
of ethnicity, it is not possible to distinguish between white groups such as English, 
Scottish, Welsh or other Europeans nor between some non-whites, e.g. Indian, 
Pakistani or Bangladeshi. The items considered to be of national importance can 
first and foremost be found in the census. 
1.4.1 Ethnicity indicators 
1.4.1.1 Ethnic group 
Prior to 1991, country of birth was the only indicator of ethnicity collected. Ethnicity 
was first incorporated in the 1991 census as a ten category item (Table 1.1). The 
categories followed immigration roots and combined geographical origin with skin 
colour. The intention was to increase the accuracy of ethnic group classification 
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where subjects originated from a multi-cultural continent, e.g. Black African, Black 
Caribbean.  In 2001, the census categories were supplemented with the addition of 
a new ‘Mixed’ categories, expansion of the ‘White’ category and the introduction of 
an ‘Other’ category, with space for free text in each category. The categories were 
arranged into five broad groups: White, Black, Mixed, Asian, Chinese and Other.   
The 2011 census saw the introduction of two further classifications, ‘Gypsy or Irish 
traveller’ and ‘Arab’ accumulating in 18 categories. Other changes included 
relocating the Chinese category from ‘Other ethnic group’ in 2001 to the 
‘Asian/Asian British’ category. A ‘not stated’ code exists for coding purposes to be 
used by those collecting the data but not offered on forms or verbally in order to 
minimise missing data (Table 1.1). No subsequent changes have been made to 
ethnic minority categorisation in the UK census. 
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Table 1.1 Ethnicity categories in thirty years of the England and Wales census 1991-2011 
1991 2001 2011 
0 White A White A White 
1 Black Caribbean 1 British 1 English/Welsh/Scottish/Northern Irish/British 
2 Black African 2 Irish 2 Irish 
3 Black other 3 Any other white background 3 Gypsy or Irish Traveller 
4 Indian B Mixed 4 Any other White background 
5 Pakistani 4 White and Black Caribbean B Mixed/multiple ethnic groups 
6 Bangladeshi 5 White and Black African 5 White and Black Caribbean 
7 Chinese 6 White and Asian 6 White and Black African 
8 Other Asian 7 Any other mixed background 7 White and Asian 
9 Any other ethnic 
group 
C Asian or British Asian 8 Any other Mixed/multiple ethnic background 
 Not stated 8 Indian C Asian/British Asian 
  9 Pakistani 9 Indian 
  10 Bangladeshi 10 Pakistani 
  11 Any other Asian background 11 Bangladeshi 
  D Black or Black British 12 Chinese 
  12 Caribbean 13 Any other Asian background 
  13 African D Black/African/Caribbean/Black British 
  14 Any other Black background 14 African 
  E Other Ethnic Groups 15 Caribbean 
  15 Chinese 16 Any other Black/African/Caribbean background 
  16 Any other ethnic group E Other ethnic group 
   Not stated 17 Arab 
    18 Any other ethnic group 
     Not stated 
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1.4.1.2 Religion 
Religion was first introduced as a census question in 2001 and remained unchanged 
for the 2011 round, it continues to be optional. The question comprises of seven 
responses: 1) Christian, 2) Buddhist, 3) Hindu, 4) Jewish, 5) Muslim, 6) Sikh, and 7) 
any other religion. The Office of National Statistics also distinguished between 
degree of religious practice (active faith and participation in religious activity and 
worship) and religious identity (belonging to a religious community even if the 
religion is not practiced). As previously, the ‘not stated’ option was not offered 
either verbally or as a category on a form.  
1.4.1.3 Language 
Language was collected as part of the 2011 census in two parts. The first asked for 
language to be specified if it was not English, with the second part asking 
respondents to indicate their level of proficiency in English using a Likert scale.  
1.4.1.4 Country of birth 
Country of birth is routinely recorded on UK birth and death certificates and has 
been collected in the census since 1841 this has often been used as a proxy for 
ethnicity mainly because of its availability. However, it has two main weaknesses. 
Firstly, it is not possible to distinguish immigrants from the children of British 
residents born overseas, even though these individuals would identify themselves 
as White. Secondly, it is unable to identify the British born offspring of immigrants 
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and with over 50% of ethnic minorities in 2001 born in the UK, country of birth is no 
longer a reliable indicator of ethnicity. 
1.4.1.5 Nationality 
Nationality was collected as part of the census between 1841 and 1961 before 
being abandoned. It was first collected in order to identify those of Scottish and 
Irish origin. However, following the mass inward migration of the 1960s the 
question caused confusion and data were difficult to collect. However, nationality 
and feeling like a member of the society in which you live are important parts of 
identity and have been recognised by the Office of National Statistics. The 2011 
census once again included a question about national identity, allowing individuals 
to choose from six categories: English, Welsh, Scottish, Northern Irish, British or 
Other, with space provided to capture free text.  
1.4.2 Limitations of common reporting categories 
Data from the census surveys are often banded together to create two broad 
categories referred to as the ‘White’ and ‘non-White’ or the more recently 
established ‘Black Minority and Ethnic Groups (BMEGs)’ and ‘Black, Asian and 
Minority Ethnic (BAME)’. Grouping data in this way means important differences 
between groups may be missed. For example, people of Irish, Polish, and European 
origin, would be lost amongst the majority White British population. These groups 
are known to have similar problems with health inequalities and inequities in access 
to healthcare as the non-White population and the need to identify these 
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communities is of equal importance (Aspinall, 1998). In other reports, the term 
‘White’ is used inconsistently and varies between contexts, sometimes it is used as 
above, referring to all people identifying themselves as ‘White’, but for a significant 
proportion it has been used to describe people of ‘White British’ origin only 
(Department of Health, 2009). 
The term ‘Black’ is often used without clarification of whether this refers to African 
or Caribbean communities. These communities differ from one another in terms of 
their migration history, religious tradition, culture and language (King’s Fund, 2006). 
African-Caribbean was abbreviated to Afro-Caribbean, however, this is no longer 
deemed acceptable and is considered to be an offensive term relating to hair 
texture (Department of Health, 2009).  
Bi-cultural terms such as ‘Asian’ or ‘Asian British’ are now used in many contexts 
including the British census (Aspinall, 2003). However, it is not clear whether ‘Asian’ 
refers to people originating from South Asia or East Asia.  In the UK, most would 
understand the use of the word to indicate someone originating from the Indian 
subcontinent. However, in the USA and Canada this term is used to indicate 
someone of East Asian origin. Caution needs to be exercised as members of the 
‘Asian’ communities vary dramatically in terms of their migration history, country of 
origin, education, social class, religion, culture and language.  
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1.4.3 The changing composition of the UK population 
In order to get a clearer picture of the UK population, the most accurate source of 
data were population surveys such as the census. The last census conducted in the 
UK was in 2011. However, as not all data had been released at the time of this 
write-up, I used data from both 2001 and 2011 to construct a picture of the ethnic 
minority population.  
The rapid growth of the non-white population since the passing of the British 
Nationality Act can be seen in Figure 1.1. The population figures for 1951 and 1961 
are estimates only, whilst the figures for 1971 and 1981 are based on country of 
birth data. An increase of 53% was observed between the non-White populations of 
2001 compared to 3 million in 1991. Calculations based upon UK population growth 
patterns predicted the non-white population would be between 6 and 7 million by 
the 2011 census (Commission for Racial Equality, 2007). This was exceeded with the 
non-White population reported to be over 7.5 million in England and Wales. 
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Figure 1.1: Growth of the Non-White population of Great Britain 
 
The 2001 census reported  6.5 million people in England and Wales identifying 
themselves as belonging to an ethnic minority group, this is inclusive of 4.5 million 
(8.7%) classified as belonging to a ‘non-white’ ethnic group (Office for National 
Statistics, 2001, Table 1.2). Over a third of all minorities were either ‘Asian’ or 
‘British Asian’, an additional 17.5% as Black or Black British (Table 1.3). Other 
Whites  were the largest group in 2001 accounting for 20.7% of the total minority 
ethnic population, followed by Indians  at 15.9% and the Pakistanis group at 11.0%.  
Table 1.2 also shows over 661,034 people in 2001 identifying themselves as of 
‘mixed’ origin and a further 219,754 who selected ‘other’, most probably because 
the existing choices did not fit their perception of their own identity. Data from the 
‘other’ categories of the 2001 census have shown approximately 4% of the 
population were unable or unhappy to choose their ethnic group from the available 
categories. ‘Other White’ was the largest of these groups, and 80% of the 1.3 
million people choosing this category were born overseas.  
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The most common ‘any other ethnic group’ entries were Arab (n=45027), Filipino 
(n=37590) and Middle Eastern (excluding Israeli, Iranian and Arab, n=37397) 
(Gardener and Connolly, 2005). White and Black Caribbean was the largest mixed 
ethnic group in 2001 (n=237,000) followed by White and Asian (n=189,000) and 
other mixed (n=155,000); White and Black Africans was the smallest (n=78,000) 
(Bradford, 2006). In total, there were over 80 additional entries suggesting that the 
16 census categories are inadequate to deal with the multi-ethnic fabric of the UK 
and more open-ended questions should be used (Aspinall, 2009). 
In comparison, data from the 2011 census showed the proportion of non-white 
minorities had increased to 14.1%, with an additional 4.4% identifying as Other 
White (Table 1.3). Indians remained the largest non-White group accounting for 
2.5%; however, the mixed group was the second largest group (2.2% in total) 
overtaking Pakistanis (2%).  
 The ethnic minority landscape in the UK has markedly changed over the last two 
decades.  The impact of this changing landscape on patients suffering with cancer 
will be explored. 
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Table 1.2 The England and Wales population by ethnic group, Census 2001 and 2011 
2001 n %  2011 n % 
White 47,520,866 91.3  White 48,209,395 86.0 
British 45,533,741 87.5  English/Welsh/Scottish/Northern Irish/British 45,134,686 
 
80.5 
Irish 641,804 1.2  Irish 531,087 
 
0.9 
    Gypsy or Irish Traveller 57,680 
 
0.1 
Any other white background 1,345,321 2.6  Any other White background 2,485,942 4.4 
Mixed 661,034 1.3  Mixed/multiple ethnic groups 1,224,400 2.2 
White and Black Caribbean 237,420 0.5  White and Black Caribbean 426,715 
 
0.8 
White and Black African 78,911 0.2  White and Black African 165,974 
 
0.3 
White and Asian 189,015 0.4  White and Asian 341,727 
 
0.6 
Any other mixed background 155,688 0.3  Any other Mixed/multiple ethnic background 289,984 0.5 
Asian or British Asian 2,500,685 4.8  Asian/British Asian 4,213,531 7.5 
Indian 1,036,807 2.0  Indian 1,412,958 
 
2.5 
Pakistani 714,826 1.4  Pakistani 1,124,511 
 
2.0 
Bangladeshi 280,830 0.5  Bangladeshi 447,201 
 
0.8 
Chinese 226,948 0.4  Chinese 393,141 
 
0.7 
Any other Asian background 241,274 0.5  Any other Asian background 835,720 1.5 
Black or Black British 1,139,577 2.2  Black/African/Caribbean/Black British 1,864,890 3.3 
African 479,665 0.9  African 989,628 
 
1.8 
Caribbean 563,843 1.1  Caribbean 594,825 
 
1.1 
Any other Black background 96,069 0.2  Any other Black/African/Caribbean 
background 
280,437 0.5 
Other Ethnic Groups 219,754 0.4  Other ethnic group 563,696 1.0 
    Arab 230,600 0.4 
Any other ethnic group 219,754 0.4  Any other ethnic group 333,096 0.6 
Non-White population 4,521,050 8.7  Non-White population 7,866,517 14.0 
All ethnic minorities 6,508,175 12.5  All ethnic minorities 10,941,226 19.5 
Total 52,041,916   Total 56,075,912  
 
1991 
 
  2001   2011   
Category n % Category n % Category n % 
White   White   White   
White 46,937,861 94.1 British 45,533,741 87.5 English/Welsh/Scottish/Northern Irish/British 45,134,686 
 
80.5 
   Irish 641,804 1.2 Irish 531,087 
 
0.9 
      Gypsy or Irish Traveller 57,680 
 
0.1 
   Any other white background 1,345,321 2.6 Any other White background 2,485,942 4.4 
   Mixed   Mixed/multiple ethnic groups   
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Table 1.3 The England and Wales ethnic minority population, Census 2001 and 2011 
2001 n %  2011 n % 
White 1,987,125 30.5  White 3,074,709 28.1 
British 45,533,741 n/a  English/Welsh/Scottish/Northern Irish/British 45,134,686 
 
n/a 
Irish 641,804 9.9  Irish 531,087 
 
4.9 
    Gypsy or Irish Traveller 57,680 
 
0.5 
Any other white background 1,345,321 20.7  Any other White background 2,485,942 22.7 
Mixed  10.2  Mixed/multiple ethnic groups 1,224,400 11.2 
White and Black Caribbean 237,420 3.6  White and Black Caribbean 426,715 
 
3.9 
White and Black African 78,911 1.2  White and Black African 165,974 
 
1.5 
White and Asian 189,015 2.9  White and Asian 341,727 
 
3.1 
Any other mixed background 155,688 2.4  Any other Mixed/multiple ethnic background 289,984 2.7 
Asian or British Asian  38.4  Asian/British Asian 4,213,531 38.5 
Indian 1,036,807 15.9  Indian 1,412,958 
 
12.9 
Pakistani 714,826 11.0  Pakistani 1,124,511 
 
10.3 
Bangladeshi 280,830 4.3  Bangladeshi 447,201 
 
4.1 
Chinese 226,948 3.5  Chinese 393,141 
 
3.6 
Any other Asian background 241,274 3.7  Any other Asian background 835,720 7.6 
Black or Black British  17.5  Black/African/Caribbean/Black British 1,864,890 17.0 
African 479,665 7.4  African 989,628 
 
9.0 
Caribbean 563,843 8.7  Caribbean 594,825 
 
5.4 
Any other Black background 96,069 1.5  Any other Black/African/Caribbean background 280,437 2.6 
Other Ethnic Groups  3.4  Other ethnic group 563,696 5.2 
    Arab 230,600 2.1 
Any other ethnic group 219,754 3.4  Any other ethnic group 333,096 3.0 
All ethnic minorities 6,508,175   All ethnic minorities 10,941,226  
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1.5 The cancer burden 
According to ‘Improving Outcomes: a strategy for cancer’, ‘every year around 
250,000 people in England are diagnosed with cancer and around 130,000 will die 
from the disease, making it the leading cause of mortality in people under the age 
of 75’. Currently, 1.8 million people are living with or beyond a cancer diagnosis 
(Department of Health, 2011).  
Cancer survival has improved greatly, since the early 1970s when only 28% survived 
beyond five years increasing to approximately 50% in more recent years. These 
improvements have been reported in the majority of the common cancers. Despite 
these changes, there are some groups for whom there is no evidence of having 
benefited from these improvements; ethnic minorities being one such group. 
Cancer registries initiated the collection of ethnicity data within the last few years 
and to date have obtained information through linkage with HES. Due to 
incomplete data, there has been little reliable information on the patterns of cancer 
incidence, mortality and survival, specific to the UK’s ethnic minorities. The source 
of evidence on inequalities stemmed from small scale studies, such as Bowen et al 
(2008), London Health Observatory (2004) and Farooq and Coleman (2005). 
Other members of society who have not benefited from the improvements in 
cancer survival include those living in deprived areas, although there is speculation 
that the overlap between these two groups is large. However, due to the gaps in 
ethnicity data there is patchy evidence reporting the correlation between ethnic 
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origin and deprivation. The Department for Work and Pensions (2001) reported 
approximately 66% of the Bangladeshi community to be living in low income 
households, and an estimated 50% of the Black Caribbean community. These 
figures were much higher when compared to 21% of the White population. 
Cancer risk is known to be increased by many of our lifestyles choices such as, 
smoking, excessive alcohol consumption, poor diet, obesity, lack of exercise and 
unprotected exposure to the sun (Gordon-Dseagu, 2008). People from ethnic 
minority backgrounds are more likely to practice ‘risky behaviours’, these are 
discussed in more detail below. 
1.6 Disparities in cancer risk factors by ethnic group 
1.6.1 Smoking status 
Smoking is a major cause of preventable cancer deaths. Tobacco is known to cause 
90% of lung cancer cases in the UK (Gordon-Dseagu, 2008). This risky behaviour has 
been shown to be more common in people from ethnic minority groups, for 
example, smoking rates were reported to be the highest in Bangladeshi males (44%) 
followed by Irish males (39%), compared to 27% in the general population. 
However, Bangladeshi women are more likely to chew tobacco (26%) than smoke 
cigarettes which is reported to increase the risk of head and neck cancers (White, 
2002). The General Household Survey of 2005, also reported elevated smoking 
rates in males and females of mixed background. Rates remained highest in the 
Bangladeshi group at 45%, followed by males of ‘White and African’, and ‘Other 
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Mixed’ origin at 38% and 39%, respectively. In females, ‘White and Asian’ women 
were found to have the highest rate of smoking at 33%, second to those of ‘White 
and Black Caribbean’ origin with 29%.  
The Health Survey for England 2004, which focused on the health of minority ethnic 
groups, also reported the use of chewing tobacco and found rates to be 
approximately 9% in Bangladeshi males and 16% of females (The Information 
Centre, 2006). Paan or ‘betal leaf chew’ originates from South East Asia and is 
commonly used as a breath freshener, palate cleanser and believed to aid 
digestion. There are many varieties, but usually consist of mixed spices such as 
cardamom and anise, lime paste, grated coconut, nuts, small piece of sweets and 
often tobacco. The concoction is wrapped in betal leafs and chewed but not usually 
swallowed. A small study by (Williams, 1999) found 78% of Bangladeshis to chew 
paan, with women chewing more frequently and more likely to add tobacco.   
1.6.2 Diet 
Diet can have an effect on the risk of cancers in the bowel, stomach, head and neck 
as well breast and prostate with an estimated third of deaths from cancer are 
related to diet (Gordon-Dseagu, 2008). Poor diet, with a high fatty and sugary 
content combined with a lack of exercise have seen the obesity rates soar in many 
countries all over the developed world. The 2004, Health Survey for England 
revealed many ethnic minority  communities to have a higher consumption of five 
or more portions of fruit and vegetables a day than the general white population. 
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Approximately, 42% of Chinese women, 36% of Indian women and 40% of Chinese 
and Indian men consumed five or more portions of fruit and vegetables a day, 
compared to 23% of men and 27% of women in the general population. However, 
this was not true of all ethnic groups; consumption rates were lower than in the 
general population for Irish males (26%) and Bangladeshi females (28%). Further to 
this, the survey also found a significantly increased amount of salt used in the 
preparation of food but fat consumption was shown to be lower than that of the 
general population for all ethnic groups.  
1.6.3 Alcohol consumption 
A relationship between excessive alcohol consumption and cancers of the mouth, 
larynx, oesophagus, liver, breast and bowel has been documented, accounting for 
an estimated 6% of cancer deaths (Cancer Research UK, 2008). According to the 
Health Survey of England 2004 (The Information Centre, 2006) all ethnic minorities 
are less likely to drink alcohol than the general population, with the exception of 
the Irish community. 71% of Irish men and 53% of Irish women were more likely to 
exceed recommended alcohol limits. Large proportions of other ethnic groups are 
likely to identify themselves as non-drinkers (Gordon-Dseagu,2008).  
1.6.4 Exercise 
Inadequate levels of exercise have been reported to be responsible for 
approximately 5% of all cancer deaths (Colditz et al, 1997, Wolin et al, 2009). 
Increased risk associated with a lack of exercise has been shown in colon and breast 
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cancer, links have also been reported with cancers occurring in the womb, lung and 
prostate. Levels of exercise were found to be particularly low in males and females 
of Pakistani and Bangladeshi origin, with many taking less than 30 minutes of 
moderate exercise a week (The Information Centre, 2006).  
1.6.5 Obesity 
Lack of exercise and poor diet have contributed to the increased rates of obesity 
which are known to increase the risk of many diseases including cancer. Cancer 
Research UK (2006) stated “13,000 cases of cancer could be prevented each year in 
the UK if no one had a BMI greater than 25”. The risk of breast cancer has been 
reported to increase by up to 30% in post-menopausal obese women (Lahman et al, 
2004, Van Den Brandt et al, 2000). In colon cancer this risk increased by 
approximately 25% in men falling into the overweight category and by 50% for 
those in the obese category (Moghaddam et al, 2007).  
According to a recent report by the National Obesity Observatory (Gatineau and 
Mathrani, 2011) which included data from  the ‘Health of Minority Ethnic Groups 
Survey’ conducted by the Department of Health (2005) obesity rates were found to 
be the highest in women of Black African and Black Caribbean origin followed by 
women of Pakistani origin (38%, 32% and 28% respectively, compared to 23% of 
women from the general population. In contrast, obesity rates were lower in men 
of Bangladeshi and Chinese background (6% and 6% respectively) when compared 
to 23% of men from the general population.  
23 
 
1.7 Variations in cancer incidence, mortality and 
survival by cancer site and ethnic group 
Up until the recent publication by the National Cancer Intelligence Network (NCIN) 
on ‘Cancer incidence and survival by major ethnic group, England, 2002-2006’ 
cancer statistics by ethnic group were unavailable (NCIN, 2009). This document 
reporting national figures is the first of its kind, but nevertheless is based upon 
incomplete data. Ethnicity was reported to be missing/unobtainable for 
approximately 25% of cancer registrations used in the analysis, and the findings are 
presented for broad ethnic categories only. Despite its limitations the data shows 
people of Asian, Chinese, and Mixed origins to unanimously be at lower risk of 
developing cancer when compared to the general White population. In spite of this, 
Asians were found to have higher rates across three cancer sites (liver, head and 
neck and cervical) but were at lower risk of developing the four most common 
cancers (breast, prostate, lung and colorectal). 
Overall, the Black group were reported to have higher rates of prostate, stomach, 
liver and multiple myeloma, but had lower rates of the three common cancers 
(breast, lung and colorectal).    
1.7.1 Cancers of the head and neck 
Females of South Asian origin were shown to have a statistically significant 
increased rate of mouth cancer; this difference remained true after adjusting for 
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age. However, there was some evidence to suggest a trend in males of South Asian 
origin having a lower risk than in the general white population (NCIN, 2009).  
1.7.2 Breast 
Bowen et al (2008) reported a difference in the age and type of breast cancer in 
women of African and West Indian origin living in the UK. This was a small study 
and the validity of the findings have been questioned. The research concluded 
women of African and West Indian origin were diagnosed on average 21 years 
younger than the White British population. Furthermore, the cancer was reported 
to be a more aggressive form (triple negative), known to be unresponsive to 
conventional drugs, hence resulting in poorer survival. These women will also fall 
under the standard screening age bracket of 50 to 70 years. However, women with 
a strong family history can request screening from the age of 40. Data from the 
NCIN report, 2009 show survival of Black women with breast cancer aged 15-64 was 
reported to be 85% at three years compared to 91% in the general population. No 
differences were found when considering those aged 65 or over or when combining 
age groups.  
In contrast, Farooq and Coleman (2005) who also reported differences in breast 
cancer by ethnic group have shown women of South Asian origin to have a lower 
incidence of breast cancer than the general White population. There was also some 
evidence to suggest survival may be different in this group. The NCIN (2009) 
reported three year survival from breast cancer to be significantly reduced in South 
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Asian women between the ages of 16-64 years, but no differences were detected in 
those aged 65 years and over.  
According to the Breast Cancer Care Policy Briefing (2005) 32% of women of ethnic 
background knew little about breast cancer, 43% reported never checking their 
breasts for lumps, 56% of those who performed examinations reported not 
knowing what to look for, and only 38% considered a lump to be symptomatic of 
breast cancer. The briefing also reported a lack of uptake of breast screening, with 
45% of women of screening age having never attended screening.    
1.7.3 Prostate 
Prostate cancer incidence and mortality amongst men of Black Caribbean and 
African origin is reported to be dramatically higher, with rates up to three times 
higher than that of the general population (Prostate Cancer Charter for Action, 
2005). Rates are also shown to be elevated in other ethnic minority groups, 
however, these are to a lesser extent. The NCIN 2009, data confirmed the elevated 
risk in males of black origin and reported risk ratios between 1.1 and 3.4 by age 
group (<65 years and >=65 years respectively) compared to white males.  
In the USA, the recommended age for prostate cancer screening has been lowered 
from the standard age of 50 to 40 years in the Black American population (BBC 
News, 2001). In the UK, a survey of men of African Caribbean background 
conducted in Birmingham found 22% of men did not know where the prostate 
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gland was and a further 50% did not know the function of the gland (Ethnic 
Minority Cancer Awareness Week, 2008).  
1.7.4 Liver 
The risk of liver cancer was estimated to be between 1.5 and 3 times higher in the 
South Asian population when compared to the general population. This difference 
remained true across gender, and age group (<65, ≥65) (NCIN, 2009). These data 
also pointed to an increased rate of liver cancer in males and females of black 
origin.  
1.7.5 Cervical 
Females of South Asian origin were found to have a significantly higher risk of 
cervical cancer compared to women from the general population. However, this 
pattern was only apparent in women of 65 years or over and was lost when 
combining with women <65 years (NCIN, 2009). This same pattern was observed 
but to a lesser extent in women of black origin aged 65 or over. 
1.7.6 Other disease areas 
Other diseases areas where marked differences in incidence/prevalence rates by 
ethnic group have been reported include diabetes, coronary heart disease, obesity, 
and mental illness.  
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There is a wealth of evidence reporting a higher incidence of non-insulin dependent 
diabetes in South Asians and Black Caribbean groups (Aspinall and Jacobson, 2004). 
This difference is also reflected in diabetes associated mortality, with patients of 
both Caribbean and South Asian origin 3.5 times more likely to die from causes 
related directly to their disease. In addition to the higher incidence, there are also 
reports suggesting onset of disease may also be earlier in South Asians compared to 
the White population. 
Diabetes is also thought to be a risk factor for Coronary Heart Disease (CHD) and 
could explain the excess reported in South Asians. Despite the evidence showing an 
unequal burden of diabetes Aspinall And Jacobson (2004) stated “non-insulin 
dependent diabetes remains undiagnosed in up to 40% of Asian diabetics and 
several studies report inadequate quality of health care for Asian and African-
Caribbean diabetics and poor compliance arising from patients’ lack of knowledge 
about the disease and its management through the inappropriateness of health 
information”.  
1.8 Randomised Controlled Trials (RCTs) 
1.8.1 What is a randomised controlled trial? 
Clinical trials are the gold standard in medical research to test the efficacy and 
safety of new drugs, procedures or treatments. Many phase III clinical trials also 
include health economics and Quality of Life components. It is important for trials 
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to recruit a representative population in order to ensure external validity so the 
findings can be extrapolated to the population of interest. 
Low participation rates in cancer trials led to the inception of the National Cancer 
Research Network (NCRN) in 2001. The network comprised of 32 local research 
networks and 700 staff. Over 330,000 cancer patient have taken part in clinical 
trials since its establishment. 
1.8.2 Under-representation of ethnic minorities in clinical 
trials 
There is some evidence to suggest clinical trial participants have better outcomes 
than non-trial participants with patients benefiting from a systematic treatment 
schedule as opposed to a clinician determined schedule (Karjalainen and Palva, 
1989).  Participating in a trial can offer closer monitoring and management of 
disease and extra follow-up for all trial participants. Excluding ethnic minority 
groups from clinical trials not only raises issues in terms of extrapolation of the 
results, but also in the equity of access to clinical trials.  Published articles rarely 
report exclusion criteria but the ability to speak English had been an eligibility 
criteria for many trials in the past (Murray and Buller, 2007). A review of clinical 
trial exclusion criteria reported many trials excluded ethnic minorities without 
clinical or scientific justification (Britton et al, 1999). The majority of trial 
participants have been reported to be white middle-class men (Killien et al, 2000). 
This contradicts the government’s NHS plan, which aimed to tackle inequalities and 
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provide culturally appropriate and accessible healthcare for all (Department of 
Health, 2005). If there is no scientific rationale for the exclusion of ethnic minorities 
from clinical trials this could indicate a form of discrimination or institutional racism 
as indicated by the Macpherson report (1999). 
Events such as the Tuskagee experiment conducted between 1932-1972 and the 
thalidomide tragedy of the 1960s led to the creation of policies to protect 
vulnerable groups such as women (particularly of child bearing age) and ethnic 
minorities in research. It was in 1993, after concerns were raised regarding the 
mass exclusion of women and ethnic minorities from research and the applicability 
of results to these populations that resulted in a change in US government policy 
(National Institute for Health, 2001). The National Institute of Health Revitalisation 
Act 1993, requires all research funded by the USA NIH to include a representative 
sample of women and ethnic minorities unless there is a clinical or scientific reason 
for exclusion.  
Under-representation of ethnic minorities in clinical trials means that results cannot 
be extrapolated to the whole population. It is known that pharmacodynamics, 
pharmacokinetics and now pharmacogenomics, can vary by ethnic group, as well as 
there being differences in disease characteristics (Krecic-Shepard et al, 2000, 
Yasuda et al, 2008, O’Donnell and Dolan, 2009). Ethnic differences have been 
reported in the effects of chemotherapy for several drug classes, such as 
antimetabolites, anthracyclines and alkylating agents (O’Donnell and Dolan, 2009).    
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Underlying differences such as this will continue to be of clinical importance despite 
the increasing acculturation of current ethnic minorities groups. Additionally, 
interactions between environment, genetics and culture are also known to play a 
part in drug metabolism (Matthews, 1995). Differences in health behaviours have 
also been reported to vary between ethnic groups stemming from cultural, religious 
and socio-economic factors making it equally important to recruit representative 
samples in non-drug trials (Gatineau and Mathrani, 2011). 
1.8.3 Barriers to participation 
Hussain-Gambles (2004) reviewed the literature and found the key motivations for 
participating in clinical trials were altruistic factors, benefits to own health, effective 
follow-up, clinician influence, communication style of doctor/nurse and satisfaction 
with previous experience.  Barriers to patient participation included the additional 
demands on the patient (e.g. extra procedures and appointments, travel, childcare 
costs and similar), geographical location of the study site, complexity of protocol, 
patient having preference for a particular treatment or no treatment, listed side-
effects of drugs, fear of experimentation, poor comprehension of clinical trials, 
distrust of hospital or medicine, process of gaining consent and socio-cultural 
aspects. However, barriers to participation reported by ethnic minorities differed 
somewhat to include: 
 Mistrust 
 Language 
 Cultural barriers 
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 Importance of family 
 Gender 
 Health beliefs 
 Modesty 
 Religion 
 Age 
 Geographical location 
 Lack of familiarity/lower awareness of trials 
 Socio-economic barriers 
In a review of barriers to clinical trial accrual for under-represented populations 
(defined as ethnic minorities, the elderly population, rural residents and those of 
low socioeconomic status) Ford et al (2008) categorised barriers into three groups 
as follows: 1) clinical trial awareness, 2) opportunities to participate and 3) the 
acceptance of enrolment, or in other words reasons for choosing not to participate. 
The results revealed the barriers relating to the opportunity to participate to be 
most frequently reported. Opportunity barriers included older age, ethnicity and 
race, no/low health insurance and exclusions based upon co-morbidities.    
1.9 Addressing health inequalities 
“The NHS is under a legal and moral obligation to provide services to all people who 
need them, regardless of the gender, age or ethnic background” (quoted from the 
Kings Fund: Access to healthcare and minority ethnic groups briefing, 2006). In fact, 
it is the duty of all public authorities, including the NHS to comply with the Race 
Relations Amendment Act 2000 now the Equality Act 2010. The government clearly 
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justifies the need for action in the Department of Health’s Race Equality Scheme 
2005-2008 (Department of Health, 2005a). It states “the NHS increasingly needs to 
take into account not only cultural and linguistic diversity but also needs to be able 
to cater for varying lifestyles and faiths”. This suggests providing a service that is 
more responsive to the needs of individual patients. The scheme also identifies 
issues of health inequalities and inequities in access to service by ethnic group as 
cause for action.  
Gill et al (2007) in his needs assessment of ethnic minority groups says: “In the past, 
data on minorities groups have been presented to highlight differences rather than 
similarities. The ethnocentric approach, where the ‘white’ group is used as the 
ideal, and partial analyses are made of a limited number of disorders, has led to a 
misinterpretation of priorities. Ethnic minorities have similar patterns of disease 
and overall health as the ethnic majority. There are a few conditions for which 
minority groups have particular health needs, such as the haemoglobinopathies”.    
The 2004 Health survey for England built upon information obtained from the 
previous survey of 1999, with an increased number of households in order to boost 
the numbers of ethnic minority respondents, of the Black African population in 
particular. The data collected included interviews with a total of 12,644 adults over 
the age of sixteen, 5,828 from the general White British population and 6,816 from 
ethnic minority groups.  
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Self-reported data consistently shows some ethnic minority groups reporting 
poorer health than others, for example, in the 2004 Health Survey of England, 15% 
of Bangladeshi males described the state of their health as “bad or very bad” 
compared to 6% in the White British population. In contrast, males of Chinese and 
Black African origin report their state of health as better than that of the general 
population (The Information Centre, 2006).  
1.9.1 Policies requiring or encouraging ethnicity data collection 
The Race Relations Act was passed in 1976 criminalising racial discrimination in the 
work place and service delivery, and defines direct and indirect discrimination. The 
Race Relations (Amendment) Act 2000 placed key public bodies (including all 
government departments) under statutory duty to promote race equality which 
meant public authorities had to take steps to eliminate unlawful discrimination and 
promote equality of opportunity. The recent Equality Act 2010 harmonised and 
strengthened existing legislation to create a super act, making it criminal to 
discriminate or unfairly treat individuals on the grounds of nine protected 
characteristics, one of these being race (Equality and human rights commission, 
date of access 23/07/13. http://www.equalityhumanrights.com/legal-and-
policy/equality-act/). Public authorities, such as the NHS, are required to make 
evident their compliance to the above legislation by publishing data and setting 
clear objectives for the future (Home Office, 2010). 
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1.10 Implications for this thesis and future research 
Ethnicity data collection, analysis and use are complex but needed to determine if 
ethnic minorities are adequately represented in RCTs. The under-representation of 
ethnic minorities in clinical trials prevents the findings of clinical trials being 
generalised to the whole population and violates government polices promoting 
equality in opportunity and access to clinical trials.  
The aims and objectives of the thesis stemmed from the challenges in ethnic 
minority data collection and analysis outlined above.   
1.11 Aim and objectives 
The aim of this thesis is to investigate ethnicity data collection in healthcare and the 
representation of ethnic minorities in RCTs, also to identify interventions to 
improve ethnic minority recruitment into RCTs and identify barriers to 
participation. This aim will be addressed through the following objectives: 
Objectives   
 Exploration of the UK ethnic minority population and how this has changed 
over 10 years 
 Literature review of methods, interventions and barriers addressing the 
collection of ethnicity data in primary and secondary care 
 Evaluation of the perceptions, experiences and willingness of lay South 
Asian volunteers to provide ethnicity data in healthcare situations 
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 Evaluation of health care professionals’ perceptions and experiences of 
collecting ethnicity data in primary and secondary care 
 Literature review of interventions to improve the recruitment and retention 
of ethnic minorities into RCTs 
 Examining local datasets to assess completeness of ethnicity data collection 
and assess the representation of ethnic minority patients in RCTs utilising 
data from Hospital Episode Statistics and a Cancer Research Network 
 Assess barriers to non-participation by ethnic group for cancer patients 
using Cancer Research Network data 
The thesis consists of ten chapters. Chapter One has set out the background 
information and consequent challenges, building up to the aims and objectives. 
Chapter Two describes the methodology used throughout the thesis in order to 
address the specified aims and objectives. Chapter Three describes the changing 
composition of the ethnic minority population. Chapters Four, Five and Six focus 
upon ethnicity data collection and were conducted as part of the CRUK 
commissioned CanEth project. More specifically, Chapter Four reports the results of 
a systematic review of improving ethnicity data, Chapters Five and Six explore 
barriers to ethnicity data collection from a participant and healthcare professional 
perspective, respectively. This is followed by two chapters concerned with the 
participation of ethnic minorities in clinical trials. Chapter Seven explores the 
literature for interventions to improve ethnic minority participation in RCTS, whilst 
Chapter Eight reports the completeness of locally collected ethnicity then uses the 
data to ascertain whether under-representation is an issue in an ethnic minority 
rich Cancer Research Network (CRN). Chapter Nine describes my journey of 
establishing ethnicity data collection alongside trials recruitment data and explores 
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barriers to participation using the newly collected ethnicity data. To round off 
Chapter Ten discusses the research in its entirety, reports conclusions, limitations, 
further work and reflections.   
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Chapter 2 Summary of methods 
The topics covered in this thesis were addressed from several different angles using 
a mixed methods approach. Quantitative, qualitative and epidemiological 
approaches were needed to tackle this undeveloped area of research, summarised 
below: 
1. Two systematic literature reviews 
 Ethnicity data collection 
 Interventions to increase ethnic minority participation in RCTs 
2. Two surveys 
 Healthcare professional’s perceptions of ethnicity data collection 
 Reasons for choosing not to participate in a RCT by ethnic group 
3. Five focus groups 
 With lay volunteers from the South Asian community 
4. Exploration/analysis of datasets:  
 Census 2001 and 2011  
 Hospital Episode Statistics (HES) inpatient and outpatient  
 Cancer Research Network (CRN) trial recruitment data 
 CRN reasons for non-trial participation by ethnic group data 
Further details of each method and their use are detailed as follows in this chapter. 
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2.1 Systematic literature reviews 
I gained experience of systematic literature reviews in an earlier project exploring 
barriers and attitudes to participation in clinical trials (Ward et al, 2000). I learnt 
about literature searching and was able to replicate the original search strategy at a 
later date to capture more recent publications. Advice and guidance on systematic 
reviews, search strategy, terms, indexed subject headings and databases were 
provided by the Cochrane Methodology Review group, Warwick Centre for 
Evidence in Ethnicity Health and Diversity (CEEHD) specialist librarians and 
University of Warwick academic support librarian for biomedical sciences. Prior to 
commencing the reviews the following databases were checked to ensure this 
review had not already been conducted: 
  Cochrane Database of Systematic Reviews (CDSR) 
 Database of Abstracts of Reviews of Effects (DARE) 
 TRIP database (clinical search engine) 
 National Research register (this includes information about on-going 
reviews) 
 Centre for Reviews and Dissemination (CRD) search filter with Medline 
(http://www.york.ac.uk/inst/crd/search.htm) 
I attended systematic literature review training provided by the Cochrane 
Methodology Review group and the Centre for Review and Dissemination in York. 
These included methods by which the literature was identified, reviewed, extracted 
and quality checked. 
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The PICOS (Population, Interventions, Comparators, Outcomes and Study designs) 
framework was used to formulate the review questions by clarifying the scope of 
the review and devising the search strategy as follows: 
 P=population or participants 
 I=Intervention been trialled 
 C=comparator between two or more alternatives 
 O=Outcomes, quantitative or qualitative 
 S=Study designs 
Electronic databases were identified and search terms explored and developed 
using indexed subject headings and exploding key words. This process was 
performed for each database independently due to the variability of indexed 
subject headings per database. Keywords from relevant publications were also 
explored (Table 2.1). Adherence to the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) reporting guidelines ensured the reviews 
would be high quality and worthy of publication in peer reviewed journals. 
Table 2.1 Search strategy development 
1 The research question was broken down into component parts/concepts 
2 A list of search terms for each concept was created through the use of 
synonyms, abbreviations, differences in spelling (transatlantic differences), 
identification of related terms 
3 Exploding MeSH headings, trees helped develop the concepts and the list of 
search terms (indexed subject headings)  
4 Use of truncation and wildcards 
5 Relevant search terms for each concept were combined using operators: OR, 
AND, NOT 
6 Limits applied included articles written in English, restricted articles about 
humans, and articles published between selected time points  
 
40 
 
2.2 Surveys 
The survey method was used to gather the views of 1) health care professionals on 
ethnicity data collection and 2) ethnicity information and reasons given by cancer 
patient’s choosing not to participate in a clinical trial. Both questionnaires were 
designed to be anonymous.  
The healthcare professionals’ survey was conducted as part of the CRUK Cancer and 
Ethnicity (CanEth) project and approved as part of the task by South Birmingham 
Ethics committee. The questionnaire was developed based upon a previous version 
by CEEHD at the University of Warwick and benefited from review by the CanEth 
project team. Perspectives of collecting ethnicity data were collected from both 
qualitative and quantitative angles.  
A survey of cancer patients who declined participation in clinical trials was 
conducted in collaboration with a cancer research network. Questionnaires were 
developed jointly by me and the cancer research network team. Questions included 
basic information, such as gender, age group and disease site, as well as ethnicity 
data and an open ended question asking why the patient chose not to participate in 
the clinical trial.  
2.3 Focus groups 
The perceptions, experiences and willingness of South Asian volunteers to provide 
ethnicity data in primary and secondary care were explored through a series of 
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focus groups in the native language of each group and English where specified. 
Focus groups maximise interaction and debate between participants, and are a 
widely accepted method of gathering data to evaluate services, needs assessment 
and to conduct exploratory research in new areas (Schneider and Palmer, 2002). 
This research was conducted in collaboration with the Mary Seacole research 
centre at De Montfort University and the Ethnic Health Forum in Manchester as 
part of the CRUK CanEth project, using trained bilingual facilitators.  A topic guide 
was developed as well as information sheets and consent forms and were granted 
ethical approval as part of the CanEth project. The facilitators used the topic guide 
which was specifically developed to focus on the five key areas of interest:  
1. General opinions on the collection of ethnicity information 
2. Experiences of providing ethnicity information 
3. Categories used in practice 
4. Language, religion and culture 
5. How information should be collected 
All sessions were recorded and transcribed by the trained facilitators.  
Data generated by the focus groups were analysed by hand using a qualitative 
thematic approach. Data from the transcripts were examined, the accounts 
compared with one and another and common themes identified. Themes were 
developed and discussed by the project working group. 
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2.4 Datasets 
I analysed four datasets as part of this thesis including census data, HES data from a 
large teaching hospital, clinical trials recruitment and reasons for non-participation 
data from a cancer research network.  
Analysis of population level data was used to explore the structure of the ethnic 
minority population by age and gender for 2001 and 2011. I commissioned a 
dataset from Office for National Statistics (ONS) who collated information from the 
England and Wales, Scottish and Irish censuses of 2001. The dataset comprised of 
population counts by ethnic group, country of birth, age and gender. I used 
Microsoft Excel to analyse the data and calculated proportions of each ethnic group 
born within or outside of the UK. This was completed for each five year age band 
and gender with the resulting data used to construct population pyramids by ethnic 
group. The census data were used to assess the composition of ethnic minorities 
within the UK and West Midlands. The plots were then compared to existing 
population pyramids based upon 1991 census data to explore changes in the ethnic 
minority population (Owen 1996).  
HES in and outpatient data were analysed using SAS statistical software (SAS 
Institute, Cary, NC) to assess quality and completion of ethnicity data across 
datasets. Further to this, I examined International Classification of Diseases version 
10 (ICD-10) codes to identify disease sites and amalgamated smaller sites into the 
broader disease categories. Data from the inpatients and outpatients were merged 
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in SAS to form a final dataset which was used to calculate rates of cancer diagnoses 
by ethnic group.  
Representation of ethnic minority patients in clinical trials was assessed using 
recruitment data from a cancer research network. Information from the analysis of 
the HES data described above was used to form a denominator for this purpose. 
Analyses were performed using Microsoft Excel with proportions of patients being 
recruited or not participating presented. Reasons for non-participation were further 
analysed using a qualitative thematic approach which I performed by hand.  
This chapter provides a summary and justification of each method, more detail is 
provided in subsequent chapters. Chapter Three presents data from the analyses of 
the 2001 Census.  
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Chapter 3 The changing structure of the UK 
ethnic minority population 
The aim of this chapter is to provide an overview of the ethnic minority population 
in the UK and illustrate how the age structure of the ethnic minority groups has 
changed over 10 years by comparing it to data from 1991 census. Only basic 
information has been presented from the 2011 census as only limited data were 
available at the time of writing this thesis.  
3.1 Census 2001 
Ethnicity data available in the 2001 census were explored by age, gender, country 
of birth and nationality, language, religion and geographic distribution of ethnic 
minorities.  
3.1.1 Age structure 
As expected the non-White population of the UK was younger than the White 
population. This can be explained by the timing in which these groups migrated to 
the UK and higher birth rates in these groups (Figure 3.1). The ‘mixed’ group was 
considerably younger than all the other groups with approximately 50% being 
under 16 years of age. This was followed by 38% under 16 years in the Bangladeshi 
and Other Black groups compared to 20% in the White group (Office for National 
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Statistics, 2006). The Chinese are the only non-White population with an ‘under 16 
years’ group smaller than the White British group. All ethnic minority groups have a 
distinctly smaller older population (65+ years) than the White population which ties 
in with the passing of the British Nationality Act in 1948, 53 years previous. An 
increase in the older non-White populations is expected in the future, however we 
may need to adjust for ‘salmon-bias’ (which refers to people returning to their 
country of origin post retirement, Bhopal, 2007).  
Figure 3.1 Age distribution by ethnic group, 2001/2002 
 
(Source: Census, April 2001, Office for National Statistics; Census, April 2001, 
General Register Office for Scotland) 
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3.1.2 Gender 
In the White population women outnumber men in the older age brackets (65 years 
plus) due to differences in life expectancy and mortality rates. In 2001, this was 58% 
vs. 42% respectively (Figure 3.2). The same pattern was also apparent in Mixed and 
Chinese groups but was reversed in the Bangladeshi, Pakistanis and Other Asian 
groups with 34%, 45% and 48% females respectively (Office for National Statistics, 
2006). The assumption that there are more South Asian male immigrants than 
females could explain this anomaly.  
 (Source: Census, April 2001, Office for National Statistics; Census, April 2001, 
General Register Office for Scotland) 
Figure 3.2 Sex distribution of people 65 & over: by ethnic group, April 
2001, GB 
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3.1.3 Country of birth and nationality 
Country of birth and nationality differ from one another for two important reasons. 
Firstly, people over the age of 18 years, who were born abroad and have been living 
in the UK for a minimum of 5 years, are eligible to apply for British Citizenship (UK 
Border Agency). This period was reduced to three years where an individual is 
married to a British citizen. Secondly, people born abroad can have British 
nationality; this is often the case of children born to parents serving in the military. 
In 2007, 266,000 people reported Germany as their country of birth, even though 
70% of these were UK nationals (Ellis, 2009).  
Reports based on the Annual Population Survey show the non-UK born population 
between 2004 and 2007 to have increased by estimated 1.1 million. The largest 
group in both 2004 and 2007 accounting for approximately 10% were born in India. 
The population born in Poland rose sharply from 95,000 in 2004 to 405,000 in 2007. 
Poland joined the European Union along with eight other Central and Eastern 
European countries in May 2004, which could explain this increase, see Table 3.1.  
Table 3.1 Five most common non-UK countries of birth in the UK, 2004 
and 2007 (thousands) 
 2004 2007 
Country Estimate Country  Estimate 
1 India 502 India 613 
2 Republic of Ireland 452 Republic of Ireland 420 
3 Pakistan 281 Poland 405 
4 Germany 275 Pakistan 377 
5 Bangladesh 225 Germany 266 
(Source: Office for National Statistics, Populations trends, Spring 2009) 
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3.1.4 Language 
Language was not available in the 2001 census, however, results from the ‘Health 
Survey of England-the health of minority ethnic groups’ showed only 20% of 
Bangladeshis reporting English as their main language, the majority of these being 
British born or young migrants (Department of Health, 1999). Groups most likely to 
speak English were young males or people who had attained some level of 
education, over 50% of Bangladeshi men and women reported not holding any 
qualifications. A survey reported large proportions of non-White ethnic groups to 
be below what was referred to as a “survival level of competence”, defined as the 
ability to read a phone book or school report (Carr-Hill et al, 1996). Rates were 
lowest amongst the Bengali group, with only 14% of those not born in the UK 
attaining this level. This level improved in the Punjabi (26%) and Gujarati groups 
(29%). The Chinese group were reported to have the highest rate, with 49% 
reaching the “survival level of competence”. 
3.1.5 Religion 
Religion was included for the first time as an optional question in the 2001 UK 
Census. Almost 8% of the population did not respond to this question (Office for 
National Statistics, 2005). Of those who responded, the majority (72%) of the White 
British population classified themselves as Christians; proportions were similar for 
the Black Caribbean group (74%) and Black African groups (69%) but lower in the 
Mixed group (52%,  see Figure 3.3). Approximately, 15% of the population classified 
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themselves as having ‘no religion’, of these 53% were of Chinese ethnicity and 23% 
of Mixed ethnicity. Only a small proportion of Pakistanis and Bangladeshis classified 
themselves as having ‘no religion’ (0.56% and 0.45% respectively).  
Muslims made up the largest non-Christian group with 52%, followed by Hindus 
(18%), Sikhs (11%), Jews (9%) and Buddhists (5%). A large proportion of the Muslim 
group comprised of people originating from South Asian countries, such as Pakistan 
and Bangladesh (where 90% of the population identify as Muslim). In addition, 20% 
of Black Africans and Other ethnic groups classified themselves as Muslim.  
Figure 3.3 Religious composition of ethnic groups in England, Scotland 
and Wales, April 2001 
 
Sources: Census, April 2001, Office for National Statistics; Census, April 2001, 
General Register Office for Scotland 
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3.1.6 Geographic distribution of the ethnic minority population 
in the UK 
In 2001, 96% of the non-White ethnic population were reported to reside in the 
busy urban areas of England, pre-dominantly London, West Midlands, West 
Yorkshire and Greater Manchester. London as the capital was appealing to many 
immigrants and was home to 45% of the non-White population, 11% resided in the 
West Midlands and 5% in West Yorkshire and Greater Manchester. Migrants of 
Pakistani origin were well dispersed between the four regions, with 19% in London, 
21% West Midlands, 20% Yorkshire, 16% Greater Manchester. In contrast, the 
Bangladeshi and Indian populations were concentrated in London (54% and 40% 
respectively) (CRE, 2007, Office for National Statistics, 2001). Furthermore, London 
was inhabited by large proportions of other ethnic minority groups, for example, 
61% of the Black Caribbean population and 78% of Black Africans. 
3.2 Commissioned census 2001 dataset 
A dataset containing ethnic group and country of birth by age and sex was 
commissioned for the UK through the ONS. Information from the England and 
Wales, Scotland and Northern Ireland 2001 censuses were collated by ONS. 
Ethnicity codes varied in each country but there was considerable overlap (Table 
3.2). Ethnic group codes were harmonised to create 11 ‘UK’ ethnicity groups which 
were used in the analyses (Table 3.3).  
51 
 
Age data were split into five year bands from 0 to 84, with ages 85 and over 
combined into a single category. Country of birth was split into a binary category 
(UK born and non-UK born). Data were available for the UK and broken down to 
local authority level for England and Wales.  
Table 3.2 Ethnic group categories for 2001 census by country 
England And Wales Scotland Northern Ireland 
01 British 01 White Scottish 01 White 
02 Irish 02 Other White British 02 Irish Traveller 
03 Other White 03 White Irish 03 Mixed 
04 White and Black Caribbean 04 Other White 04 Indian 
05 White and Black African 05 Any Mixed Background 05 Pakistani 
06 White and Asian 06 Indian 06 Bangladeshi 
07 Other Mixed 07 Pakistani 07 Black Caribbean 
08 Indian 08 Bangladeshi 08 Black African 
09 Pakistani 09 Other South Asian 09 Other Black 
10 Bangladeshi 13 Chinese 10 Chinese 
11 Other Asian 10 Caribbean 11 Other Ethnic Group 
12 Black Caribbean 11 African 12 Other Asian 
13 Black African 12 Black Scottish or Other Black  
14 Other Black 14 Other Ethnic Group  
15 Chinese   
16 Other Ethnic Group   
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Table 3.3 Harmonising ethnicity categories to create UK ethnic groups 
code 
UK ETHNIC GROUPS EW Codes used NI Codes used S Codes used 
White 01; 02; 03 01; 02; 03; 04 01; 02 
Mixed 04; 05; 06; 07 05 03 
Indian 08 06 04 
Pakistani 09 07 05 
Bangladeshi 10 08 06 
Other Asian 11 09 12 
Black Caribbean 12 10 07 
Black African 13 11 08 
Black Other 14 12 09 
Chinese 15 13 10 
Other    16 14 11 
(Office for National Statistics, 2013) 
Once the ethnic codes were collated and data tables constructed by ONS, I was able 
to use these data to explore the population structure of UK ethnic minorities.  
3.2.1 Population pyramids 
Population pyramids of the age and gender structure of the UK were constructed 
for grouped populations, such as all the UK, Whites and non-White minorities as 
well as for ethnic minority groups independently. Proportions of male and female 
populations were calculated according to country of birth and displayed in five year 
age bands with the youngest at the base and the oldest at the top. Births outside of 
the UK are presented as dark shading.  
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The population structure of the whole population and the White group were very 
similar (Figures 3.4a and b). The shape displays slow population growth with age 
bands of roughly equal size with a rapid shrinkage post retirement age. It was also 
possible to see the imbalance of males and females due to longer female life 
expectancy as well as the post-war baby booms. In contrast, the population 
structure of the ethnic minorities starts with a broad base and gradually diminishes 
to a small apex creating a pyramid like shape (Figure 3.4c). This is reflective of the 
large numbers of children and young adults and sparse older population. 
Age and sex pyramids with shading to indicate the proportions of the population 
not born in the UK, plainly demonstrates the younger age structure of the ethnic 
minorities compared to the White populations of 1991 and 2001 (Figures 3.4b and 
c). Figure 3.4c clearly show two distinct sections revealing a non-UK born shaded 
top half, in contrast to a bottom half made up of their UK born offspring.  Over 50% 
of ethnic minorities in the UK in 2001 were born in the UK, which means that 
variables such as country of birth which were once informative were no longer 
effective indicators of ethnicity.  
In the Pakistani and Bangladeshi groups an age imbalance can be observed with a 
much smaller proportion of females to males (Figures 3.4g and h). This may be 
because during migration it was the males that relocated first in order to secure 
employment and housing, families followed later. This gender imbalance was also 
present in the Black Caribbean population in 1991 where men outnumbered the 
women but was not evident from the 2001 data (Figure 3.4d). The structure of the 
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Black ethnic groups forms a pyramid like shape with the addition of two protrusions 
or bulges. The first represents the influx of early migrants and the second larger 
protrusion represents the British born children of these migrants. In the African 
group it is possible to see the base broadening out once more as a result of a 
growing third generation.  
The South Asian group populations are very pyramid-like having a wide base 
narrowing to a small apex (Figures 3.4f, g and h). There are more males than 
females in the older age groups. Both the Pakistani and Bangladeshi populations are 
widest at the base indicative of a large number of children and young people, unlike 
the Indian population where the groups are roughly equal into the middle age 
groups. The Chinese population structure tells a different story. The base is much 
narrower than that of the other groups (Figure 3.4i). The largest group was the 
young adults, most likely overseas university students.  
Comparison of the 1991 and 2001 population pyramids particularly the two bands 
(0-4 and 5-9 years), reveals a decrease in proportions of younger populations 
compared to previous years. Decreasing band widths were displayed in the charts 
of the whole population, Whites, Black Caribbean’s, Indians and Chinese groups 
(Figures 3.4a, b, d, f and i). Bands were seen to widen in the ethnic minorities as a 
whole, in particular in the Black Africans, Pakistanis and Bangladeshi groups (Figures 
3.4c, e, g and h).    
 
55 
 
Figure 3.4 Age and sex distribution of persons born within and outside of 
the UK by ethnic group 1991 (Owen, 1996) compared to 2001 
Note: persons darker shading represents born outside the UK 
a) All                    1991                                                          2001 
 
 
 
 
 
 
 
 
b) White             1991                                                           2001 
 
 
 
   
 
 
c) Non-white ethnic minorities 
                          1991                                                                         2001 
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d) Black Caribbean 
                                    1991                                                                2001 
 
 
 
 
 
 
 
e) Black African 
                                    1991                                                                2001 
 
 
 
 
 
f) Indian 
                       1991                                                                2001 
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g) Pakistani 
            1991                                                          2001 
 
 
 
 
 
 
 
 
 
 
 
 
 
h) Bangladeshi 
                     1991                                                        2001  
 
 
 
 
 
 
 
 
 
 
i) Chinese 
              1991                                                           2001 
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Ethnic minorities are getting older and increasing in number. Disease burden will 
rise and health services will need to adapt to meet the needs of the ageing ethnic 
minority population. However, it will be difficult to plan given the current poor 
collection of ethnicity data. In the next chapter, I present results from a review of 
the evidence base to see how we can improve ethnicity data collection in 
healthcare and present examples of good practice.  
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Chapter 4 Systematic literature review 1: 
Methods, interventions and barriers 
addressing the collection of ethnicity data in 
healthcare 
Ethnicity data is known to be poorly collected in healthcare. Although there have 
been significant improvements over recent years the data remains incomplete and 
of poor quality (HES online, 2004 and HES online, 2011). This literature review aims 
to identify methods, interventions and barriers to the collection of ethnicity data 
(or ethnicity profiling) in primary and secondary care. The review was conducted as 
part of CanEth, the CRUK commissioned feasibility project. 
4.1 Methods 
Literature searches were carried out in Embase, Psychlit, MEDLINE, PsycINFO and 
CINAHL databases in conjunction with the Warwick Centre for Evidence in Ethnicity 
Health and Diversity (CEEHD) with the aid of an information scientist specialising in 
ethnicity. The searches aimed to capture literature pre- and post the passing of the 
Race Relations Act (Amendment) in the UK in 2000, and the USA National Institute 
for Health Revitalisation Act of 1993 which prompted interested in the inclusion of 
ethnic minorities in clinical trials (NIH, 2001). The searches were also limited to 
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articles and reports written in the English language due to the time limitations of 
this thesis and the CanEth project.  
The literature review encompassed searches of published literature on 
bibliographic databases supplemented with World Wide Web Google searches and 
searches of specific websites to identify “grey” literature. 
4.1.1 Search strategy 
The search terms were developed in conjunction with the Centre for Evidence in 
Ethnicity Health and Diversity (CEEHD) ethnicity information specialists at Warwick, 
who also advised on the choice of databases. The search strategy focused on three 
key concepts:  
1) Ethnicity  
2) Data collection or data monitoring  
3) Disease sites (cancer or other chronic or long term diseases such as 
stroke, diabetes, coronary heart disease) 
Table 4.1 presents free text and Medical Subject Headings (MeSH) indexing terms 
identified for each concept. 
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Table 4.1 Free text and MeSH indexing terms  
Ethnicity Disease sites Data collection 
1. (multicultural or multi-cultural).mp. 
[mp=ti, hw, ab, it, sh, tn, ot, dm, mf, nm] 
1. exp Diabetes Mellitus/ 1. Pro-forma$.ab,ti. 
2. (crosscultural or cross-cultural).mp. 
[mp=ti, hw, ab, it, sh, tn, ot, dm, mf, nm] 
2. diabet$.ab,ti. 2. coding.ab,ti. 
3. (transcultural or trans-cultural).mp. 
[mp=ti, hw, ab, it, sh, tn, ot, dm, mf, nm] 
3. exp Hypertension/ 3. (record$ and 
keep$).ab,ti. 
4. (multiethnic or multi-ethnic).mp. [mp=ti, 
hw, ab, it, sh, tn, ot, dm, mf, nm] 
4. hypertension.ab,ti. 4. (data adj3 
collect$).ab,ti. 
5. (multiracial or multi-racial).mp. [mp=ti, 
hw, ab, it, sh, tn, ot, dm, mf, nm] 
5. Coronary heart 
disease.mp. or exp Coronary 
Disease/ 
5. (ethnic$ and 
(record$ or profil$ or 
monitor$)).ab,ti. 
6. (migrant$ or immigrant$).mp. [mp=ti, 
hw, ab, it, sh, tn, ot, dm, mf, nm] 
6. heart disease$.ab,ti.  
7. refugee$.mp. [mp=ti, hw, ab, it, sh, tn, 
ot, dm, mf, nm] 
7. (CHD and heart).ab,ti.  
8. cultural diversity.mp. [mp=ti, hw, ab, it, 
sh, tn, ot, dm, mf, nm] 
8. exp Cerebrovascular 
Accident/ 
 
9. (multilingual or multi-lingual).mp. [mp=ti, 
hw, ab, it, sh, tn, ot, dm, mf, nm] 
9. stroke$.ab,ti.  
10. (romany or romanies or gypsy or 
gypsies).mp. [mp=ti, hw, ab, it, sh, tn, ot, 
dm, mf, nm] 
10. exp neoplasms/  
11. asylum seeker$.mp. [mp=ti, hw, ab, it, 
sh, tn, ot, dm, mf, nm] 
11. (cancer$ or tumor$ or 
tumour$ or malignan$ or 
oncolog$ or carcinoma$ or 
neoplasm$).ab,ti. 
 
12. (arab$ or somali$ or yemini$ or 
Vietnamese or chinese or caribbean or 
pakistani$ or indian$ or bangladeshi$).mp. 
[mp=ti, hw, ab, it, sh, tn, ot, dm, mf, nm] 
12. long term disease$.ab,ti.  
13. (Islam$ or Hindu$ or Sikh$ or buddhis$ 
or muslim$ or moslem$).mp. [mp=ti, hw, 
ab, it, sh, tn, ot, dm, mf, nm] 
13. Chronic disease$.ab  
14. mixed race$.mp. [mp=ti, hw, ab, it, sh, 
tn, ot, dm, mf, nm] 
14. disease$.ab  
15. (ethnocultural or sociocultural).mp. 
[mp=ti, hw, ab, it, sh, tn, ot, dm, mf, nm] 
  
16. diverse population$.mp. [mp=ti, hw, ab, 
it, sh, tn, ot, dm, mf, nm] 
  
17. (Black or ethnic or minorit$) adj5 
population$).ab,ti. 
  
18. (BME and ethnic$).ab,ti.   
19. BME.mp. [mp=ti, hw, ab, it, sh, tn, ot, 
dm, mf, nm] 
  
(Iqbal et al, 2009) 
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The first literature search was limited to 2000-2007 with the aim of identifying 
recent literature and good practice guidelines. The literature search was re-run 
using the same search terms but limited to literature published between 1990-1999 
to ensure all relevant articles around the time of the 1993 Revitalization Act were 
captured (NIH, 2001). A third cancer site specific literature search was conducted 
with no restrictions on the year of publication, which included cancer sites known 
to have differing risks by ethnic group (e.g. Breast, Prostate, Head and Neck, 
Colorectal and Cervical malignancies). Search terms for ethnicity and data collection 
were used as previously described whilst terms related to the cancer site of interest 
were added. Cancer site specific searches were conducted in each database for 
each disease site independently. These were then concatenated. Duplicates were 
removed using the Endnote software function and further by hand. 
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4.1.2 Selection criteria 
Selection and inclusion and exclusion criteria for the populations of interest, 
interventions and study designs were developed prior to commencing the review 
(Table 4.2). I was already aware from a scoping search that many articles used 
ethnicity but did not report how the information was collected. Articles such as this 
and those discussing the need to collect ethnicity data were excluded. 
Table 4.2 Selection criteria and inclusion and exclusion criteria 
Selection criteria Inclusion criteria Exclusion criteria 
Population Patients from a Black, 
Minority or Ethnic group. 
This includes indigenous 
populations of invaded 
countries, e.g. Australia 
and USA 
Black, minority and ethnic 
groups in their countries 
of origin 
Interventions Any method, intervention 
or barriers addressing 
ethnicity data collection 
Methods, intervention or 
barriers NOT addressing 
ethnicity data collection 
OR use of ethnicity but no 
explanation as to how it 
was collected 
Study design Any 
 
Opinion pieces discussing 
the importance of 
collecting ethnicity data 
and reporting collecting 
data  
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4.1.3 The selection process 
The review process was broken down into three stages: 1) title, 2) abstract and 3) 
article review. Categories emerged during the title screening process and were used 
to categorise abstracts and articles (Table 4.3). 
Table 4.3 Coding used during screening process 
Code Description 
M Definitely/possibly contains methodology of ethnicity data collection 
U Use of ethnicity data but no explanation of how the data were collected 
I Insubstantial 
D Duplicate 
N Not relevant 
  
The following steps were taken in order to minimise selection bias: 
 Two reviewers independently screened titles, abstracts and articles 
 Two reviewers independently applied the inclusion criteria to the full 
articles. Any differences were resolved by consensus or referral to a third 
reviewer 
 Two reviewers independently extracted data from the final selection. As 
before, any differences were resolved by consensus or referral to a third 
reviewer 
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4.1.4 Grey literature review 
Grey literature was searched as not all research is published, or all published 
research indexed in the main databases, nor do all databases index consistently. In 
addition not all authors describe their research using the same terms. 
Publication types considered 
 Conference proceedings/abstracts 
 Theses 
 Reports, government documents 
 Key websites, such as the Kings Fund and Commission for Racial Equality 
Grey literature searches were conducted using the keywords in the search, such as: 
(“data collection” OR “data monitoring”) AND (“ethnic” OR “ethnicity”). The 
searches were conducted in Google and Google Scholar. Due to the large volume of 
results obtained using this method, screening was restricted to the first 50 pages 
only. The majority of grey literature was rejected because they discussed the need 
for the collection of ethnicity or used ethnicity data for reporting outcomes. Only 
articles which described their own ethnicity data collection methods, policies or 
procedures, or those providing guidance to improve ethnicity data collection were 
considered.  
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In addition, extensive searches were carried out on key websites and links from 
these websites:    
 Specialist Library for Ethnicity and Health (SLEH) 
 (http://www.library.nhs.uk/ethnicity/) 
 Centre for Evidence in Ethnicity Health and Diversity (CEEHD)  
 (http://www2.warwick.ac.uk/fac/med/research/csri/ethnicityhealth/) 
 London Health Observatory   
 (http://www.lho.org.uk/) 
 National Cancer Library  
 (http://www.library.nhs.uk/cancer/) 
 Office for National Statistics  
 (http://www.statistics.gov.uk/) 
 Department of Health 
 (http://www.dh.gov.uk/en/index.htm) 
4.1.5 Data extraction 
The data extraction form was designed to capture the following information:    
1. Type of cancer 
2. Country of study 
3. Ethnic group 
4. Type of study 
5. Focus of the study 
6. Key findings 
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4.2 Results 
Due to the nature of the evidence, published literature was reviewed using 
different steps to grey literature. The published papers were screened in three 
stages – 1) title review, 2) abstract review and 3) article review, and the grey 
literature reviewed by full article. The number of hits from the grey literature 
searches were too many and too duplicated to be able to present rejected articles 
in a meaningful way (e.g. links to the same report listed on multiple websites), 
therefore only the relevant articles are presented. 
4.2.1 Published Literature 
The systematic review of the published literature produced a total of 2404 ‘hits’; 
720 for the period 1990-1999 and a further 1684 for 2000-2007 (Table 4.4). 
Table 4.4 Search ‘hits’ by database* 
Literature search Database No of ‘Hits’ 
1990-1999 Medline 
PsychInfo 
CINAHL 
Embase 
Duplicates 
Total remaining 
492 
147 
64 
380 
362 
720 
2000-2007* Medline 
PsychInfo 
CINAHL 
Embase 
Total remaining 
Grand Total 
1059 
356 
96 
173 
1684 
2404 
* Numbers excluding duplicates are shown (total considered 2658). (Iqbal et al, 
2008)  
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Upon review of the 2404 selected titles, only 322 appeared to suggest that they 
discussed the methodology of either collecting or monitoring ethnicity data. A full 
review of these 322 abstracts revealed only 26 potentially fulfilling the inclusion 
criteria, Table 4.5. The majority of articles rejected (57%) were due to the article 
using ethnicity data as opposed to the methods for collection. 
Table 4.5 Stages 1 and 2: Title and abstract review 
   Abstract category*  
Period No of 
titles 
No of 
Abstracts 
M U I D N No meeting 
criteria 
1990-1999 720 218 8 127 46 7 30 8 
2000-2007 1684 104 18 57 29 0 0 18 
Total 2404 322 26 184 75 7 30 26 
*M=Methodology, U=Use, I=Insubstantial, D=Duplicate, N=Not relevant 
The 26 potential articles which assessed ethnicity data collection or ethnicity 
monitoring were reviewed in full; only 19 of these included information about data 
collection or monitoring. Once again, the main reason for rejecting articles was due 
to the ‘use’ of ethnicity and not data collection or monitoring (Table 4.6). Please 
note, one of the potentially relevant papers was included based upon the abstract 
only as the full paper was unavailable at the time of review. 
Table 4.6 Stage 3 article review 
  Article category*  
Period No of 
articles 
M U I D N No of articles 
remaining 
1990-1999 218 8 127 46 7 30 8 
2000-2007 104 18 57 29 0 0 18 
Total 322 26 184 75 7 30 26 
*M=Methodology, U=Use, I=Insubstantial, A=Abstract only (Iqbal et al, 2008) 
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Owing to the low numbers of papers fulfilling the inclusion criteria for acceptance 
and the interest in cancer sites given the research was funded by CRUK, the search 
was repeated for specific cancer sites as shown in Table 4.7. 
Table 4.7 ‘Hits’ by database for cancer site specific searches 
Literature search Database No of ‘Hits’ 
Breast Medline 
PsychInfo 
CINAHL 
Embase 
Duplicates 
Total remaining 
151 
60 
24 
119 
102 
252 
Colorectal Medline 
PsychInfo 
CINAHL 
Embase 
Duplicates 
Total remaining 
71 
4 
5 
63 
38 
105 
Cervical Medline 
PsychInfo 
CINAHL 
Embase 
Duplicates 
Total remaining 
50 
26 
20 
39 
41 
94 
Prostate Medline 
PsychInfo 
CINAHL 
Embase 
Duplicates 
Total remaining 
42 
4 
2 
43 
24 
67 
Head and neck Medline 
PsychInfo 
CINAHL 
Embase 
Duplicates 
Total remaining 
15 
1 
2 
12 
9 
21 
(Iqbal et al, 2008) 
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This resulted in 539 potential articles of which 469 were deemed to possibly fulfil 
the criteria specified for acceptance following the screening of titles and abstracts 
as shown in Table 4.8 (Iqbal et al, 2008).  
Table 4.8 Cancer site specific Stages 1 and 2 review 
   Abstract category*  
 
Disease site 
No of 
titles 
No of 
abstracts 
 
M 
 
U 
 
I 
 
D 
 
N 
No of 
articles 
Breast 252 231 0 111 38 7 75 0 
Colorectal 105 87 2 51 1 3 30 2 
Cervical 94 81 1 52 15 0 13 1 
Prostate 67 53 0 37 9 0 7 0 
Head & Neck 21 17 1 4 0 0 12 1 
Total 539 469 4 253 62 10 137 4 
*M=Methodology, U=Use, I=Insubstantial, D=Duplicate, N=Not relevant.  
Only four articles of the 469 abstracts reviewed discussed ethnicity data collection 
or monitoring, with two of these having been identified in the previous non-disease 
site specific searches. The remaining two papers did not involve data collection or 
monitoring upon full review of the article (Table 4.9) (Iqbal et al, 2008).  
Table 4.9 Cancer site specific Stage 3 article review 
  Article category*  
 
Disease site 
No of 
articles 
 
M 
 
U 
 
I 
 
A 
No of articles 
remaining 
Breast       
Colorectal 2  1  1 1 duplicate 
Cervical 1  1    
Prostate       
Head & Neck 1 1    1 duplicate 
Total 4 1 2  1 2 
*M=Methodology, U=Use, I=Insubstantial, A=Abstract only 
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4.2.2 Grey literature 
Searches on key websites and Google identified a large amount of information 
linked to ethnicity. Upon review, 53 reports were identified as being possibly linked 
with the collection or monitoring of ethnicity data. The main reason for rejection of 
potentially relevant reports was on the grounds that they discussed the need for 
the collection of ethnicity or used ethnicity data for reporting outcomes. Of the 53 
reports screened, 16 were selected for inclusion in the review (Figure 4.1). 
4.2.3 Summary of literature searches and reasons for rejection 
The paucity of evidence identified by the literature review highlights the emerging 
nature of research into this area. Of the 2404 possible published articles, only 19 
(0.8%) were selected for inclusion in this review (Figure 4.1). The main reason for 
rejection was articles using ethnicity (57%) but providing no description of the 
methods used for ethnicity data collection. Ethnicity ‘use’ included research aimed 
at specific ethnic groups, e.g. ‘Chinese’ or ‘South Asian’ for health promotion or 
interventions.  
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(Iqbal et al, 2009) 
 
Many articles used the term ‘multi-ethnic’ to describe their study populations 
where ethnicity had not been recorded but participants were considered to be a 
representative sample, e.g. smoking cessation in a multi-ethnic deprived area. 
Articles such as this were rejected where they did not provide any information 
about ethnicity data collection. Other reasons for rejection included published 
2404 titles in total
1684 hits (2000-2007)720 hits (1990-1999)
2082 titles excluded
322 abstracts screened
296 abstracts excluded: 
184 use of ethnicity data only
75 insubstantial information
7 duplicates
30 not relevant                     
25 potential articles                          
(plus one which is an abstract only)
6 articles excluded:           
4 use of ethnicity data only
2 insubstantial information
19 methodology published articles 
(plus one which is an abstract only)
16 grey literature 
methodology reports
35 relevant documents
Figure 4.1 Ethnicity data collection and monitoring review selection process  
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articles which discussed the population of their own country, such as multiple births 
in Saudi Arabian desert climate.  
A systematic review by Ma et al (2007) similarly found a lack of reporting of the 
methods of ethnicity data collection when examining reporting practice of 
race/ethnicity and socioeconomic status in biomedical journals. Additionally, there 
was a large amount of grey literature but upon review only 16 reports were 
considered relevant to this review. Of the articles included in the review, 19 (54%) 
were identified from published literature with an additional 16 (46%) from grey 
literature. Data extracted from the selected published and grey literature are 
presented in tables 4.10 and 4.11 respectively. 
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Table 4.10 Summary of published articles  
 
 
Author , year  
Of publication 
 
 
Type of 
 cancer 
 
 
Country  
of study 
 
 
Ethnic  
group 
 
 
Type of 
 study 
Description of content 
 
Focus of the study 
 
Key findings 
Baker, 2007 
 
Non-
cancer 
specific 
USA All Cross 
sectional 
Patients attitudes towards 
healthcare providers collecting 
their ethnicity, race and 
language data 
88% of patients thought the data 
should be collected. 46% worried that 
the information would be used to 
discriminate against them. 17% were 
not comfortable reporting their own 
ethnicity. 
Ma, 2007 
 
Non-
cancer 
specific 
All All Systematic 
review 
Methods of reporting race in 
medical journal articles 
116 terms used to describe ethnic 
groups, only 13% reported data 
collection method (1152 articles) 
Weinick, 2007 
 
Non-
cancer 
specific 
USA All Review New enactment of ethnicity data 
collection in acute care 
hospitals. Lessons learnt from 
implementing publicly 
mandated data collection 
Implementation of a change of policy 
needs to map onto existing systems, be 
flexible and be standardised. Train the 
trainer central sessions proved 
successful. Patient engagement and 
emphasis on the importance of data 
collection for improvements of care.  
Hasnain-Wynia, 
2006 
 
Non-
cancer 
specific 
USA All Overview Ethnicity data collection in 
healthcare, current practice, 
barriers and solutions 
Highlighted the need for self-reporting, 
why the data are needed and how 
professionals should ask for it 
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Author , year  
Of publication 
 
 
Type of 
 cancer 
 
 
Country  
of study 
 
 
Ethnic  
group 
 
 
Type of 
 study 
Description of content 
 
Focus of the study 
 
Key findings 
Jack, 2006 
 
All UK All Audit To determine completeness of 
ethnicity data in Thames cancer 
registry and HES data held by 
London Health Observatory 
81% of HES data had ethnicity recorded 
compared to 23% in the registry. Better 
collaboration needed between sources 
in  order to improve registry ethnicity 
data 
Baker, 2005 
 
Non-
cancer 
specific 
USA All Cross 
sectional 
Patients attitudes towards 
healthcare providers collecting 
ethnicity data 
Patients more willing to provide 
ethnicity data when reasons for 
collection are explained by staff in an 
appropriate manner. Staff should be 
comfortable collecting this data 
Buescher, 2005 Live birth 
records 
USA All Audit Discrepancies between 
published data on racial 
classification and self-reported 
race 
Measures of racial disparity vary 
depending on whether self-reported or 
official coded race is used 
Ford, 2005 Veteran 
Affairs 
USA All Review Importance of conceptualising 
and categorising ethnicity data 
Better and more consistent methods of 
ethnicity data collection need to be 
developed 
Gotay, 2004 All Hawaii Japanese 
Hawaiian 
Europeans 
Filipinos 
Cross 
sectional 
To assess ethnic self-identity in 
367 recently diagnosed ethnic 
patients. Explores acculturation. 
Findings show medical records well 
linked to individual self-reported 
ethnicity 
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Author , year  
Of publication 
 
 
Type of 
 cancer 
 
 
Country  
of study 
 
 
Ethnic  
group 
 
 
Type of 
 study 
Description of content 
 
Focus of the study 
 
Key findings 
Lin, 2001 All USA All Audit SEER initiative to assess the 
completeness of country of birth 
data 
67% of patients on the register had 
birthplace recorded. Completeness 
varied between ethnic groups 
suggesting bias in collection of this item 
Chattar-Cora, 
2000 
(abstract only) 
Colorectal USA All Audit To determine the demographic 
and tumour characteristics of a 
multi-ethnic group 
Patient notes were used to successfully 
identify 685 out of 688 patients. 
Ethnicity could not be identified for 3 
patients 
Olatokunbo, 2000 Non-
cancer 
specific 
UK All Feasibility 
study 
Feasibility study of ethnic 
monitoring in primary care 
Ethnic monitoring is feasible in primary 
care.  The inclusion of ethnicity as an 
automated field on GP referral letters 
was shown to be a simple yet powerful 
method which can be used to populate 
hospitals databases.  
Centers for 
disease control, 
1999 
Non-
cancer 
USA All Report To assess the collection of race 
data in health surveillance 
systems between 1994-1997 
No improvement in race data collection 
was observed between 1994 and 1997 
Warnakulasuriya, 
1999 
Mouth 
Pharynx 
Nasophary
nx 
UK Asian 
Chinese 
Audit Incidence of head and neck 
cancers in Asian and Chinese 
groups, flagged by Thames 
cancer registry using name and 
place of birth 
Ethnic groups can with certain 
precision be identified using names and 
place of birth data, as well as manual 
checking 
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Author , year  
Of publication 
 
 
Type of 
 cancer 
 
 
Country  
of study 
 
 
Ethnic  
group 
 
 
Type of 
 study 
Description of content 
 
Focus of the study 
 
Key findings 
Sheth, 1997 Non-
cancer, 
Mortality 
database 
Canada South Asian 
Chinese 
Audit Novel method to identify ethnic 
origin using names and country 
of birth 
Use of name and country of birth more 
accurate than using country of birth 
alone 
Swallen, 1997 All cancer USA Hispanic Audit Misclassification of Spanish 
ethnic groups in cancer register 
using census Spanish surname 
list, GUESS (name recognition 
software) and telephone 
interviews 
This sample showed Hispanics over 
reported for 38% of cases. 
Recommends using both recorded 
ethnicity and name for increased 
accuracy 
Kelly, 1996 Non-
cancer, 
AIDS 
USA All Audit Validation of ethnicity 
classification for AIDS patients 
across 3 national data sources 
Inconsistencies greatest for American 
Indians and Alaska Natives, up to 57% 
disagreement 
Frost, 1994 Non-
cancer 
USA American 
Indians 
Alaska 
Natives 
Audit To validate race on Washington 
state death certificates with 
those on the Indian Health 
Service database 
Race was correct for 87% of death 
certificates. Deaths from cancer were 
more likely to be coded incorrectly. 
People who are born and died in 
Washington are more likely to be 
coded correctly 
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Author , year  
Of publication 
 
 
Type of 
 cancer 
 
 
Country  
of study 
 
 
Ethnic  
group 
 
 
Type of 
 study 
Description of content 
 
Focus of the study 
 
Key findings 
Sugarman, 1993 Non-
cancer, 
End stage 
renal 
disease  
USA American 
Indians 
Alaska 
Natives 
Audit Misclassification of American 
Indians ad Alaska natives on the 
Renal Disease Stage register and 
the impact upon disease 
statistics 
Ethnicity validated against the Indian 
Health Service database using names, 
date of birth and social security 
numbers. Incidence of renal disease 
increased from 268 per million to 312 
per million after corrections to 
ethnicity coding 
(Iqbal, et al, 2008 and 2009) 
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Table 4.11 Summary of grey literature 
 
Title, year of 
publication 
 
 
Authors 
 
Country  
of report 
 
Ethnic 
groups 
 
Type of 
research 
Description of content 
Focus(es) of report  
Key findings 
HRET Disparities 
Toolkit: A toolkit 
for collecting 
race, ethnicity 
and primary 
language 
information for 
patients  
(amended 
version), 2007 
Health Research 
and Education 
Trust 
USA All Online toolkit Designed to help health 
care workers understand 
the importance of 
collecting good quality 
ethnicity, race and 
preferred language data 
Toolkit includes topics: 
1. Who should use the Toolkit  
2.Why collect race, ethnicity, and primary 
language data  
3.Why collect data using a uniform 
framework  
4.The nuts and bolts of data collection  
5.How to ask questions about race, ethnicity, 
and primary language  
6.How to use the race, ethnicity, and primary 
language data to improve quality of care  
7.How to train staff to collect this 
information  
Lambeth PCT 
review, 2006 
Race for Health UK All Paper How successful is Lambeth 
Primary Care Trust at 
collecting, recording, 
analysing and using 
ethnicity monitoring 
information? 
Good practice includes: 
1.Individual Patient Registration Profile 
(IPRP) started in 2002 now over 30 practices 
are taking part. IPRP includes collection of 
religion, language, need for interpreter and 
ethnicity as well usual data. Existing patients 
contacted by means of postal questionnaire 
2.Training for practice staff 
3.Datanet system aids use of collected data 
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Title, year of 
publication 
 
 
Authors 
 
Country  
of report 
 
Ethnic 
groups 
 
Type of 
research 
Description of content 
Focus(es) of report  
Key findings 
Race, ethnicity, 
and language of 
patients. 
Hospital 
practices 
regarding 
collection of 
information to 
address 
disparities in 
health care, 
2006 
 
Regenstein and 
Sickler, The 
Robert Wood 
Johnson 
Foundation 
USA All Surveys Current practices of US 
hospitals, completeness of 
data, methods of collection 
and barriers 
Overall collection of data is good but not put 
to use. Some confusion between ethnicity 
and race. Single most important barrier to 
collection is staff not knowing why the data 
is important. Examples of good practice 
include: training given to new staff members 
as part of induction. Training for all staff 
collecting data on the importance of self-
identification and uses of data. Members of 
staff working in registration areas are 
subjected to quality review. Managers able 
to identify staff who record a large number 
of unknowns or blanks 
Black and 
minority ethnic 
groups 
Gill, Kai, Bhopal, 
Wild 
UK All Needs 
assessment 
A needs assessment 
overview for Black Minority 
Ethnic Groups (BMEGs) in 
the UK. Part of needs 
assessment series 
No differences reported in the rate of 
minority groups consulting their GPs or 
being admitted to hospital. However, Afro-
Caribbean males are less likely to have 
registered with a GP. Despite being 
mandatory there is still a lack of good ethnic 
data in secondary care services 
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Title, year of 
publication 
 
 
Authors 
 
Country  
of report 
 
Ethnic 
groups 
 
Type of 
research 
Description of content 
Focus(es) of report  
Key findings 
A practical guide 
to ethnic 
monitoring in 
the NHS and 
social care, July 
2005 
Department of 
Health 
UK All Guidelines Practical guide to ethnic 
monitoring in the NHS 
Examples of best practice in the UK, 
including self-reporting and use of census 
categories 
Ethnic 
Monitoring Tool 
NHS National 
Services Scotland/ 
Health Scotland 
UK All Toolkit The tool has been designed 
for NHS Scotland staff 
involved with the collection 
or use of ethnicity data 
Explains need for data monitoring, who 
should be involved, what needs to be in 
place and provides some  training materials 
Who, when, and 
how: The 
current state of 
race, ethnicity, 
and primary 
language data 
collection in 
hospitals, 2004 
Health Research 
and Educational 
Trust, The 
commonwealth 
fund 
USA All Report Survey and site visits to 
hospitals nationwide and 
report  current  practice, 
and identify problems  
Reports inconsistencies in methods of 
collection, questions asked, and response 
categories. Report makes 5 
recommendations:  
1.Standardise method of collection (self-
report should be used whenever possible) 
2.Point of data collection (admission) 
3.Standardise categories, ideally US census 
4.Data storage should be standardised, e.g. 
race and ethnicity stored as two separate 
variables 
5.Response to patient concerns and 
explanations should also be standardised  
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Title, year of 
publication 
 
 
Authors 
 
Country  
of report 
 
Ethnic 
groups 
 
Type of 
research 
Description of content 
Focus(es) of report  
Key findings 
Ethnicity data 
protocols 
training 
presentation, 
2003 
Gardi, M. Ministry 
of Health, Manatu 
Hauora 
New 
Zealand 
All Training 
presentation 
Ethnicity data protocols, 
how to collect, classify, use 
ethnicity data  
Ensure ethnic groups of policy importance 
are not swamped by NZ ethnic group. Each 
patient only appears once so sum of the 
population adds up to NZ population. 
Advises against transferring ethnicity from 
one form to another. 
Ethnicity: A 
review of data 
collection and 
dissemination, 
2003 
 
Social and 
Housing Statistics 
Section, 
Demographic and 
Social Statistics 
Branch, United 
Nations Statistics 
Division 
UN All Report Analysis of census data for 
countries including an 
ethnicity question. Report 
describes the ethnicity 
questions and responses 
allowed 
The results show 107 questions were asked 
by 95 countries. These can be placed in five 
categories: 43% of questions used a form of 
tick box categories with an open ended box 
for ‘other’, 20% had tick box categories only, 
21% were open ended questions, 4% had yes 
or no responses, 12% did not give enough 
information. 
Ethnic group 
statistics: A 
guide for the 
collection and 
classification of 
ethnicity data, 
2003 
A National 
Statistics 
publication 
UK All Guidelines To suggest standards to 
ensure comparability of 
ethnicity data over time 
and meet the users needs  
2 methods are proposed, one question 
(ethnicity) and 2 question (ethnicity and 
nationality). 2 question method should be 
used whenever possible 
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Title, year of 
publication 
 
 
Authors 
 
Country  
of report 
 
Ethnic 
groups 
 
Type of 
research 
Description of content 
Focus(es) of report  
Key findings 
Diversity counts: 
Ethnic health 
intelligence in 
London, the 
story so far, 
2003 
London Health 
Observatory 
UK All Report Ethnicity monitoring issues 
in the NHS in London 
Valid ethnicity data ranged from 17% to 
100% by London’s healthcare providers. 
Primary care identified as the poorest area, 
routine systems/integrated patient record 
could be possible solutions  
Ethnic 
monitoring: A 
guide for public 
authorities, 2002 
Commission for 
Racial Equality 
UK All Guidelines Ethnicity data collection 
and monitoring guidance 
for employment, service 
providers, schools etc 
Highlights the need for well designed 
mechanisms for ethnicity data collection and 
monitoring from dedicated personnel to 
databases and use of the data. Suggest 
method of collection also be recorded. 
Collecting ethnic 
category data: 
Guidance and 
training material 
for 
implementation 
of the new 
ethnic 
categories, 2001 
Department of 
Health  
UK All Guidelines Guidance for NHS staff 
collecting ethnicity data 
using the new 2001 
categories and barriers to 
collection 
Points explained include the new 16+1 
codes, training for staff, and the importance 
of self-identification. There are brief 
summaries defining ethnicities and the 
usefulness of the data at a local and national 
level.  
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Title, year of 
publication 
 
 
Authors 
 
Country  
of report 
 
Ethnic 
groups 
 
Type of 
research 
Description of content 
Focus(es) of report  
Key findings 
New federal 
standards for 
racial and ethnic 
data collection 
and reporting, 
1998 
Air Alert USA All Guidelines Changes to data collection 
following revised Office of 
Management and Budget 
(OMB) standards 
Ethnicity data collection legal requirement 
for all federal agencies. 
Self-identification should be used wherever 
possible. Propose a 2 question method for 
self-reports and single question method for 
collection by observation 
Patient profiling 
in primary care. 
The Princes Park 
Health Centre 
Model 2000 
Liverpool John 
Moores 
University 
UK All with 
specific 
reference to 
Somali and 
Yemeni 
communitie
s 
Report Reporting of patient 
profiling in primary care 
following the 
implementation of a 
Service Development 
initiative 
 Patient profiling data collected through the 
development and use of a Patient 
Information Form broken down into 4 
sections: personal details, patient 
satisfaction, health and ill health, ethnic 
classification. The data has been used to 
inform planning strategies, detailed in the 
report. 
HES online, 2004 NHS UK All Report Ethnicity coding in 
HES:1997-98 to 2002-2003 
Overall records with missing ethnic data has 
decreased in the latest 5 year period 
(Iqbal, et al, 2008 and 2009) 
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4.3 Synthesis of results 
Seven themes emerged from the systematic literature review as listed: 
1. Ethnicity data collection and monitoring 
2. Categories for defining ethnic group 
3. Other Indicators of ethnicity 
4. Methods of collection 
5. Barriers to collection 
6. Interventions 
7. Data quality and completeness 
Each identified theme is discussed in more detail below. 
4.3.1 Ethnicity data collection and monitoring 
The following six guidelines and reports providing examples of good practice were 
the most useful in determining methods for ethnicity data collection and 
monitoring: 
1. UK Commission for Racial Equality (2002) 
2. UK Department of Health practical guide to ethnic monitoring in the NHS 
and social care (2005) 
3. USA The Robert Wood Johnson Foundation Report (2006) 
4. UK Lambeth PCT review (2006) 
5. USA Health Research and Educational Trust (HRET) online toolkit (2007) 
6. NHS National Services Scotland Ethnic Monitoring Tool (2005) 
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These grey literature reports presented the best practice evidence for ethnicity 
data collection and coding, addressing barriers to ethnicity data collection, 
interventions to combat incompleteness of data, best practice policy, the need for 
complete ethnicity data and training of healthcare professionals to collect these 
data. However, none of the above reports discussed the validation of ethnicity data 
or the use of name recognition programs as a validation tool. This may be due to 
the consensus that self-reported ethnicity is the gold standard. Several of the above 
reports discussed the collection of self-reported ethnicity data at a single time 
point, which was then verified at subsequent visits. The Department of Health 2005 
guidelines presented examples of best practice across the UK (Department of 
Health, 2005). A common barrier to ethnicity data collection which affects both 
patients and healthcare professionals was the concept that ethnicity data was 
collected but not utilised. Key reports where ethnicity data collection/monitoring 
has been successfully conducted stated, demonstrating how the collected data will 
be used, is just as important to improved collection as adequate resources and 
awareness and training (Race for Health, 2006; Regenstein and Sickler, 2006).  
In a report which aimed to investigate the state of ethnicity data collection in US 
hospitals through the use of surveys and hospital site visits revealed that a lack of 
standardisation made this difficult in practice, although there were good levels of 
commitment to ethnicity data collection (Hasnain-Wynia et al, 2004).  
Weinick et al (2007) described the lessons learnt from executing a publicly 
mandated racial and ethnic data collection program in Boston and Massachusetts 
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acute care hospitals. The authors recommended data collection tools to be 
standardised across hospitals whilst still catering for the needs of individual 
hospitals and allowing patients a choice in how they choose to describe themselves. 
These findings were confirmed by Ford and Kelly (2005) who also stressed the 
importance of consistent methods of collection and the need for improved data 
collection tools. 
 ‘Who, when, and how: The current state of race, ethnicity, and primary language 
data collection in hospitals’ report (Hasnain-Wynia et al, 2004) made five 
recommendations for improving ethnic data collection and quality as listed below: 
 Hospitals need to standardise the method of collection (self-identification 
should be used whenever possible) 
 Point of data collection, e.g. on admission/registration recommended 
 Categories used for race and ethnicity should be the same across the board, 
ideally census but refinement is supported as long as data can be combined 
into census categories 
 Data storage should be standardised, e.g. race and ethnicity stored as two 
separate variables. New systems allow the data to be merged with clinical 
data records and be imported or exported 
 Patient concerns should be addressed prior to collection, response to 
concerns and explanations of data use should also be standardised 
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The impact of accurate ethnicity data collection has not yet been fully recognised 
and there is still a long way to go before the data are complete and reliable 
(Hasnain-Wynia et al, 2004, 2001a).  It is important to collect accurate ethnicity 
data for planning and policy making reasons.  
4.3.2 Categories for defining ethnic group 
Ethnic groups may vary greatly between countries and therefore categories differ 
depending on the country where the research is carried out. A report looking at 
ethnicity questions asked in census surveys in and across the United Nations found 
a total of 107 questions were being asked by 95 countries collecting ethnic group as 
part of their census. Only 12% of the countries collecting ethnicity data offered 
categories for ‘mixed’ identities’ or allowed for multiple boxes to be selected 
(National statistics, 2003). Other international guidelines specified that the gold 
standard categories could be expanded to cater for local populations as long as they 
could be concatenated back to the standard national categories (Race for health, 
2006; Weinick et al, 2007; Commission for Racial Equality, 2002).  
Inconsistencies were found in response type being used in connection with 
ethnicity questions in the censuses, five different types of response category were 
identified by the United Nations report as follows: 
 Coded categories with text boxes 
 Coded categories without text boxes 
 Yes/No questions 
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 Free text self-report 
 Unknown response 
The UK gold standard categories were taken from the census ‘ethnicity’ question. 
Ethnicity was first collected in the 1991 census when 10 categories were collected, 
this was later expanded in 2001 to the 16+1 categories which saw the introduction 
of a ‘mixed’ category and expansion of the ‘White’ category (as described in 
Chapter One). The Commission for Racial Equality (CRE) report (2002) and the 
Department of Health (DoH) guide to ethnic monitoring (2005) both stressed the 
importance of not allowing patients to see the ‘not stated’ category on paper forms 
or offering the patient this option verbally, nor misled the patient into thinking the 
question is compulsory. Another key difference between the 1991 and 2001 census 
ethnicity categories was the ability to state ethnicity in more detail by writing in 
free text field where ‘other’ was selected within any ethnic group category.  
4.3.3 Other indicators of ethnicity  
The UK DoH guidelines (2005) encouraged the collection of religion through the use 
of seven categories (Christian, Buddhist, Hindu, Jewish, Muslim, Sikh, any other 
religion, not stated). The ONS went one step further and distinguished between 
religious practice (active faith and participation in religious activity and worship) 
and religious identity (belonging to a religious community even if the religion is not 
necessarily practiced). Special attention was given to the main religious groups: 
Christian, Buddhist, Hindu, Jewish, Muslim and Sikh as people from many diverse 
backgrounds make-up these religious groups.  
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The collection of information about diet as five categories was actively encouraged 
(no special requirements, vegetarian, vegan, restriction according to religion, e.g. 
Kosher or Halal, and food allergies or medical conditions). The term ‘Kosher’ is used 
to describe food prepared according to Jewish ritual; ‘Halal’ is used to describe 
meat prepared in accordance with Muslim law. Both terms ‘Halal’ and ‘Kosher’ are 
listed in the Oxford English dictionary.  
Language was believed to be important to record so interpreters can be called for if 
needed. Relatives were not deemed to be adequate interpreters as they may not 
have the vocabulary or understand the technical nature of questions, especially 
when in a medical setting. There is also the uncertainty of not knowing whether you 
have been told everything or if the information has been edited, this may certainly 
apply when intensely personal questions are asked. There are also problems when 
patients need to make decisions because it is difficult to know who made the 
decision.  
The ONS recommended Nationality also be collected, the six suggested categories 
were: English, Scottish, Irish, Welsh, British and Other (National Statistics, 2003). 
Responses should be re-ordered according to where the question is asked, e.g. 
English should be at the top of the list when asked in England.  
The Individual Patient Registration Profile (IPRP) developed by Lambeth Primary 
Care Trust collected self-reported ethnicity, religion, language and need for an 
interpreter in addition to the routinely collected data items, such as gender, date of 
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birth and smoking status. Ethnicity group codes were expanded to meet the needs 
of the local population, but this was done in a way that allowed the categories to be 
concatenated down to the 16 census 2001 categories when required (Race for 
Health, 2006). The IPRP is an on-going project which attempts to collect data on a 
central database (Datanet) and includes a system which allows the collected 
ethnicity and profiling data to be used in research projects. Central Liverpool NHS 
Primary Care Trust also conducted a similar patient profiling exercise and collected 
detailed ethnicity data including ‘spoken’ and ‘written’ language, as well as 
additional information about general health (Adebayo and Mitchell, 2004).  
Indicators of ethnicity and their usefulness were discussed by Gill et al (2006) as 
part of the needs assessment series. Country of birth has been collected since 1841 
but is no longer deemed a reliable indicator of ethnic origin with over 50% of ethnic 
minorities being born in the UK. Country of origin or ancestry was reported to be a 
reasonably reliable indicator but was problematic for mixed ethnic group. Name 
recognition software was reported to be a useful tool for identifying South Asians 
and could be used for validation purposes (Gill et al, 2006).  
In summary, other indicators of ethnicity apart from ethnic group itself were 
country of birth, nationality, language spoken in the home, country of origin in 
conjunction with country of birth, skin colour (white and black), 
national/geographic origin, diet and religious beliefs. The UK Department of Health 
guidelines (2005) give many examples of good practice throughout the UK with a 
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variety of ethnicity indicators collected in practice, revealing the indicators 
collected were based upon local needs.  
4.3.4 Methods of collection 
Self-reported ethnicity was consistently recommended to be the gold standard and 
the reasons for this were discussed in many good practice guidelines and papers 
(Regenstein and Sickler, 2006; Commission for Racial Equality, 2002; Department of 
Health, 2005). As ethnicity is difficult to determine by observation, there is good 
evidence to justify the need for self-reported ethnicity data and active 
discouragement of obtaining ethnicity by observation. Observation may often lead 
to ‘stereotyping’ by skin colour and name and should be restricted to situations 
where obtaining self-reported data is not possible, e.g. language barriers. A USA 
paper by Hasnain-Wynia and Baker (2006), explained how staff should ask for these 
data and also emphasised the need for self-reported ethnicity. The HRET toolkit 
included training on how ethnicity data should be collected and again there was 
emphasis on the need for self-reported ethnicity (Health Research and Education 
Trust, 2007).  
Results from hospital surveys conducted in the USA by the Robert Wood Johnson 
group revealed 61% of respondents reported usually asking the patient to self-
identify. However, 25% filled in the ethnicity themselves based upon observation. 
They believed using the observation method was easier for both themselves and 
the patients as it avoided discomfort for both parties, they felt the data to be 
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accurate as they believed they knew their local population (Regenstein and Sickler, 
2006).   
As the literature has indicated, collecting self-reported ethnicity is important and 
this suggests it would also be informative to record the method of collection, i.e. 
self-reporting, observation or other, as important biases could occur if assumptions 
are made about the reporting (Commission for Racial Equality, 2002). Sugarman 
and Lawson (1993) revealed racial disparities varied according to the method of 
ethnicity data collection. The incidence of renal disease was reported to increase 
from 268 per million to 312 per million in American Indians/Alaska Natives after 
corrections to coding were made.  
In the UK, the number of boxes an individual can select when providing ethnicity 
data is not restricted (Department of Health, 2005 and National Statistics, 2003). 
This was also reported to be the case in New Zealand where their training kit 
recommended patients should tick as many boxes as they felt necessary to describe 
their ethnicity (Gardi, 2003).  However, this was not the case internationally where 
only a small proportion of countries allowed the selection of multiple boxes or 
provided specific categories for mixed race individuals (Mason et al, 2003). 
There was evidence to show that self-reported ethnicity was the most effective way 
to obtain accurate information, especially for the ‘mixed’ or ‘other’ ethnic groups 
where methods, such as observation or name recognition were known to be poor 
indicators. Buescher et al (2005) reported discrepancies between published data on 
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racial classification and self-reported race in a study of 118,000 live births in North 
Carolina in 2002. Mothers chose to describe their ethnicity using over 600 different 
terms on birth certificates. However, two thirds of these mothers from Hispanic 
origin would have been coded as ‘Other’ using official ethnicity coding.  This 
highlights the need to re-examine official categories, especially as ethnic and racial 
diversity continues to increase. It is also important to distinguish differences for 
missing data, occasions when staff ‘failed to ask’ and when patients ‘preferred not 
to say’ indicate two sets of problems (Department of Health, 2005).  
Methods of ethnicity data collection other than self-report and observer 
assessment included the use of name recognition software. However, this method 
is becoming increasing unreliable, especially in younger generations where there 
the prevalence of mixed marriages is on the increase. However, use of such 
software can be useful for obtaining missing data or obtaining ethnicity where none 
was recorded. Chattar-Cora et al (2000) demonstrated successful use of obtaining 
ethnicity information from patient’s medical notes. This method was used to 
identify most patients in the USA study, showing names can be used to obtain 
ethnicity data with some precision when no other data are available. Furthermore, 
the use of name recognition software in conjunction with country of birth data has 
been reported to result in improved accuracy of ethnicity (Sheth et al 1997, Swalen 
et al, 1997, Warnakulasuriya et al, 1999).  
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4.3.5 Barriers to collection 
Site visits in the USA to six consortium member hospitals and a 1,000 nationwide 
hospital survey to focusing on current data collection practices found 30% of 
respondents reported problems collecting these data (Hasnain-Wynia et al, 2004). 
The barriers reported by Hasnain-Wynia et al (2004) were comparable to those 
found in the Robert Wood Johnson Report (Regenstein and Sickler, 2006); these 
being: 
 Reluctance of staff to ask for this type of information for fear of offending 
the patient or encountering resistance 
 Confusion about race/ethnicity categories  
 Lack of understanding of the need to collect these data 
 Reluctance of patients to provide this type of information 
 Limitations of IT systems to capture this type of data 
 Lack of resources (e.g. time constraints, staff training)  
 Concerns that ethnicity data collection may expose the hospital to legal 
liability 
 Lack of agreement of executive management on the need to collect these 
data 
Many of the reports reviewed stated that there was a need to use the collected 
ethnicity data in research projects, for setting targets and comparing outcomes. The 
research should also be published to motivate healthcare professionals and 
patients to collect and provide these data having seen evidence of it being used for 
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meaningful research/changes/commissioning of policies to reduce health 
inequalities (Race for Health, 2006). Until ethnicity data are collected and reported 
and are shown to have a demonstrated use neither patients nor healthcare 
professionals will believe these data to be useful or important. 
One of the other main barriers to ethnicity data collection was reported to be the 
patient perceptions. Patients would be more willing to provide data if the reasons 
for the data collection are explained; also healthcare professionals should appear 
comfortable when asking for these data (Baker et al, 2005). Baker et al (2007) 
reported 46% of patients worried that their data would be used by health care 
professionals to discriminate against them.  
4.3.6 Interventions 
All of the best practice guidelines agreed that the main intervention needed for 
improved completeness and accuracy of ethnicity data collection was staff training, 
followed by the provision of adequate resources for data collection, and thirdly 
‘use’ of the data (Health Scotland, 2005; Department of Health, 2005; Commission 
for Racial Equality, 2002; Regenstein and Sickler, 2006; Health  Research and 
Education Trust, 2007).  
The UK DoH NHS ‘practical guide to ethnic monitoring in the NHS and social care’ 
(2005) described the importance of staff training and provision of information 
regarding the importance of ethnic monitoring, how the data will be used and the 
best methods by which to collect it. Training should be compulsory for healthcare 
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professionals that may be involved in collecting or using ethnicity data; for new 
members of staff this could be incorporated into induction training. Self-reporting 
was described as vital as ethnicity is part of an individuals’ identity that may or may 
not be visible to a third party.  
In the USA, the HRET toolkit provides a comprehensive training package for the 
collection of ethnicity data (Health Research and Education Trust, 2007). It has been 
written for multiple levels of healthcare professionals, including Chief Executive 
Officers, Clinicians, registration staff, database managers and patients, so that users 
can select the training information most relevant to them (Health Research and 
Education Trust, 2007). Once registered, the toolkit is free to access. The training 
emphasised the importance of the individual’s perception of their own ethnicity, 
the need for self-reporting and a Patient Response Matrix which was a tool 
designed to help healthcare professionals respond to frequently asked questions in 
a standardised manner. The Patient Response Matrix lists common questions asked 
by actual patients and provides an appropriate standardised response. The Patient 
Response Matrix was designed to grow with the addition of information from users.   
The ‘Ethnic monitoring tool’ developed by NHS Scotland is one of the most 
comprehensive training packages in the UK (Health Scotland, 2005). It was 
developed with NHS Scotland staff in mind and provides information relating to the 
reasons for carrying out ethnicity monitoring, who should be involved in monitoring 
and what needs to be in put place. Training materials provided included PowerPoint 
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presentations which can be downloaded and modified, train the trainer notes and 
role play scenarios are also available.  
The importance of staff training was also emphasised by the Robert Wood Johnson 
Report where three different training methods were used across three separate 
hospitals. In Central Georgia, training in data collection was given to all new 
members of staff as part of their induction training program. In Boston, training on 
the importance of self-reporting and the importance of and uses of the data to 
improve services/healthcare was given to all staff involved in the collection of 
ethnicity data. In Seattle, members of staff working in the registration areas were 
quality reviewed; managers were able to identify members of staff recording a 
large number of unknowns or leaving the ethnicity field blank and provide training 
to these individuals to address the problems (Regenstein and Sickler, 2006).  
4.3.7 Data quality and completeness 
Incompleteness of ethnicity data is an on-going problem, reports based on 
incomplete or bad quality data can provide misleading and inconsistent results. In 
the USA, ethnicity data reported on death certificates was validated against data in 
the Indian Health Services database, 87% were found to be correct (Frost et al, 
1994).  Ethnicity data validated across three sources for AIDS patients showed 57% 
conflicts in American Indians and Alaskan Natives (Kelly et al, 1996). 
Numerous studies, in the USA in particular, have compared self-reported data to 
official statistics and found inaccuracies (Buescher et al, 2005); it is important to 
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have more complete self-reported ethnicity information. Ethnicity data were 
assessed in 376 patients recently diagnosed with cancer, findings showed that 
medical records were well linked to self-defined ethnicity (Gotay and Holup, 2004).  
The incompleteness of ethnicity data has been a major problem in the UK for 
cancer registration as up until recently they did not routinely collect these data but 
instead depended on obtaining these data from other sources. Jack et al (2006) 
reported only 23% of registry data having ethnicity compared to 81% in HES data, 
linking records was favoured as it helped reduce the duplication of work. In the 
USA, an initiative as part of the Surveillance, Epidemiology and End Results (SEER) 
program to assess the completeness of country of birth data reported only 67% to 
have recorded data with levels of completeness varying by ethnic group which 
suggested bias in the data collection (Lin et al, 2001).  
The USA Centres for Disease Control (CDC) saw no improvement in the collection of 
‘race’ data between 1994 and 1997 in the wake of the Revitalization Act of 1993 
(Centres for Disease Control and Prevention, 1999). In 1995, it became UK 
government policy to collect ethnicity data in secondary care setting as an addition 
to HES. Completeness of ethnicity in HES has improved in London since the first 
collection in 1996/97 from 48% to 65% complete data in 2001/02 (HES online, 2004 
and London Health Observatory, 2003). 
The importance of data collection was increasingly recognised with new DoH 
initiatives put in place for GPs to collect ethnicity for newly registered patients 
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(Quality Outcomes Framework (QOF) points), although this initiative was 
unsuccessful and was abandoned. There is some way to go before databases have 
complete and self-validated ethnicity data. However, the Lambeth PCT project 
demonstrated that with dedicated resources, training and monitoring, 
improvements can be made in a relatively short amount of time. 
4.4 Conclusion 
To summarise, there is a need to increase awareness about the importance of 
routinely collecting ethnicity information. Self-reported ethnicity should preferably 
be collected as a mandatory item at the primary care level (with a ‘not stated’ 
option for patients who refuse to provide their ethnicity for coding purposes). 
Collection through the GP for all newly registered patients as well as self-reported 
ethnicity for existing patients may help to improve ethnicity data collection. It could 
also be collected at first hospital visit. Ideally databases could be linked between 
primary and secondary care so data are only collected once and verified at 
subsequent visits. One possibility would be to add ethnicity to the new patient 
Summary Care Record (NHS Care Records Service, 2011). Sangowawa and Bhopal 
(2000) showed successful collection of ethnicity data in a primary care feasibility 
study also demonstrating the ease with which ethnicity could be included on 
hospital referral letters by creating an automated field.  
Many projects are on-going, e.g. the development of the NHS for Scotland toolkit. 
The Department of Health training developed in conjunction with the 2005 
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guidelines can be used to raise awareness and improve quality and completeness of 
ethnic data collection (Health Scotland, 2005 and Department of Health, 2005). At 
the cancer registration level, identification of high risk groups can only be based on 
the data collected.  If these data are not available, incomplete and not validated, 
then reports based upon such data are unreliable. 
4.5 Summary 
This chapter reviewed literature discussing methods of improving ethnicity data 
collection. The next two chapters report investigations into the perceptions and 
experiences of ethnicity data collection from two different perspectives. Chapter 
Five presents results of focus groups with lay members from the South Asian 
community and Chapter Six the results from a survey of health care professionals.  
102 
 
Chapter 5 Focus groups with South Asian 
lay community members 
5.1 Introduction 
A component of the CRUK commissioned CanEth project was to explore barriers to 
ethnicity data collection by evaluating the perceptions and experiences of ethnic 
minority participants and their willingness to provide these data. This topic was 
investigated in the form of a series of five focus groups conducted with healthy lay 
volunteers from South Asian communities. South Asians were the largest ethnic 
minority group in 2001 making up 4.4% of the total England and Wales population 
and over 34% of the ethnic minority population (UK census 2001 
[http://www.statistics.gov.uk/census2001/census2001.asp). In addition, South 
Asians from India, Pakistan, and Bangladesh are heterogeneous in terms of culture, 
language, religious beliefs, diet, migration history, educational attainment and 
social class despite having a similar outward appearance (Gill et al, 2007). 
5.2 Methods 
Five focus groups were conducted in collaboration with the Mary Seacole research 
centre at De Montfort University and the Ethnic Health Forum in Manchester 
through whom focus group facilitators were recruited. Facilitators spoke both 
English and either Mirpuri, Punjabi, Bengali or Urdu. Ethnic minorities selected for 
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focus groups were based upon the languages spoken by the facilitators. Discussions 
took place in the native language of each group. Two focus groups discussions took 
place in Urdu for males and females independently, three further discussions took 
place in Bengali, Mirpuri and Punjabi with the Punjabi group being the only mixed 
gender discussion. A topic guide, participant information sheet and consent forms 
were developed and approved by South Birmingham Local Research Ethics 
Committee as part of the CanEth project application (Appendix 1). Focus group 
facilitators used the topic guide which was developed to focus on five areas of 
interest (Table 5.1).The areas of interest and subtopics were developed in 
collaboration with the CanEth project team which included Mark Johnson who had 
expertise in the area of conducting focus groups with ethnic minority groups, and 
further refined following discussion with the CanEth Advisory Board. Lay South 
Asian volunteers were recruited by the trained facilitators from local sources such 
as, community centres and places of worship. The focus group discussions were 
also conducted at these venues to ensure the participants were in familiar 
surroundings in order to encourage open discussion.  Facilitators aimed to recruit 
between five to ten participants per group and gender segregation was observed 
according to cultural customs for the Urdu, Bengali and Mirpuri speaking focus 
groups which were also conducted by a gender-matched facilitator. 
Small incentives were offered to encourage participation. Facilitators selected the 
incentive they believed would be the most suited to their local population. The 
older Bengali group were provided with refreshments at the meeting and lunch 
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post discussion. The Urdu, Mirpuri and Punjabi groups were offered high street 
vouchers worth £20.  
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Table 5.1 Focus group topic guide  
1. General opinions on the collection of ethnicity 
 Do you think accurate recording is important? 
 What do you think it can be used for? 
 Any objections/worries about providing these data? 
2. Experiences of providing ethnicity information 
 General discussion THEN Focus down on healthcare situations 
 Does anyone know people who have been asked this in relation to 
‘health research’ 
 Does anyone know if the Cancer clinics ask these questions? 
3. Categories used in practice (provide examples on sheets) 
 Census  
 Hospital admissions 
 GP data 
 Other 
 What categories would you like – how would you prefer to describe 
yourself 
4. What about language, Religion, Culture: 
 Do people ask, do you offer this information, do you mind.  
 Are there problems with ‘stereotypes’ (Explain) 
5. How should this information be collected (if it has to be: Note – the ‘Race 
Relations Act’ says that public services should so they can ‘combat ethnic 
inequality’) 
 Would you recommend the routine collection at hospital/GP/other? 
 When would be the best time to collect these data (admission/follow-up 
after you’ve been to the hospital once)? 
 How should people ask you – and what should they tell you? 
 Has anyone in the group been asked to take part in ‘research’ at the 
hospital or their GP? (i.e. medical research) – Can you tell us about it? 
Closing comments 
 Does it make a difference in the case of a disease like cancer – or is it the 
same for any health matter? 
Is there anything else you want to tell us about? 
(Iqbal et al, 2008 and 2012a) 
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Discussions were recorded using either a cassette or digital recording device, then 
transcribed and translated by facilitators. Discussions ranged from 50 minutes in 
the smallest Punjabi group with five participants to 90 minutes in the Urdu females 
group with ten participants. Focus group discussions were quality checked by 
independent reviewers who listened to recordings in the native language and then 
reviewed the translated transcripts. The transcripts were reported to be accurate, 
with no key issues reported to be lost in translation. All groups apart from Urdu 
(males and females) were transcribed with the ability to identify participants by 
number. Participant number is provided in the results where possible in order to 
distinguish individuals dominating the conversation and to get a feel for the group 
dynamics. 
The translated transcripts were analysed using a qualitative thematic approach. 
This process involved thorough examination of the data, comparing responses with 
one and another and identifying common themes. The focus groups undertaken 
were dependent on the availability of facilitators who were required to speak in the 
native tongue of the focus group and English, as follows:  
1. Mirpuri speaking Muslim females of Azad Kashmiri origin 
2. Bengali speaking Muslim males of Bangladeshi origin 
3. Urdu speaking Muslim males of Pakistani origin 
4. Urdu speaking Muslim females of Pakistani origin  
5. Punjabi speaking Hindu males and females of Indian origin 
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Informed consent was taken by the facilitator where English was not the 
participants choice of language. A short introduction was given by the facilitator in 
the language appropriate for the group. Discussion took place in both the native 
language and English particularly where younger volunteers were involved e.g. 
Urdu females. I was present at two of the focus groups (Bengali males and Urdu 
females) and was introduced to the participants as the researcher and able to make 
additional notes.  
5.3 Results 
Five focus groups were conducted by trained facilitators, all speaking in the 
preferred language of their group and also in English.  The number of participants in 
each group ranged from five to ten. The characteristics of the 36 volunteer sample 
are shown in Table 5.2. 
Table 5.2 Characteristics of participants 
   Gender   
Group Country of 
origin 
 
Language 
 
M 
 
F 
Median age 
(range) 
 
Total 
1 Azad Kashmir Mirpuri 0 5 - 5 
2 Bangladesh Sylheti/Bengali 8 0 63 (45-70) 8 
3 Pakistan Urdu 0 10 28.5 (18-35) 10 
4 Pakistan Urdu 8 0 30 (24-44) 8 
5 India Punjabi 2 3 31 (26-51) 5 
Total     18 18 31.5 (18-70) 36 
(Iqbal et al, 2008 and 2012a) 
The facilitators used the topic guide which was specifically developed to focus on 
the five key areas of interest and consisted of sub-categories. The subthemes that 
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emerged in the focus group discussion within the main themes are summarised in 
table 5.3 and also highlight the order in which the result s are presented: 
Table 5.3: Summary of focus group themes 
 Main theme Subtheme 
1 General opinions on 
the collection of 
ethnicity 
 Objections or worries about providing ethnicity 
information 
2 Experiences of 
providing ethnicity 
information 
 General feelings of providing ethnicity 
information 
 Effects of providing ethnicity information in 
healthcare situations 
3 Ethnicity categories 
used in practice  
 Thoughts on current ethnicity categories and 
preferred terms  
4 Provision of data on 
language, Religion, 
Culture: 
 Experience of being asked to provide data on 
language, religion and culture 
 Fears related to the risk of stereotyping 
5 How should this 
information be 
collected? 
 Recommended point of collection for routine 
ethnicity data capture (hospital/GP/other) 
 How ethnicity information should be collected 
and what staff should tell you 
 
5.3.1 General opinions on the collection of ethnicity 
Overall, participants thought accurate recording of ethnicity data was important. 
Most were proud of their origins and were familiar with the differences between 
their culture and other cultures, particularly other South Asians and displayed some 
understanding of the usefulness of ethnicity data in the healthcare setting. A 
number of participants also knew of the increased prevalence of certain diseases in 
minority ethnic groups and indicated this as the reasons why ethnicity data 
collection is important in healthcare:     
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“Sometimes it is helpful to provide ethnicity as it helps care providers understand 
our background and determine common illnesses due to dietary habits or genetic 
findings, i.e. there are some health problems for which the incidence is far higher in 
Indians than is say for examples British whites so in these cases it would be useful to 
collect ethnicity. However, we should be told why it is being collected when asked 
for it” [Punjabi female, participant 4] 
“Sometimes certain illnesses are directly linked to our ethnicity. If a doctor does not 
know the right ethnicity he cannot do anything. For example stroke or diabetes is 
directly linked to ethnicity” [Urdu female participant] 
 “….say you have diabetes, they want to know how many Bangladeshis suffer from 
diabetes, why they suffer from diabetes; how many Pakistanis, how many Somalis.  
Later they total up these figures to obtain another figure – the percentage for South 
East Asians altogether….” [Bengali male, participant 4] 
Several participants mentioned the importance of monitoring access and uptake of 
services. Others mentioned the need for collection of ethnicity data for future 
planning. Younger participants felt providing ethnicity was acceptable in healthcare 
but not in other areas, such as job applications: 
“It could be alright with diseases but when you have to give this information while 
applying a job it would be felt like discrimination. In case of jobs ability should be 
taken into the account instead of appearance or colour. In case of health, it could be 
OK but in case of jobs it is not right” [Urdu female participant] 
“It differs according to situation like if we are going for health service then it is 
acceptable as we are also getting some services in return but I don’t see any point of 
providing information for employment purposes” [Urdu male participant] 
A small proportion (4 out of 36) did not understand the need for ethnicity data 
collection stating it was not relevant to treatment, or believed they may be 
discriminated against if ethnicity is given: 
“Because ethnicity should never be a deterrent or an incitement when it comes to 
service or health provision so there’s no reason for why it should be collected” 
[Mirpuri female, participant 1] 
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“Because we are all human and the same and so our ethnic origin should not 
interfere with the care we receive. After all it is our health that should be the main 
concern here” [Punjabi female, participant 1] 
 “It is important for government point of view but there is no importance from our 
point of view” [Urdu male participant] 
 
Any objections/worries about providing this information? 
When asked about objections or worries about providing ethnicity data the vast 
majority had no objections. However, most of the participants’ experiences of 
providing ethnicity information was for job applications which was not viewed in a 
positively and many felt that it may discriminate against them getting the job. 
Several had concerns, or sometimes felt unease on occasions when the purpose of 
ethnicity data collection was not fully explained, and worried about being 
stereotyped. There was a feeling of dissatisfaction when the appropriate category 
did not appear on a form and feelings of the data not being utilised. One participant 
did not believe discrimination to be a problem given the multi-cultural nature of 
NHS work force: 
“I feel uneasy sometimes and you start wondering why they ask me questions about 
my ethnicity“ [Urdu male participant] 
“Sometimes patients may not be treated as individuals, we may judge by ethnicity 
and assume they have this problem as its high in their group” [Mirpuri female, 
participant 5] 
“My only problem is when the category is not available on a form, e.g. British Asian, 
I very rarely see this category. However, I have no problems as the information is 
confidential and most of the time nothing is done with information apart from 
stored on their files for years to come“ [Punjabi female, participant 4] 
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“The NHS is so large with multi-cultural staff that I am not concerned I will be 
discriminated if my ethnicity is collected. However, I feel they should tell us when 
the information is collected and what it will be used for“ [Punjabi female, 
participant 5]  
 
5.3.2 Experiences of providing ethnicity information 
In general, when asked about how they felt about providing ethnicity information, 
the majority of people did not mind.  Others only minded when they were asked at 
repeatedly. The majority wanted an explanation as to why the data were being 
collected and how it would be used.  
General feelings of providing about your ethnicity information 
“No one tells us why are they asking such questions and I feel they should tell me 
why do they need this information“ [Urdu male participant] 
 
Positive experiences reported included a participant who did not speak English and 
was offered an interpreter which helped. The main reason given for negative 
experiences was inadequate ethnicity codes and the fact that they would be coded 
as ‘other’ which resulted in frustration and feelings of being insignificant:   
“When I have to state ‘Other’ as my ethnicity is not on the form and I feel even now 
my origin is not widely recognised” [Punjabi male, participant 3] 
“Most forms did not differentiate Asians, as Asian can be different groups, and not 
just Pakistani, not just Chinese, also people are living in Kashmir part of Pakistan do 
not like calling themselves Asian Pakistani, but want to be grouped as Asian 
Kashmiri, and recently that has been acknowledged” [Mirpuri female, participant 5] 
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No participants voiced objections to providing ethnicity information in a healthcare 
setting. However, there was some confusion regarding the procedure for ethnicity 
data collection in healthcare and the need for standardisation:  
“My child was born in the same hospital yet they ask ethnic data about him 
whenever I took him to hospital“ [Urdu male participant] 
“Sometimes they ask these questions about ethnicity and sometimes they do not so 
we are not sure what is the standard routine“ [Urdu male participant] 
Do you think there are any effects of providing such information in healthcare 
situations? (Please give details of any experiences you may have had): 
“Yes, I don’t have any such experience myself but when my brother was admitted to 
hospital, before he was even allocated a bed or seen by a doctor we had to provide 
his demographic details. Makes me wonder whether based on that information he 
was given a bed next to the toilets or was that coincidence” [Mirpuri female, 
participant 1] 
  “The NHS deals with thousands of patients a day from all different cultural 
backgrounds that I don’t think they have time to discriminate. It may seem that we 
are getting discriminated by some staff but then it could be that an individual’s 
personality is not the best! “ [Punjabi female, participant 5] 
5.3.3 Categories used in practice 
When discussion was focused on ethnic group categories used in practice, many 
participants felt additional ethnicity indicators, such as country of birth, language 
and religion should be collected in order to distinguish between South Asian 
groups.  One participant also thought information on diet would be useful; another 
participant added that it would also be useful to be asked whether you were willing 
to be a donor or not.   
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What categories would you like with regards to providing personal information 
and– how would you prefer to describe yourself? 
 “The current ones are fine but language would be good as there are cultural 
differences depending on what language you speak“ [Punjabi male, participant 2] 
 “My background is I am from Bangladesh, so British Bangladeshi, this is fine. My 
son was born and brought up here, so he will say British - that’s it“ [Bengali male, 
participant 6] 
“British Bangladeshi gives them accurate information for research [this was 
supported by two more participants]. For political reasons I say ‘British Muslim’, 
When it comes for ethnicity for medical research I would say British Bangladeshi“ 
[Bengali male, participant 7, most of the others in the group agreed with him] 
 “The ethnicity should not be confused with the colour of the skin“ [Urdu female 
participant] 
5.3.4 Language, religion and culture 
All participants were happy to disclose their religion and language as long as they 
felt they were not being stereotyped. The discussion on culture centred on the 
reasons why religion was a better indicator of culture in South Asian communities 
than ‘ethnic group’. Some Muslims participants felt they were stereotyped, 
particularly in connection with terrorism. Also, some Bengalis reported having 
experienced being called ‘Paki’ purely based on stereotypes relating to skin colour. 
Others did not feel stereotyping to be a problem and were proud of their language, 
religion and culture and did not mind providing this information: 
Do you get asked, do you offer this information, and do you mind? 
“I have been asked, I have provided only because I’m not ashamed of my religion 
and whether I mind would depend on why I’m being asked“ [Mirpuri female, 
participant 1]  
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 “I would not hesitate to describe my language as Bengali, no reason to feel 
“sonkuchito” [“sense of shame”- others agreed with him] “ [Bengali male, 
participant 3] 
“Religion should be a part of ethnicity because that is the base of one’s lifestyle and 
dietary requirements. We do not know if the medicines we are taking are in 
accordance with the dietary requirements of our religion, e.g. most of the cough 
medicines may have alcohol in them“ [Urdu female participant] 
“Language is important because sometimes an interpreter may be required. The 
participants were confused on how much information should be asked, e.g. should 
they be asked about the mother tongue? How much fluency one has in which 
language? British born people often get confused on it because English is their main 
language and they have got fluency in it but still they are asked questions about 
their language“ [Urdu female participant]  
Do you think there is a risk of ‘stereotyping’  
“There is always that risk in everyday life, but I guess people are far too busy with 
other duties to take notice“ [Mirpuri female, participant 5] 
“Yes, if certain members of the community or culture do not agree or follow certain 
ways, it doesn't mean everyone will be the same, choices, independence to decide, 
options and opinions should be offered and noted“ [Mirpuri female, participant 5] 
“Yes, I feel that I am regarded as a vulnerable women because I am a non-English 
speaking person“ [Punjabi female, participant 1] 
 “I am not Pakistani, I am a Bangladeshi. Because of my colour and appearance 
someone is calling me “Paki”. This is stereotyping“ [Bengali male, participant 2] 
“The suspicion is that all Muslims are terrorist.  This is a stereotyped view. This kinds 
of stereotype views should not be allowed“ [Bengali male, participant 7] 
“Fear of stereotyping is there. Any brown complexion person may be called a Paki or 
a girl with head scarf may be labelled a terrorist. This is the main fear of disclosing 
one’s origin“ [Urdu female participant]  
Stereotyping by healthcare professionals was an issue for some participants: 
“Walk-in centres provide independent advice but I feel my GP knows my family 
history so makes assumptions about me“ [Punjabi male, participant 3] 
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5.3.5 How information should be collected? 
The Bengali focus group summed up how ethnicity data should be collected: 
“They should explain why they collect the data; the reason behind it; what benefit 
there will be for people.  Also, where the data will be used and how secure this data 
will be.  It should be kept secret [confidential]” [Bengali focus group; all 
participants]. 
The majority of participants agreed that GPs should collect ethnicity data and that 
this information should then be made available to hospitals and other healthcare 
providers. There was a general consensus that not enough is known as to the value, 
importance and use of these data.   
Would you recommend the routine collection at hospital/GP/other? 
“No way. There is no need for routine collection. If it really has to be it only needs to 
be collected once at each institution“ [Mirpuri female, participant 1] 
“The information should be collected at the GP surgery as patients are already 
distressed in hospital“ [Punjabi female, participant 1] 
How should staff ask you – and what should they tell you?  
“They should tell us why they need this information. A reason other than its just 
procedure. And who has access to the information“ [Mirpuri female, participant 1]   
“If they explain its importance before they ask question about ethnicity, I will feel 
more comfortable in providing such information“ [Urdu male participant] 
 
5.3.6 Discussion 
On the whole, the majority of focus group participants were happy to provide 
ethnicity data in healthcare situations providing they were offered an explanation 
as why it was needed and how the data will be used. Focus groups participants felt 
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staff should seem comfortable when asking questions about ethnic origin. The 
exhibition of discomfort by staff could make patients suspicious of the purposes for 
the questions and exacerbate non-compliance. Baker et al (2007), trialed four 
rationale justifying the collection of race and ethnicity data in the USA (1) quality 
monitoring, 2) government recommendation, 3) needs assessment and 4) personal 
gain and reported changes in patient comfort levels. Levels were reported to be the 
highest when quality monitoring was stated as the reason for collection. Similar 
rationale could be explored in the UK based upon well-known artefacts such 
differences in disease burden or the promotion of equality in access to healthcare.  
5.3.7 Discomfort 
Several focus group participants had reservations about providing ethnicity data 
and conveyed feelings of discomfort when the purpose of the data collection and 
how it would be used was not fully explained. Participants considered a brief 
explanation of why the data were required and its intended use would increase the 
willingness to provide ethnicity. Insubstantial explanations, such as ‘it’s routine’ or 
‘procedure’ or neglecting to offer any rationale were deemed unsatisfactory. It was 
felt that data collected ‘for statistical purposes’ were not utilised. These findings 
confirm previous reports from Pringle and Rothera (1996) and Hasnain-Wynia et al 
(2011) who recommended patients were informed of the reasons for collection and 
how the data will be used to improve services for patients.   
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5.3.8 Understanding of differences in disease risk and 
justification 
Focus groups with lay members of South Asian communities overwhelmingly 
indicated their willingness to provide ethnicity data for healthcare purposes. A 
number of participants demonstrated an understanding of variations in disease 
patterns by ethnic group, particularly in the incidence of diabetes and heart 
disease. The increased risk of these conditions was highlighted as the main reason 
for accurate data collection.  
5.3.9 Additional indicators 
There was also a consensus that collection of additional items such as religion, 
language, country of birth and diet were required to distinguish between the UK’s 
heterogeneous South Asian population. Focus group participants discussed 
descriptors of ethnicity they felt to be important in healthcare and also to 
distinguish between ethnic groups. Language, religion and country of birth were 
considered to be crucial for this group of South Asians who are culturally diverse 
despite having a similar outward appearance, and possessing similar genetic 
information.  
In one focus group participants stated they would describe themselves as “British 
Muslims” excluding their country of origin as they felt their religious beliefs were 
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the most significant indicator of their culture, for example religion dictates diet and 
consumption of alcohol and tobacco and therefore could be linked to health risk. 
5.3.10 Limitations of current categories 
A selection of participants expressed frustration when their ethnic group was not 
listed on the form and they were forced to tick ‘other’. The ethnicity categories 
were expanded from the original in both 2001 and 2011 based upon responses 
described in the ‘other’ category. 
5.3.11 Streamlined collection 
The focus groups also raised the issue of repeated ethnicity data collection and did 
not feel they should be asked for this information repeatedly, especially as it rarely 
changed. The majority agreed primary care was the preferred point of collection 
where patients are less distressed have some acquaintance with the staff. Raleigh 
(2008) also stated with 90% of all patient contact occurring in primary care there 
are more chances to capture this information in this setting (Raleigh, 2008). Several 
studies have reported the feasibility of automatically linking data collected in 
primary care to secondary care, eliminating the need for repetition (Pringle and 
Rothera, 1996; Information Services Division Scotland, 2010; Sangowawa and 
Bhopal, 2000).  
Providing data at first hospital visit was viewed as acceptable but repeated 
collection at subsequent visits was not thought necessary, however repeat visits 
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were a good opportunity to verify recorded data. Recent initiatives such as NHS 
electronic Summary Care Record which enable the sharing of selected patient 
information should prove useful for healthcare professionals and reduce treatment 
delays, but should also ease the problem of repeatedly giving the same information 
for patients; ethnicity could be incorporated as part of the patient demographics 
data (NHS Care Record Service, 2011). 
5.3.12 Limitations 
The focus groups conducted for this thesis were limited to South Asian groups.  
However, South Asians were the largest ethnic minority group in the UK 2001 and 
2011 censuses. Focus groups with Bengali females and Mirpuri males were missed 
due to a lack of finding an appropriate facilitator. Younger participants were 
bilingual (e.g. in the Urdu females and Punjabi groups) which enabled me to gather 
data from English speaking and non-English speaking South Asians,  although the  
discussions took place mainly in the native language in order to include all 
participants. Focus groups with English speaking ethnic minority groups such as 
Black African, Black Caribbean, White Irish and Mixed populations would have been 
informative but were not conducted due to time limitations and financial 
constraints imposed by the CanEth feasibility study.  
A further limitation to be considered is that I was not present at all the focus 
groups, therefore did not have firsthand experience of all the discussions. 
Moreover, the sample was relatively young with a median age of 31.5 years and 
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would have benefitted from including older ethnic minorities who are more likely to 
be health service users. Selection bias was also likely to be an issue as the focus 
groups were made up of a purposive sample and all participants were voluntary. As 
a consequence, these groups may be biased in favour of providing ethnicity data 
and the results may not be as generalisable to other South Asians.  
5.4 Conclusion 
In summary, results showed ethnicity should ideally only be collected once by GP or 
at first hospital visit and verified at subsequent visits if needed. ‘Ethnicity’ 
information collected should include religion, country of birth and language to 
account for cultural differences. In general, there was no objection to providing 
ethnicity data for healthcare purposes. There was some understanding of 
differences in disease patterns, e.g. higher incidence of diabetes in South Asians, 
and the importance of recording these trends. Explanations of why the data is 
needed and how it will be used to improve health care/services would increase 
willingness to provide the data. Ethnicity data should be collected at GP practice 
level where the staff are familiar and the patients less distressed than in a hospital 
setting. 
To follow on, Chapter Six now presents the results of a survey of healthcare 
professional perceptions and experiences of collecting ethnicity data. 
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Chapter 6 Health care professionals 
ethnicity data collection survey 
Ethnicity data are generally collected once in primary care at the point of first 
registration. In the hospital setting, in both in- and outpatient clinics ethnicity is 
usually requested by reception staff when a patient arrives for an appointment. 
However, in cases where the patient presents in an accident and emergency 
situation this information may be requested from relatives or friends accompanying 
the patient.  
Despite the drive towards improving UK ethnicity data collection in healthcare, 
relatively little is known about how healthcare professionals (HCP) in the UK 
perceive the collection of these data. The systematic literature review of ethnicity 
data collection methodology reported in Chapter Four revealed healthcare 
professionals’ perceptions to be a major barrier to ethnicity data collection. 
Research into healthcare professionals attitudes towards ethnicity data collection 
have been reported in primary care where it was generally viewed in a positive light 
(Pringle and Rothera 1996). Sixteen GPs and practice managers described ethnicity 
data collection to be valuable for service evaluation and health promotion purposes 
(Sangowawa and Bhopal, 2000). In spite of this, ethnicity data collection has been 
shown to be poorly collected in primary care with research concentrating on 
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acceptability, resources, database restrictions and ethnicity coding (Kumarapeli et 
al, 2006, Pringle and Rothera, 1996).  
‘Barriers to collection’ was as one of seven themes identified by the literature 
review of ethnicity data collection reported in Chapter Four. HCP barriers to 
ethnicity data collection in two reports from the USA included a fear of causing 
offence to patients, meeting with resistance, confusion with regards to ethnicity 
categories and a lack of understanding of the need for the data (Hasnain-Wynia et 
al. 2004, Regenstein and Sickler, 2006). Yet, little is known about healthcare 
professional perceptions and experiences of ethnicity data collection in secondary 
care in the UK. 
The aim of this chapter was to explore the likely reasons for gaps in ethnicity data 
by evaluating the perceptions and experiences of UK HCPs responsible for collecting 
this information.  
6.1 Methods 
The questionnaire was based on one previously developed by the Centre for 
Evidence in Ethnicity Health and Diversity (CEEHD) at Warwick and was adjusted by 
the CanEth working group. The modified two page questionnaire consisted of nine 
items including:  1) perceived importance, 2) current practice, 3) reasons for not 
collecting ethnicity data, 4) problems encountered when data are collected, 5) 
disease areas, 6) method of collection, 7) items collected, 8) use of name 
recognition software and 9) ethnicity data collection training (Appendix 2).  The 
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questionnaire was intended to be quick and easy to complete, ensuring most 
questions could be answered using tick box responses but also allowed additional 
space for comments.  The questionnaire could be printed, completed and returned 
by post or emailed.  
The questionnaire was aimed at clinicians, managers and nurses and any other 
healthcare professionals involved in collecting or using ethnicity data in a 
healthcare setting (e.g. statisticians, information scientists, data managers).  
Questionnaires or a link to the questionnaire were distributed to: 
 Minority-Ethnic-Health jiscmail list  
(http://www.jiscmail.ac.uk/lists/MINORITY-ETHNIC-HEALTH.html)  
 ALLSTAT jiscmail list, emailed (http://www.jiscmail.ac.uk/lists/allstat.html) 
 National Cancer Research Network (NCRN) head office for  circulation 
 Questionnaire posted on CEEHD website  
(http://www2.warwick.ac.uk/fac/med/research/csri/ethnicityhealth/) 
 Link to questionnaire on CEEHD posted on Specialist Library for Ethnicity and 
Health (SLEH) website (http://www.library.nhs.uk/ethnicity/) 
 Thread created on Academic Clinical Oncology and Radiobiology Research 
Network (ACCORN) thread (http://www.acorrn.org/ResearchDB/) 
 Thread on NHS discussion forum and news item on `new@networks’ 
electronic bulletin in June (http://www.networks.nhs.uk/forums/) 
 News item in the Welsh Cancer network newsletter  
 Emailed to all Cancer Network managers in England and Wales 
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 Circulated to all Race for Health PCTs, also posted on `Race for Health` 
website http://raceforhealth.org/)  
The questionnaire was distributed throughout England and Wales in 2007, via 
Minority-Ethnic-Health and ALLSTAT JISCmail lists (National Academic Mailing List 
Service for Academic and research communities). In addition, the questionnaire 
was also circulated to the 23 Race for Health Primary Care Trusts and to registered 
members of the Race for Health mailing list. It was posted on the Warwick CEEHD 
website and a link was placed on the NHS Evidence - Ethnicity and Health (formerly 
the Specialist Library for Ethnicity and Health) website. The questionnaire was 
circulated to the National Cancer Research Network (NCRN) head office and 24 
Cancer Networks in England and Wales. Threads on relevant websites, such as, NHS 
and ACCORN discussion forums were created. There was a special interest in the 
cancer networks because the survey formed part of the CanEth CRUK 
commissioned project. 
A four week deadline to return the questionnaire was set and extended for a 
further four weeks (on the web-site links) to increase response. The NCRN was the 
only mailshot to be repeated after an initial poor response, when sent through the 
NCRN head office. The repeated mailshot was sent individually to each network 
manager which improved the response rate.  
The role of healthcare professionals are summarised in tabular form. Responses to 
questionnaires are presented as charts or direct quotes in the case of open ended 
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questions. Quotes are presented as anonymous as possible without losing 
information, respondents role and geographic area were provided where available. 
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6.2 Results 
Thirty healthcare professionals completed and returned the questionnaire. The 
sample was distributed throughout England & Wales, with eight from Midlands, six 
from Wales, eight from the North of England, two from South England whilst six 
responders did not provide location information. Breakdown of respondent by role 
in the NHS is shown in Table 6.1, the majority of questionnaires been completed by 
clinicians, nurses or information officers. Role was not provided for six respondents. 
Table 6.1 Questionnaire respondents by role 
Role N 
Clinician 7 
Nurse 6 
Information Officer 5 
Radiographer 2 
Cancer Services coordinator 1 
Patient profiling development officer 1 
Lead quality coordinator 1 
Diabetes educator 1 
Not stated 6 
Total 30 
(Iqbal et al, 2008) 
6.2.1 Do you attempt to collect any ethnicity data on patients? 
Two-thirds of respondents (n=20) attempted to collect some ethnicity data; two 
further respondents (6.5%) did not consistently collect ethnicity data, six (20%) 
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reported not collecting ethnicity and two (6.5%) did not complete the question, see 
Figure 6.1. 
Figure 6.6.1: Attempts to collect data 
 
(Iqbal et al, 2008) 
6.2.2 Reasons given why ethnicity data are not collected 
Of the 30 responders, 20 routinely collected ethnicity and 10 did not. Reasons for 
not collecting ethnicity were requested and are presented in Table 6.2. 
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Table 6.2 Reasons ethnicity data not collected 
“It is very difficult to record ethnicity data for our cancer records as it is not 
documented in the patient's case notes, to the best of my knowledge. Due to this, it 
would take a great deal of time to collect and is however, not asked for in any 
reports that are asked of me” (Cancer professional, Wales) 
“Ethnicity data collection currently limited to Midwifery as Trust is taking part in the 
Welsh Assembly Government Patient Equality Monitoring Project and staff are 
awaiting training in how to collect information” (Human Resources Manager, 
Wales) 
“We have not to date regarded it as sufficiently important” (Consultant, Wales) 
“Not relevant to care or treatment given to patients. York has very few ethnic 
groups therefore language diet etc not required. Would access if appropriate” 
(Research Nurse, York) 
“Only if it is required as part of a research trial and the company require that 
information. We then only fill it in, but it is very rare. We do not routinely collect 
this” (Research Nurse, Sheffield)  
“Carried out retrospective 5 year audit to see if ethnicity influenced presentation 
with cancer, routes of referral, treatment received etc. Found study very difficult as 
ethnicity often not recorded on computer, had to check written notes.” 
(Consultant, Birmingham) 
“Ethnicity data is not collected if it is not relevant. For example if an audit is being 
done and the question to be answered does not include an ethnicity component. 
Ethnicity data is difficult to collect because it involves asking the patient what they 
want it to be and they are not always available or willing to answer.” (Informatics 
Lead, London) 
“Ethnicity data is not part of the datasets that are collected” (Information Manager, 
Yorkshire) 
“Not part of my job” (Radiographer, Gloucestershire) 
“Sometime ethnicity data is collected in the front of medical notes, but I expect the 
clerical staff don't understand the purpose of collecting such data” (Radiographer, 
Brighton and Sussex)  
“Our data collection is poorly resourced as it is so we have to stay entirely focused 
on what is clinically relevant” (Oncologist, Birmingham)  
(*Note: Responders identity presented as anonymous as possible without losing 
information). (Iqbal et al, 2008) 
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6.2.3 Disease areas for which ethnicity data are routinely 
collected 
Of the 22 respondents who collected ethnicity data (either routinely or sometimes), 
37% collected it in cancer, 32% collected it for all disease areas whilst 5% collected 
ethnicity in diabetes and hypertension. ‘Other’ areas included midwifery, all 
hospital registrations, contraception and sexual health. 
6.2.4 Method of collection 
The majority of respondents who collected ethnicity data reported using the self-
report method (n=12), assessment by observation was used less frequently (n=4). A 
number of respondents reported using a combination of methods, e.g. self and 
observer assessment (Figure 6.2). 
Figure 6.2 Data collection methods (n=22) 
 
 (Iqbal et al, 2008 and 2012b) 
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6.2.5 Indicators routinely collected 
Ethnicity data was most commonly reported to be collected using the 16 census 
categories. Other routinely collected ethnicity indicators included religion, language 
and country of origin. Race and country of birth were the least likely to be collected. 
‘Need for an interpreter’ was listed as an ‘other’ indicator (Figure 6.3).  
Figure 6.3 Which indicators of ethnicity do you routinely collect? 
 
(Iqbal et al, 2008 and 2012b) 
6.2.6 Problems encountered during ethnicity data collection 
The 22 patients who collected ethnicity were asked if they had encountered any 
problems in the process of collecting these data and were asked to provide details. 
Respondents experienced a variety of problems, see Table 6.3. 
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Table 6.3 Problems encountered collecting ethnicity data 
 “We depend on third parties in hospital trusts-poor data quality” (Welsh Cancer 
Intelligence and surveillance unit) 
“We have been collecting data surrounding ethnicity etc for around 7 years. The 
main issue is the patients’ lack of understanding of what ethnicity is. Also practice 
staffs lack of awareness of why we need to collect this information. On the whole 
though there have been very few problems.” (Patient profiling development officer, 
Liverpool) 
“We currently only record ethnic group in its widest sense” (Manager, Sandwell) 
“Often not recorded on software, so had to retrieve old notes and read through 
pages of clerking notes. Ethnicity usually recorded by junior doctors + written in. I 
did not wish to assume ethnicity from name alone.” (Consultant, Birmingham)  
“People collecting the data may not realise that they have to ask the patient.” 
(Informatics Lead, London) 
“Patients will ask why you need to know. If they come for anonymous info do not 
want to be listed. Do not accept that you need to have an idea of Ethnic origin so as 
to be able to review/develop/change service that is provided.” (Information & 
Support Services Manager, Birmingham) 
“I feel this is a difficult area due to fear of offending anyone. Most of the younger 
generation are British, I would have thought.” (Nurse, Birmingham) 
“Clients have the option of not stating their ethnic origin so there will always be a 
gap in the data” (Service Development Officer, Sheffield) 
“Failure of required process (i.e. patient not asked to self-select)” (Information 
Services, Bradford 
“Vague 'Asian' (and similar for other groups) labels do not provide information due 
to heterogeneity of many groups” (Macmillan Cancer Information Facilitator) 
“Existing data collection systems are not made for it. Ethnic categories are not up to 
date, follow old traditional immigration routes” (Information Analyst, Luton)  
“We have had difficulty releasing the vast numbers of staff required to attend 
'patient equality monitoring' training sessions, however this has been made easier 
by an all Wales Patient Equality Monitoring project sponsored by the Welsh 
Assembly Government and run by the NHS Wales Centre for Equality & Human 
Rights, who have produced an excellent Train the Trainer pack for Patient Equality 
Monitoring.” (Manager, Wales) 
(Note: Responders identity presented as anonymous as possible without losing 
information). (Iqbal et al, 2008) 
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6.2.7 Perceived importance of ethnicity data collection 
  
 
 
 
 
 
 
(Iqbal et al, 2008) 
The majority of respondents believed the collection of ethnicity data was more 
important to them personally compared to their perception of its value to their 
organisation. This may be symptomatic of the organisations weak policies on 
ethnicity data collection and lack of training provision (Figure 6.4 and 6.5). 
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Figure 6.4 Please rate how important you personally think the 
collection of ethnicity data is? 
Figure 6.5 Please rate the value of collecting ethnicity to your 
organisation 
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6.3 Discussion 
A number of issues were identified by the HCP survey, including the methods of 
collection utilised. Self-report is universally agreed to be the best method of 
collection and recommended by many guidelines as the ideal (Commission for 
Racial Equality, 2002; Department of Health, 2005b; Regenstein and Sickler, 2006). 
Yet, assessment by observation alone judged by appearance (such as skin colour, 
hair colour and/or type) although discouraged by guidelines was the second most 
used technique. Explanations given for using observation included the avoidance of 
discomfort and confrontation, but also the fear of causing offence to patients.  
An earlier project focusing on the collection of ethnicity data in the NHS also 
identified a fear of offending patients as a barrier to collection. This was 
accompanied by a fear of being accused of discrimination, concern that the 
questions were too sensitive and embarrassment when asking the questions 
(Johnson et al. 1993). Other concerns revealed by the survey included dealing with 
younger generations who are more likely to be British born and may wish to 
identify themselves as British. One respondent stressed the difficulty of obtaining 
self-reported data where the patient is unwilling to provide ethnicity (Department 
of Health, 2005a). The Commission for Racial Equality (2002) discourages other 
methods as a rule but stipulates they may be used in circumstances where self-
report is not possible. In surveys carried out by the USA Robert Wood Johnson 
Foundation 61% of healthcare professionals reported using the self-report to obtain 
ethnicity, but 25% utilised the observer method.  The healthcare professionals felt 
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the recorded data to be accurate based upon their knowledge of the local 
population, and believed that this eradicated discomfort for both themselves and 
patients (Regenstein and Sickler, 2006). 
Several HCP survey respondents reported not collecting any ethnicity data. For 
many, this was a consequence of their, or their organisation’s lack of awareness of 
the importance of the data and believed it not to be relevant to patient care or 
treatment. Exceptions to this were if the information was required for a specific 
purpose, such as meals, requesting an interpreter or for clinical trial participants 
(where requested). Physicians from the USA felt ethnicity and race to be clinically 
irrelevant (Hasnain-Wynia et al, 2010). Other barriers included worries about 
privacy and the legality of collection coupled with discomfort and resistance for 
patients and staff. These findings concur with previous reports by Regenstein and 
Sickler (2006) who reported the main barrier to data collection is staff not knowing 
why the data is of importance. This was not a major issue in the HCP survey where 
only one participant stated ethnicity was ‘not relevant to care or treatment’. 
Several respondents reported difficulties in releasing staff for training to attend off-
site courses. However, training packages which offer a range of free material online 
have been developed by Health Scotland and Health Research and Education Trust 
which can be used for in-house training (Health Scotland, 2005; Health Research 
and Education Trust, 2007. Weinick et al (2007) reported releasing a few members 
for ‘train the trainer’ sessions to be a viable alternative.  
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A selection of respondents in the survey of healthcare professionals reported a lack 
of understanding of the need for ethnicity data, a lack of training on how to collect 
it along with a lack of resources. The source of this problem is ultimately the lack of 
training received by healthcare professionals. Training should include giving 
explanations to patients as to the reason for the collection and how the data will be 
used. Standardising the phrasing of questions, and the method and point of 
collection, available responses and explanations to frequently asked questions as 
suggested by Hasnain-Wynia et al (2004) may be beneficial to both healthcare 
professionals requesting these data. 
In summary, two-thirds of responders routinely collect ethnicity data with the 
commonest form of collection being self-assessment.  Reasons for not collecting 
ethnicity stem from lack of understanding, lack of resources and lack of training. Of 
those who do collect the data, most perceive it to be important, and surprisingly a 
few of these perceive it to be less important to the organisation.  
6.3.1 Limitations 
The survey of healthcare professionals was limited in time and resources which 
meant I was not able to carry out large mailshots. Instead links to the questionnaire 
were posted on websites, forums, newsletters and mailing lists and a small mailshot 
to the NCRN. Unfortunately, the methods used meant I was unable to calculate a 
response rate. As it was, only 30 completed questionnaires were received despite 
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extending the deadline for returns. In hindsight, an online questionnaire may have 
been easier to complete and resulted in increased responses.  
Circulation of the questionnaire amongst groups with an active interest in ethnic 
minority health (e.g. Race for Health and Ethnic Minority Health mailing lists) may 
have biased the findings of the survey in favour of the collection of ethnicity data. 
In hindsight and given more time and resources, I could have targeted mailshots at 
other groups e.g. primary care networks. Based upon the findings of my systematic 
literature review of ethnicity data collection, surveying reception staff may have 
provided a more realistic account of the barriers experienced on a day to day basis 
and how these vary according to the environment e.g. between primary care and 
secondary care. However, given the paucity of research in this area the data 
provides a useful insight into the perceptions and experiences of healthcare 
professionals and provides a basis for further work. 
6.3.2 Summary 
In the introduction I discussed the under-representation of ethnic minorities in 
clinical trials and the problem of poor ethnicity data collection. The previous three 
chapters have revealed much can be done to improve the current state of 
collection primarily by using available data to show how it can be used to improve 
health care provision and to highlight the problems with the data. This may 
motivate the collection and provision of data for use in future reports. Secondly, 
the provision of training to empower health care professionals to collect these data 
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and how to collect it, e.g. the importance of self-reported ethnicity would be 
beneficial. 
In the next two chapters, I delve into ethnic minority participation in RCTs. 
Commencing with a systematic literature review of interventions used to facilitate 
the recruitment and retention of ethnic minorities into clinical trials in Chapter 
Seven. This is followed by an exploration of Hospital Episode Statistics (HES) data 
from a large teaching hospital and trial recruitment data from a cancer research 
network in Chapter Eight to assess the quality and completeness of ethnicity data 
collected locally. I then proceed to use these data to assess the representativeness 
of ethnic minorities in cancer clinical trials. Chapter Nine describes my journey 
towards establishing ethnicity data collection in conjunction with a CRN and uses 
these data to explore barriers to participation.  
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Chapter 7 Systematic literature review 2: 
Interventions to improve the recruitment 
and retention of ethnic minority patients 
into RCTs 
7.1 Aim of the review 
The aim of this chapter is to scrutinise the evidence base and synthesise the 
available information to identify effective interventions that have been used to 
facilitate the recruitment and/or retention of ethnic minority populations into RCTs. 
7.2 Background 
Ethnic minorities are reported to be under-represented in clinical trials. This topic 
will be explored in depth in Chapter Eight where I will attempt to investigate 
whether this is a problem using several locally sourced datasets. There has been 
some research into barriers to and attitudes towards participation in clinical trials 
suggesting clinicians may be hesitant to offer ethnic minority patients clinical trials 
due to time restrictions and a lack of resources (Ross et al, 1999, Ward et al, 2000). 
Hussain-Gambles et al (2004) reported results from an exploration of issues 
surrounding the participation of British South Asians in clinical trials. Common 
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deterrents to participation were concerns about drug side-effects, busy lifestyles, 
language, mistrust and not feeling part of the British society. 
Two years later, Fayter (2006) published the results of a systematic review of 
barriers, modifiers and benefits of participating in cancer clinical trials. Fayter found 
the evidence was too weak to permit a clear interpretation. To improve the 
participation rates of ethnic minority patients into clinical trials we must identify 
methods which effectively overcome these barriers to participation as well as to 
continue to identify deterrents in the Black, Minority and Ethnic groups. 
7.3 What’s already known 
Before I started this systematic review I searched the Database of Abstracts of 
Reviews of Effects (DARE) and the Cochrane Database of Systematic Reviews (CDSR) 
to ensure this review was not already being conducted elsewhere. Two systematic 
reviews in similar areas had been completed. Ford et al (2007) conducted a 
literature review of barriers to recruiting underrepresented populations to cancer 
trials. McDaid et al (2006) reviewed the literature with a view to identifying 
interventions to increase participation of cancer patients in RCTs. However, this 
review included all patients and was not specific to ethnic minorities and both 
reviews were only interested in cancer trials. Both found a dearth of research in this 
area. McDaid et al, found only eight articles meeting the inclusion criteria whilst 
Ford et al found five.  
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Both of the above identified reviews were restricted to cancer and only one 
considered interventions to improve participation in RCTs. Expanding to trials 
outside of cancer may yield more results. In addition, interventions that may be 
effective in a cancer population may not be so effective in other areas since the 
word ‘cancer’ provokes fear in people. Expanding the review to all clinical trials may 
also permit comparison by disease type. Furthermore, the effectiveness of 
interventions may also differ by ethnic group concerned, and this issue has not 
been addressed to date.        
7.4 Focus of the current systematic literature review 
My review focused upon interventions to improve the recruitment and retention of 
ethnic minorities into clinical trials. All disease sites were considered as well as all 
ethnic minorities. All studies with the exception of screening studies were 
considered. Screening studies were excluded because it was hypothesised that 
there are inherent differences in the process of deciding to participate in research 
between individuals with and without specific health problems. Joining a screening 
study where a ‘healthy’ individual may receive bad news may not be welcomed.  
7.5 Methods 
This systematic review was both conducted and reported according to the Centre 
for Reviews and Dissemination’s guidance for undertaking reviews in health care, 
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University of York (NHS Centre for Reviews and Dissemination/University of York, 
2001).  
7.5.1 Search strategy 
The following steps were undertaken in order to create the search strategy: 
1. The research question was broken down into component parts/concepts 
2. A list of search terms for each concept was created through the use of 
synonyms, abbreviations, differences in spelling (transatlantic 
differences), identification of related terms 
3. Imploding and exploding of Medical Subject Headings (MeSH) and 
exploration of indexed subject trees helped develop the concepts and 
the list of search terms  
4. Use of truncation and wildcards ($) 
5. Relevant search terms for each concept were combined using operators: 
OR, AND, NOT 
6. Proximity of search terms to one another was also utilised, e.g. adj5 
displays terms within five words of another pre-specified term  
7. Limits applied included articles written in English, restricted to humans  
and articles published between 1990 to Current (Nov 2012 at the time of 
review)  
All randomised clinical trials, pilot studies and feasibility studies were included. The 
systematic literature review search strategy focused on four key concepts: 
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Key concept 1: Ethnicity 
Ethnicity were taken from the previous literature review reported in Chapter Four, 
see Table 4.1. 
Key concept 2: Recruitment and retention 
Expanded terms:  
 Patient Selection 
 Patient Participation 
Mapped terms and keywords: 
 Recruit$ or enrol$ or register$ or screen$  
 Retention or retain$  
 Participa$ or inclu$  
 Enter$ or nonentry or non-entry or non entry 
Key concept 3: Interventions 
Expanded terms: None 
Mapped terms and keywords: 
 Intervention$ 
 Strateg$ 
 Initiative$ 
Key concept 4: Randomised Clinical Trials 
Expanded terms: 
 Randomized Controlled Trials as Topic 
 Clinical Trial 
 Pilot Projects/ or pilot stud$.mp. 
Mapped terms and keywords: 
 Randomised Controlled Trial$ or RCT$.mp.  
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The search terms used for ‘ethnicity’ are based upon the previous systematic 
literature review of ethnicity data collection developed in conjunction with the 
Centre for Evidence in Ethnicity, Health and Diversity 
(http://www2.warwick.ac.uk/fac/med/research/csri/ethnicityhealth/). 
Literature searches were conducted in Embase, MEDLINE, PsycINFO CINAHL, AMED, 
ASSIA and Race Relations databases using Ovid, EBSCO and Proquest 
platforms/engines. The literature search was limited from 1990 to the time of 
search (Nov 2012) with the view to capture literature pre- and post the Race 
Relations Act amendment in 2000 and the USA National Institute of Health (NIH) 
Revitalisation Act in 1993. The search was also limited to articles and reports 
written in the English language due to the time limitations of this thesis.  
7.5.2 Inclusion and exclusion criteria 
Populations of interest were Black, Minority and Ethnic groups as specified in Table 
7.1. Articles reporting on ethnic minority populations within their countries of 
origin were excluded. All interventions, strategies, initiatives, incentives or 
techniques not used to facilitate recruitment or retention were excluded. Articles 
not comparing recruitment and/or retention by intervention and/or ethnicity 
minorities were also excluded. All trials designs were considered with the exception 
of screening trials and retrospective comparisons.  
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Table 7.1 Selection criteria and inclusion and exclusion criteria 
Selection criteria Inclusion criteria Exclusion criteria 
Population Patients from a Black, 
Minority or Ethnic group. 
This includes indigenous 
populations of invaded 
countries e.g. Australia and 
USA 
OR 
Under-represented/under-
served populations 
Black, minority and 
ethnic groups in trials 
conducted in their 
countries of origin 
Interventions Any intervention or strategy 
or incentive or initiative  
OR  
any other device/technique 
etc used to facilitate 
recruitment into an RCT 
Results of a trialled: 
Intervention 
Strategy 
Incentive 
Initiative etc that is NOT 
focused on recruiting to 
an RCT  
Outcomes Rates of ethnic minorities 
recruited/enrolled/registered 
into a trial as a result of an 
applied intervention. 
Comparison by strategy 
not presented 
Study design Any of the below providing 
they are discussing recruiting 
to an RCT: 
Clinical trial 
Randomised Clinical Trial  
Pilot study  
Feasibility study 
Screening trials 
Retrospective 
comparisons 
Studies with no 
comparison data 
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7.5.3 The selection process 
The review process was broken down into three screening stages: 1) title, 2) 
abstract and 3) article review. Articles deemed relevant at stage three were 
subjected to quality assessment and data extraction. Three main steps were taken 
in order to minimise selection bias. Firstly, two reviewers independently screened 
titles, abstracts and articles. Any differences were resolved by consensus or by 
referral to a third reviewer. Secondly, two reviewers independently applied the 
inclusion criteria to the full articles. Again any differences were resolved by 
consensus or referral to a third reviewer. Thirdly, two reviewers’ independently 
extracted data from the final selection and any differences were resolved as 
previously described. 
I was the main reviewer and was assisted through the review process by both 
supervisors. Margaret Thorogood acted as the second reviewer, whilst Janet Dunn 
acted as the third reviewer when required. 
7.5.4 Data extraction 
The data extraction form was designed to capture the following information:    
1. Target population 
2. Intervention or strategy 
3. Study design  
4. Outcomes measured or reported 
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5. Setting in which they were conducted 
6. Country of origin of the study and year of intervention 
7. Numbers approached or screened, and numbers recruited and retained 
8. Comparison between strategies and/or ethnic groups 
9. Details of before and after comparisons where appropriate 
10. Any other information 
Themes identified during the course of the review were included as part of the data 
extraction framework as follows: 
 Use of incentives, financial and non-financial (provision of free healthcare, 
transport to and from study visits, provision of refreshments or meals, gifts, 
money or gift vouchers). These also differed as to whether they were 
offered to potential participants or recruiters 
 Involvement of community members or community organisations, e.g. 
places of worship 
 Language (study materials, use of bilingual recruiters and similar)  
7.5.5 Quality assessment 
Quality assessment was performed on the final selection of articles in this review 
which focused on RCTs. Studies were quality assessed in accordance with the 
Centre for Reviews and Dissemination (CRD) guidelines for ‘Undertaking Systematic 
reviews of research on effectiveness: CRD’s guidance for those carrying out or 
commissioning reviews’ (University of York, 2001, see Table 7.2). The quality 
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assessment criteria included whether study investigators had taken steps to 
minimise selection, attrition and performance bias and contamination. Further to 
this, whether the interventions and target populations were clearly defined was 
assessed. Quality assessment was conducted by two reviewers independently and 
presented according to the design of the study.  
Table 7.2 Assessment of study quality 
Selection bias (RCTs only)  
Was the method used to assign patients really random? Yes/no/unclear 
Was the allocation to the intervention concealed? Yes/no/unclear 
Selection bias (uncontrolled/before and after studies) 
Retrospective or prospective study?  
Was the patient selection process described? Yes/no 
Were details provided of the population from which the 
sample was selected? 
Yes/no 
Were there inclusion criteria? Yes/no/unclear 
Were all eligible patients invited to participate? Yes/no/unclear 
Is it possible that the investigators had discretion over who 
was selected? 
Yes/no/unclear 
Attrition bias (all studies) 
Were at least 80% of patients considered at follow-up? Yes/no/unclear 
Was it similar across groups? Yes/no/unclear 
Was a valid ITT analysis carried out? (all eligible patients 
included in the analyses) 
Yes/no/unclear 
The intervention (all studies) 
Did the design protect against contamination? Yes/no/unclear 
Did the design protect against performance bias? Yes/no/unclear 
Further comments:  
Relevance (all studies) 
Was the nature of the intervention clear? Yes/no/partially 
Was the target of the intervention clearly defined? Yes/no/partially 
General comments on relevance/ applicability  
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7.5.6 Data synthesis 
Key characteristics of included studies are presented in addition to a narrative 
synthesis of review findings. A table of excluded studies from the article screening 
stage and the reason for their expulsion are presented in a separate table within 
the results section.  
7.6 Results 
A total of 2643 hits were obtained but reduced to 2127 following de-duplication. 
Hits from each database with and without duplicates are shown in Table 7.3. 
 
Table 7.3 Results of search by database 
Host Database Hits Hits without duplicates 
Ovid Medline 1510 1455 
Ovid Embase 687 389 
EBSCO Cinahl 262 150 
Ovid Amed 75 75 
ProQUEST PsychINFO 96 46 
EBSCO Race Relations  13 12 
 Total 2643 2127 
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7.6.1 Study selection 
The search identified 2127 references for screening (Figure 1). Of these, 406 
abstracts were reviewed and 99 of these were subjected to re-review following 
disagreements in classification between the two reviewers. One hundred and sixty 
four articles were selected for article review, however, 24 articles were excluded 
because they focused on screening programs. Full articles for 140 references 
meeting the inclusion criteria were obtained for detailed review. Seven of the 140 
articles met the inclusion criteria. Many of the articles excluded were retrospective 
comparisons. The study design was varied in the seven selected studies, two were 
RCTs (Du et al, 2009, Kiernan et al, 2000), two non-randomised comparisons   (Cook 
et al, 2010, Horowitz et al, 2009) and three were before and after comparisons 
(Harris et al, 2003; Germino et al, 2011; Martin et al, 2011).  
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Figure 7.1 Process of study selection 
 
7.6.2 Excluded studies 
The majority of papers were excluded at abstract review because they did not 
provide any comparison with other recruitment strategies. However, the majority 
of papers excluded at the article review stage were due to the nature of the 
evidence, with many articles describing the lessons they learnt during the course of 
their research or reporting retrospective recruitment figures for a single group, and 
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therefore not providing comparison data. Other articles were excluded because the 
interventions were not focussed on facilitating recruitment to an RCT. Table 7.4 
summarises reasons for exclusion at the article stage. 
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Table 7.4 Description of excluded articles (continued on the next page) 
First author and 
year of 
publication 
Description Reason excluded 
Anderson 2007 No comparison as such. Recruitment of African American was slower 
than non-African American using conventional methods therefore 
additional/tailored strategies were used 
Exclude as there is not a true comparison. The 
African American tailored strategies were 
introduced part way through once they realised 
there was a problem so timespans different 
Arean 2003 Methods of recruitment in 2 trials Two separate trials, no direct comparison data  
Bistrick 2010 Data presented by recruitment methods and ethnic group Retrospective study, rejected due to lack 
of/poor comparison data 
Douglas 2011 Recruitment methods, same target group (South Asians) Emphasis of the article was on the screening 
stage of the trial not recruitment 
Ellish 2009 Comparison of recruitment methods, same target group (African 
American) 
Rates not accurate as numbers attending 
health fairs was estimated as was the number 
of people approached directly 
Fitzgibbon 1998 Two different trials (Hip Hop vs FRITAA). Different strategies and 
different populations (hip hop included children) 
Exclude because no like with like comparison. 
Hip Hop low income community and children. 
FRITAA medium level income adults 
Gallagher 2004 Three recruitment source categories by ethnicity (Caucasian and 
Latino) 
Retrospective study, rejected due to lack 
of/poor comparison data 
Gallagher 
Thompson 2006 
Three recruitment source categories by ethnicity (Caucasian and 
Chinese) 
Retrospective study, rejected due to lack 
of/poor comparison data 
Hatfield 2010 Comparison of several recruitment methods by ethnic group Retrospective study, rejected due to lack 
of/poor comparison data 
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Heiney 2010 Implementation of the Heiney-Adams recruitment framework. 
Comparison between strategies 
Retrospective study, rejected due to lack 
of/poor comparison data 
Kennedy 2005 Recruitment techniques: mass mailing, mass media and personal 
contacts 
Retrospective study, rejected due to lack 
of/poor comparison data 
Kennedy 2010 Comparison by strategy and  ethnicity (African American vs Non-
Hispanic whites) 
Retrospective study, rejected due to lack 
of/poor comparison data 
Lindenstruth 2006 Comparison of various methods by ethnic group Retrospective study, rejected due to lack 
of/poor comparison data 
Mhurchu 2009 Comparison of various methods by ethnic group Retrospective study, rejected due to lack 
of/poor comparison data 
Sharp 2008 Comparison of flyers vs approaching folks on the street Retrospective study, rejected due to lack 
of/poor comparison data 
Stoy 1995 Comparison of various methods by ethnic group (Whites vs Blacks) Retrospective study, rejected due to lack 
of/poor comparison data 
Sweet 2008 Comparison of various methods by ethnic group (Whites vs Blacks) Retrospective study, rejected due to lack 
of/poor comparison data 
Unson 2004 Comparison of various methods by ethnic group (whites, African 
American, Hispanics) 
Retrospective study, rejected due to lack 
of/poor comparison data 
Vollmer 1998 Recruitment/retention by ethnic group but not by strategy Retrospective study, rejected due to lack 
of/poor comparison data 
Wisdom 2002 Compares different methods of recruiting African American Retrospective study, rejected due to lack 
of/poor comparison data 
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7.6.3 Characteristics of included studies 
Of the seven studies included in the review, three focused on recruiting patients to 
cancer treatment trials (Cook et al, 2010; Du et al, 2009; Germino et al, 2011), two 
on diabetes treatment trials (Horowitz et al, 2009 and Martin et al, 2011), one on a 
heart disease treatment trial (Kiernan et al, 2000) and one on a smoking cessation 
trial (Harris et al, 2003) see Table 7.5. Three studies focused on one ethnic minority 
group (Harris et al, 2003; Kiernan et al, 2000; Martin et al, 2011), while three 
studies included multiple groups alongside the ethnic minority group of interest 
(Cook et al, 2010; Germino et al, 2011 and Horowitz et al, 2009), and one targeted 
Whites only alongside the ethnic minorities group of interest (Du et al, 2009).  
The numbers of participants per study varied widely from 33 to 8532. The studies 
were conducted between 1999 and 2007 (two did not provide dates). Three 
focused on one intervention to aid recruitment; one of these was an RCT, one a 
non-randomised prospective comparison and one before and after design. One 
study attempted to compare two strategies (one passive, one reactive), two 
compared three strategies and one compared five.  
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Table 7.5 Summary characteristics of the seven included studies 
Factor Grouping No of studies 
Study design RCTs 
Non-randomised comparisons 
Before and after studies 
2 
2 
3 
Country USA 7 
Disease area Cancer 
Diabetes 
Heart disease 
Smoking cessation 
3 
2 
1 
1 
Target groups Single group 
Multiple groups 
3 
4 
Year of study Min 
Max 
1999 
2007 
No recruited  Min 
Max 
33 
8532 
No of 
interventions/strategies 
One 
Two 
Three 
Four 
Five 
3 
1 
2 
0 
1 
 
A more detailed description of the seven selected studies is presented in Table 7.6. 
Four studies targeted African Americans (Cook, Du, Germino, Harris), two targeted 
Spanish speaking Hispanics or Mexicans (Kiernan, Martin), with the last targeting all 
ethnic minorities (Horowitz). Three studies were cancer focussed, two on breast 
cancer (Du, Germino) and one prostate cancer prevention trial (Cook). All studies 
were recruiting from the community setting apart from the study reported by Du et 
al (2009) which recruited from cancer clinics and the study reported by Kiernan et al 
(2000) which targeted University employees.  
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Table 7.6 Description of included studies 
Author & year Target population Design Disease area Setting Country Year of study 
Cook 2010 African American men 
vs non- African Americans 
Non-randomised prospective comparison Prostate cancer  Community USA 2001-2004 
Du 2009 African Americans vs 
Whites 
RCT Breast cancer Cancer clinic USA 2003-2005 
Germino 2011 African American women 
vs non-African Americans 
Before and after Breast cancer Community USA Not stated 
Harris 2003 African Americans Before and after Smokers Community USA 1999-2000 
Horowitz 2009 Ethnic minority 
populations 
Non-randomised prospective comparison Pre-diabetes Community USA 2007 
Kiernan 2000 Hispanic RCT Heart disease University USA Not stated 
Martin 2011 Mexican Before and after Diabetes Community USA Not stated 
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Table 7.7 provides an overview of the data extracted from all studies. Four of the 
seven studies included a financial incentive as part of their recruitment strategy 
(Germino et al, 2011, Harris et al, 2003, Horowitz et al, 2009 and Martin et al, 
2011). Four involved or consulted community members to ensure the intervention 
was  culturally appropriate (Cook et al, 2010, Germino et al, 2011, Horowitz et al, 
2009 and Martin et al, 2011) and three also addressed language barriers (Germino 
et al, 2011, Horowitz et al, 2009 and Martin et al, 2011). Neither of the two RCTs 
used financial incentives, involved community members or addressed language 
barriers (Du et al, 2009 and Kieran 2000). By contrast, Germino et al (2011), 
Horowitz et al, (2009) and Martin et al (2011) incorporated all three elements into 
their strategies.  
Four studies reported the number of potential participants screened/approached in 
addition to the total recruited (Harris, Horowitz, Kiernan and Martin). Only two 
studies reported rates of retention (Du, Germino). Fours studies presented data 
comparing the effectiveness of the intervention by ethnic group (Cook, Du, 
Germino and Horowitz), this was not applicable in three studies where only one 
group was been targeted (Harris, Kiernan, Martin). All except one study also 
compared recruitment by strategy (Germino). Finally, only two studies reported 
data relating to retention (Du et al, 2009 and Germino et al, 2011). 
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Table 7.7 Overview of the seven included studies 
1 Physicians’ offices were paid by researchers to review records and invite potential participants  
 
Author & year Target 
group 
Financial 
incentive 
Community 
members 
Targeted 
language 
Screened 
/approached 
Recruited Retained Ethnicity Strategies 
Cook 2010 African American N Y N N Y N Y Y 
Du 2009 African American N N N N Y  Y Y Y 
Germino 2011 African American Y Y Y N Y Y Y N 
Harris 2003 African American Y N N  Y Y N n/a Y 
Horowitz 2009 Mix Y Y Y Y Y N Y Y 
Kiernan 2000 Hispanic N N N Y Y N n/a Y 
Martin 2011 Mexican  Y1 Y Y Y Y N n/a Y 
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7.6.4 Characteristics of study populations 
One study was targeted at men (Cook et al, 2010), two at women (Du et al, 2009, 
Germino et al, 2011), and the remaining four were open to both genders. The 
average age of participants ranged from 43 to 54 years. One study did not provide 
this information, and two described their target populations as being <50 years or 
55 years and greater (Germino et al, 2011 and Cook et al, 2010 respectively).  
Three studies reported data relating to socio-economic status, employment or 
income. Harris et al (2003) found 33% of participants recruited through the 
proactive phase to be in full time employment compared to 70% of those recruited 
using reactive methods. This difference was also noted in monthly income with 17% 
earning a minimum of $1,800 in the proactive arm versus 48% in the reactive arm. 
Horowitz et al (2009) reported 70% of enrolees to be unemployed, much higher 
than the already high rate in the general East Harlem population where 52% were 
unemployed at the time of the research. Furthermore, 45% reported having an 
annual income of <$15,000 with 49% consequently having no health insurance. The 
study population can be summarised as middle-aged, Latino, Spanish-only speaking, 
overweight or obese women.  Almost half the participants (48%) in the study 
reported by Du et al (2009) fell into a low socioeconomic group.  
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7.6.5 Quality assessment  
The quality of the selected articles was found to vary, but were on the whole of 
intermediate to poor quality. Definitions of trial recruitment reported were found 
to vary between studies with some reporting numbers enrolled whilst others 
provided numbers recruited either with or without ineligible participants. Cook et al 
(2010) reported numbers enrolled but did not explicitly state if all of these patients 
were then randomised to receive the supplement in this randomised cancer 
prevention trial (tables 7.8a, 7.8b and 7.8c). In contrast, Du et al (2009) reported 
proportions willing to enrol in a study before and after exposure to an educational 
video designed to raise awareness of clinical trials.  
7.6.5.1 Study design 
Of the seven studies, the five that were not RCTs inherently had potential for 
selection bias. In addition, neither of the two RCTs provided any information with 
regards to the method of randomisation utilised (e.g. minimisation, stratified block 
randomisation), nor was any information given to indicate the intervention 
allocation list was concealed (Table 7.8). In one RCT, Du et al (2009) randomised 
patients to view an educational video about research and trial participation or usual 
care. Kiernan et al (2000) randomised potential participants to one of three mailing 
strategies inviting them to participate in the study. 
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All five non-RCTs (two of which were non-randomised prospective comparisons and 
three before and after studies) were prospective studies and described the patient 
selection process and inclusion criteria (see tables 7.9 and 7.10). The non-
randomised study reported by Cook et al (2010) discussed the effectiveness of 
recruiting African Americans through the provision of grants to selected sites. 
Horowitz et al (2009) however, compared the effectiveness of conventional 
recruitment methods to recruitment by members of the community of interest.  
Two of the three studies having a ‘before and after’ design consisted of a 
community element (Germino et al, 2011 and Martin et al 2011), see Table 7.10. 
However, the third study, Harris et al (2003) used ethnicity matched researchers 
along with incentives for the participants and extended clinic opening hours.   
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Table 7.8 Quality assessment of RCTs 
Bias Criteria Author and year 
  Du 2009 Kiernan 2000 
Selection bias (RCTs only) Was the method used to assign patients truly random? Unclear Unclear 
 Was the allocation to intervention concealed? Unclear Unclear 
 Comments Consent taken before 
randomisation so assume 
allocation concealed 
Randomised to 3 direct 
mailing strategies which 
was the initial point of 
contact 
Attrition bias (all studies) Were at least 80% of patients considered at follow-up? Yes Yes 
 Was it similar across groups? Yes Yes 
 Was a valid ITT analysis carried out?  
(all eligible patients included in the analyses) 
Yes Yes 
The intervention (all studies) Did the design protect against contamination? Unclear No 
 Did the design protect against performance bias? Yes Yes 
 Further comments? Patients in the same waiting 
room but significant 
contamination unlikely.  
 
Relevance (all studies) Was the nature of the intervention clear? Yes Yes 
 Was the target of the intervention clearly defined? Target was all breast cancer 
patients, there was no tailoring 
for racial differences but results 
were analysed by race 
Yes 
General comments on relevance and applicability Trial didn’t set out to address 
ethnic minority participation, 
but does provide information 
on differences in response to a 
video by race. 
Useful information for 
trials recruiting Hispanic 
workers 
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Table 7.9 Quality assessment of non-randomised prospective comparison studies 
Bias Criteria Author and year 
  Cook 2010 Horowitz 2009 
Selection bias  Retrospective or prospective study? Prospective Prospective 
(uncontrolled/before and  Was the patient selection process described? Yes Yes 
after studies) Were details provided of the population from which 
the sample was selected? 
Were there inclusion criteria? 
Were all eligible patients invited to participate? 
Is it possible that the investigators had discretion over 
who was selected? 
Yes 
 
Yes 
Unclear 
Unclear 
Yes 
 
Yes 
Yes 
Yes 
Attrition bias (all studies) Were at least 80% of patients considered at follow-
up? 
Unclear Unclear 
 Was it similar across groups? Unclear n/a 
 Was a valid ITT analysis carried out? (all eligible 
patients included in the analyses) 
Unclear 
 
n/a 
The intervention (all  Did the design protect against contamination? No Unclear 
studies) Did the design protect against performance bias? No Unclear 
 Further comments? No protection against biases 
built in 
Will participants respond more favourably to 
members of their community vs conventional 
methods 
Relevance (all studies) Was the nature of the intervention clear? Yes Yes 
 Was the target of the intervention clearly defined? Yes Yes 
General comments on relevance and applicability Good comparative data 
between grant awarded  and 
non-awarded sites as well as 
pre and post grant data 
Relevant paper concerning CBPR methods and 
how they could be used with great effective for 
hard-to -reach populations. Unfortunately not a 
randomised comparison and small numbers but 
good basis for further work 
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Table 7.10 Quality assessment of before and after comparison studies 
  Article author and year of publication 
Bias Criteria Germino 2011 Harris 2003 Martin 2011 
Selection bias  Retrospective or prospective study? Prospective Prospective Prospective 
(uncontrolled/ before and  Was the patient selection process described? Yes Yes Yes 
after studies) Were details provided of the population from 
which the sample was selected? 
Were there inclusion criteria? 
Were all eligible patients invited to participate? 
Is it possible that the investigators had 
discretion over who was selected? 
No 
 
Yes 
N/a 
 
Yes 
Yes 
 
Yes 
Yes 
 
Yes 
Yes 
 
Yes 
Yes 
 
Yes 
Attrition bias (all studies) Were at least 80% of patients considered at 
follow-up? 
Yes Unclear Unclear 
 Was it similar across groups? Yes N/a Unclear 
 Was a valid ITT analysis carried out? (all eligible 
patients included in the analyses) 
Unclear N/a Unclear 
The intervention (all studies) Did the design protect against contamination? Unclear No Unclear 
 Did the design protect against performance 
bias? 
Unclear N/a Unclear 
 Further comments? Partial CBPR approach  
partnering with 
community leaders 
/organisations  
Thought out design e.g. ethnicity 
matched researchers, incentives 
to attract low income population, 
evening appointments etc 
CHWs useful in 
recruitment as they have 
trust within the 
community 
Relevance (all studies) Was the nature of the intervention clear? Yes Yes Yes 
 Was the target of the intervention clearly 
defined? 
Yes Yes Yes 
General comments on relevance and applicability Not known which parts 
of the strategy were 
the most effective 
Good comparison data although 
not clean comparison e.g. the 
reactive phase covered a wider 
area than the proactive phase 
Good before and after 
data showing the 
efficiency of CHWs and 
their role in recruitment 
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7.6.5.2 Selection and attrition bias 
Selection bias occurs when there are systematic differences between the selection 
of participants to different treatment groups. Attrition bias refers to systematic 
differences in withdrawal rates, or exclusion from either the study sample or 
analysis across treatment groups. It is not clear from the information provided 
whether the RCTs were subject to selection bias (Table 7.8). However, for the five 
non-RCTs, it is possible that researchers may have inadvertently selected people 
who were either more or less likely to participate, thus influencing the results which 
could lead to either an under or overestimation of the effectiveness of the 
intervention (Table 7.9 and 7.10). Four of the five non-RCTs described the 
population from which the participants were selected. It was not clear whether all 
eligible patients were asked to participate in two of five non-RCTs.  
7.6.5.3 Performance bias 
Given the nature of the interventions, blinding was not feasible in any of the seven 
studies which may have resulted in an element of performance bias. Performance 
bias can be defined as systematic differences in the way in which participants are 
treated or interacted with, other than the intervention of interest. In this particular 
field, this could have been recruiters spending more time with potential 
participants, providing fuller answers or generally having a friendlier approach. 
Performance bias is minimised by ensuring interventions are delivered in a 
standardised way by all recruiters or researchers. The two RCTs (Du et al, 2009 and 
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Kiernan et al, 2000) were protected against performance bias through their study 
design, but whether this had been done was unclear or not known in the remaining 
five studies (Table 7.9 and 7.10).  
7.6.5.4 Contamination  
Contamination between groups is another important problem which can occur 
when the same researcher is delivering more than one intervention and an element 
of one intervention leaks into the other. It can also occur through contact between 
potential participants.  No steps to minimise contamination were reported in any of 
the seven studies and so it is possible that the effects reported may have been 
exposed to this bias (Table 7.8, 7.9 and 7.10).  
7.6.5.5 Summary of the quality of the selected studies 
To summarise, the selected studies were of intermediate to poor quality with little 
evidence to suggest bias had been taken into account. The studies were varied in 
design with only two identifying themselves as RCTs, although, no information 
regarding the randomisation method used was provided. Given the differences in 
the types of study and the small number of studies meeting the selection criteria it 
was not possible to perform any further analysis, such as meta-analysis, using these 
data. The reliability of these data is questionable given the large potential for bias. 
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In three of the seven included studies, a minimum of 80% of patients were still 
being followed up in the study at time of reporting (Du et al, 2009; Kiernan et al, 
2000 and Germino et al, 2011). All three studies also reported the percentage 
follow up to be similar across groups. None of the seven articles described any 
measures to minimise contamination. One study protected against performance 
bias by delivering a standardised intervention in the form of an educational video 
(Du et al, 2009). The intervention itself and the group the intervention was aimed at 
were described in all seven studies (tables 7.8, 7.9 and 7.10). 
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7.7 Synthesis  
The interventions tested were varied but can be grouped into five themes: 
Community outreach 
 Use of cultural brokers 
 Partner-led recruitment 
 Community based/recruitment events 
 Recruitment at targeted local organisations 
 Faith based promotion 
Advertising 
 Flyers 
 Adverts in targeted outlets/centres 
 Media (radio/television/newspaper adverts) 
Incentives 
 Government grants 
 Financial incentives for staff and participants 
 Non-financial incentives 
Targeted mailing 
 Direct mailings (e.g. postcodes with high African American population) 
Referral 
 Mailshots through health insurers 
 Referral by physician 
Further information relating to the interventions used can be seen in Table 7.11 and 
the effect upon recruitment by ethnic group and strategy in Table 7.12. As 
interventions were used in various combinations and given the small number of 
studies each is described in detail in order to provide a clearer picture. 
169 
 
Table 7.11: Interventions used in included studies 
Author & year Intervention/strategy Financial incentive Community members Targeted language 
Cook 2010 Grant to boost recruitment. $1.1m in 
total awarded to 15 sites by the National 
Cancer Institute 
No but funds were used to aid parking 
and transportation and provide 
refreshments at recruitment meetings 
Sites awarded the funding consulted 
community leaders and spokes people but 
reported these as less successful 
strategies 
No, targeted AA 
Du 2009 Educational video No No N/a (AA/Whites) 
Germino 2011 Increasing familiarity with study, and 
availability and accessibility of study 
literature through cultural brokers 
$20 at each data collection plus a small 
gift every 2 months 
Yes. Worked with community organisation 
who trained lay health advocates. Also 
used cultural brokers and involved pastors 
Language and tone in 
materials adjusted 
for young AA 
audience 
Harris 2003 Personal approaches (proactive) vs 
flyers, media, church based promotions 
(reactive) 
$100 across 3 visits ($20,40,40) plus 
small promotional gifts e.g. t-shirts, 
tote bag, key chain, water bottle, pen, 
magnet. Participants were also 
presented with certificates of 
accomplishment. 
No but community-based research at well 
know community health centres using AA 
researchers 
N/a 
Horowitz 2009 1. 1. Physician referral, 2.  recruiting at 
large  events, 3. holding recruitment 
events, 4. recruitment at local 
organisations, 5. partner-led recruitment 
$50 gift certificates. Small gifts such as 
study t-shirts and pens were also 
offered as well as a 'healthy box lunch' 
Community-based participatory research 
(CBPR), collaboration between community 
and academia/researchers. Developed 
and tested 5 community led strategies. 
English and Spanish 
Kiernan 2000 1. Flyer alone, 2. Flyer plus personalised 
letter, 3 Personalised letter specifically 
mentioning Hispanic heart disease risk 
No No No 
Martin 2011 1. Community outreach, 2. adverts, 3. 
recruiting through insurers 
Financial incentive offered to Physician 
offices to review their records and 
invite any potential participants 
Yes. Community Health Workers (lay 
people from the target population) hired 
to deliver the diabetes self-management 
intervention in this trial joined the 
researchers to aid recruitment.  
Bilingual ads and 
personnel 
appearances 
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Table 7.12: Recruitment by retention for included studies (continued on the following page) 
Author & year Approached/
screened 
Recruite
d 
Retained Recruited by 
ethnicity 
Recruited by strategy Before and after comparison 
Cook 2010 - 8532 - Non AA=6355 (76%) 
AA=2177 (26%) 
Total=8532 
All mean participants per month 
at grant sites went from 8.8 to 9.1 
compared to 6.8 to 3.0.  
 
Increase observed in grant/non 
grant sites in AA (2.4 to 2.9 vs 1.8 
to 1.1) 
Mean accrual of AA participants 
increased from 34% pre to 44% post 
grant. In comparison sites the 
increase for the same period was 
25% to 28%. All mean participants 
per month at grant sites went from 
8.8 to 9.1 compared to 6.8 to 3.0. An 
increase was also observed between 
grant/non grant sites in AA (2.4 to 
2.9 vs 1.8 to 1.1) 
Du 2009 - 218  98% (193) AA=89 (45%) vs 
Whites=107 (55%) 
At baseline 23% whites vs 12% AA 
indicated that they would be 
extremely likely to enroll. At FU 
this was 22% vs 15%.  
N/a 
Germino 2011 - 104 87% AA made 31% of the 
final sample (over-
represented by 10%. 
State AA pop=21%) 
No comparison by strategy. 
Overall figures presented. 
Increased from 22 pre-strategy to  
104 post strategy 
Harris 2003  1490 600 - None as AA only Proactive phase resulted in 66 
pts, reactive in 534 pts (18% and 
48% of those screened). 
Newspaper and TV ads gave the 
best yields (59% and 58%), the 
Health Centre gave the worst at 
20.3% (% from no’s screened)  
Proactive phase=66 recruits  
Reactive phase=534 recruits 
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Horowitz 
2009 
555 99 - 89% Latino, 9% 
black, 1% Asian, and 
1% Native American 
99 enrolled, 18% of approached. 
Clinician referral=0, Special 
events=17%, Community 
organisations=9%, Public 
events=6%, Partner-led=34% 
n/a 
Kiernan 2000 561 38 - n/a as all Hispanic Flyer alone=2.1%. Flyer + general 
population risk statistics for heart 
disease=6.5% Flyer + Hispanic 
population risk statistics for heart 
disease=9.1% 
n/a 
Martin 2011 343 144 - n/a, all Mexicans 53.5% of all patients randomised 
came from CHWs. 
Church/community events were 
least successful at 3.5%. When 
looking at proportions recruited 
by source family/friend (word of 
mouth) was the most efficient 
with 55% of folks screened being 
randomised. Followed closely by 
CHWs at 53%. Community events 
were least efficient at 23%. 
Twelve months were allocated to 
complete recruitment of 144 
participants. The insurer enrolled 259 
Hispanics with diabetes, but despite 
vigorous attempts (up to 10 
letters/phone calls) only one 
participant was randomized. 
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Du et al (2009) who focussed on the willingness of breast cancer patients to enter a 
trial found attitudes did not change significantly post video intervention. Kiernan et 
al (2000) reported improvement in recruitment rates in her RCT. Hispanic University 
employees were mailed either 1) a flyer about heart disease, 2) a flyer containing 
heart disease risk statistics for the general population, or 3) a flyer containing heart 
disease risk statistics for the Hispanic population. Results show 2.1% were recruited 
through method 1, 6.5% via method 2 and 9.1% via method 3. No incentives were 
offered in this study.  Although, performance bias was controlled for by the design 
of the study it is unclear whether there was an element of contamination.  
Cook et al (2010) reported that government grants to enhance the recruitment of 
ethnic minorities improved recruitment into their study. Comparisons were made 
pre and post award for grant sites as well as between grant awarded and non-grant 
awarded sites. Reimbursement of travel and parking fees were available and 
refreshments were provided free of charge at recruitment meetings. Cook reported 
mean accrual of all participants to increase from 8.8 to 9.1 participants per month 
pre and post grant award compared to 6.8 to 3.0 in non-awarded sites in the same 
time window. The change was also apparent when examining African American 
groups alone (2.4 to 2.9 in awarded sites vs 1.8 to 1.1 in non-awarded sites).  
Martin et al (2011) offered physician’s offices a financial incentive to review their 
records and invite any potential participants. This method was unsuccessful, 
resulting in the randomisation of one participant out of a possible 259. In contrast, 
enlisting the help of local Community Health Workers yielded 53.5% of all recruited 
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participants. Horowitz et al (2009) conducted a Community-Based Participatory 
Research (CBPR) exercise in which researchers and community members developed 
five recruitment strategies. Participants were also offered $50 gift certificates, small 
promotional gifts and a healthy packed lunch. Recruitment through partner-led 
organisations was the most successful yielding 34% of participants. Clinician referral 
was the poorest strategy resulting in no enrolees.  
Proactive methods rely upon recruiters seeking out and inviting potential 
participants whereas reactive recruitment methods rely upon the potential 
participants to make contact with the research team if they are interested in 
participating. Harris et al (2003) set out to compare the strategies using a before 
and after design with the first stage being proactive recruitment from a Health 
Centre. This resulted in 66 recruits (18%) compared to the latter phase where 534 
patients were recruited (48%) following a newspaper and television advertising 
campaign. The comparison is not a clean one as both strategies were in operation in 
the latter phase coupled with the fact that the proactive phase was restricted to the 
health centre whereas the methods used in the reactive phase reached a much 
larger population e.g. television advertisements and large mailshots. This suggests 
strategies that enable researchers to reach larger populations may be more 
efficient in attracting potential participants whereas individual orientated 
approaches may be more effective once a patient has expressed an interest.  
Participants were also offered a total of $100 payment as well as promotional gifts 
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which may have improved uptake. Certificates of achievement upon completion 
were awarded, but rates of retention were not reported in this article. 
Germino et al (2011) used cultural brokers, worked with community organisations 
that trained lay health advocates and enlisted the help of pastors. In addition, the 
language and tone of the study materials were enhanced to be more appealing to 
this young African American breast cancer population. Supplemented with a 
financial incentive at each data collection point plus small gifts every couple of 
months resulted in 22 recruits pre-interventions and 104 post. However, the article 
did not break recruitment down by strategy so it is not possible to decipher if a 
particular element was more effective. Based upon pilot study data Germino et al 
(2011) reported African American women to be more likely to be single parents 
than their Caucasian counterparts and hence the researchers put great effort into 
working around the women’s availability. Furthermore, participants were sent 
birthday cards and gifts letting them know how valuable their contribution was in 
an effort to boost retention. By the end of the study 87% of participants had been 
retained.  
Two of the seven selected trials addressed non-English speaking ethnic minorities 
whilst four focussed on African Americans. The single most significant barrier to 
African American participation is well documented to be mistrust, a legacy left by 
the Tuskegee experiment (Brawley, 1998). As demonstrated by Harris et al (2003) 
and Martin et al (2011) using ethnicity matched researchers appears to be an 
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effective three pronged tool as it not only bridges language and cultural gaps but 
also trust issues. 
Cook et al (2010) demonstrated how grants may be a good way of improving the 
recruitment of ethnic minority groups because it gives the site the flexibility to use 
the grant in ways which are appropriate for their local population. The grants were 
not awarded randomly. Instead a points system was used which took into 
consideration the proportions of ethnic minorities served by the site and any track 
record of recruiting these populations into research. The authors emphasised the 
need to have grants and any interventions in place prior to the start of recruitment.  
Trust issues, particularly within the African American communities of the US 
dominated the literature (Cook et al, 2010; Du et al, 2009; Germino et al, 2011; 
Harris et al, 2003). The Tuskegee study of syphilis conducted between 1932 and 
1972 which left African American males untreated is considered to be the main 
source of distrust and suspicion of healthcare professionals in the US (Brawley, 
1998).   
The motivation to include ethnic minorities in the USA was driven by a change in 
legislation. The NIH Revitalization Act (1993) which stipulates all minorities 
including women, who were routinely excluded from research in the aftermath of 
the thalidomide catastrophe, to be represented in clinical trials in accordance with 
the representation of these groups in a geographical area or proportion suffering 
with the condition of interest. To ensure adherence to this policy the NIH linked 
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recruitment to funding provision with trials failing to recruit representative samples 
of women and ethnic minority groups having their funding terminated (NIH, 2001 
and Air Alert, 1998). 
The motivation to participate in clinical trials in the USA may differ from the UK 
where access to health care is freely available on the NHS. Patients without 
insurance or with inadequate cover in the USA may be more likely to participate in 
a clinical trial in order to benefit from free health care provision. Further to this, the 
USA also has a different attitude to the use of financial incentives to attract trial 
participants compared to the UK where payment above and beyond expenses 
occurred as a result of participating in a trial are classed as inducement. Three of 
the seven selected studies offered financial incentives to the participants (Germino 
et al, 2011; Harris et al, 2003; Horowitz et al, 2009), with a further study offering a 
financial incentive to healthcare professionals who invited patients to participate 
(Martin et al, 2011). 
To summarise, interventions that were reported to be effective in facilitating the 
recruitment of ethnic minority participants included the provision of government 
grants to this end.  Community health workers and ethnicity matched researchers 
were reported to improve recruitment rates along with targeted mailshots, and 
television, radio and newspaper campaigns. As most studies used a combination of 
intervention or strategies it was not possible to obtain a clear picture of the 
effectiveness of each method in turn. Authors reported recruiting through health 
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insurance companies, at church events and health fairs to be the least successful 
strategies.  
Further to the article by Kiernan et al (2000), results from a study of two direct 
mailing strategies in a weight management trial have recently been published by 
the same group (Brown et al, 2012). The articles reports potential participants to be 
more likely to respond to a letter inviting them to participate in a study containing 
an ethnically targeted statement compared to a personalised letter. 
 
7.7.1 Limitations of the review 
Extensive searches were performed to identify potential articles for this review.   
However, the lack of indexed terms for ethnic minorities resulted in the search 
strategies relying heavily upon keyword searching which limited it to the common 
terms used by the authors. As a consequence it is possible that studies may have 
been missed. The review was also restricted to articles written in English and so it is 
possible that relevant studies published in other languages have been missed. 
Further to this, this review focused on interventions to improve recruitment and 
retention of ethnic minority and under-represented groups into clinical trials. 
Screening trials were excluded as it was felt that motivations for entering a 
screening trial would be different to that of other trials, e.g. disease specific. 
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Lastly, the quality assessment criteria for attrition bias were included in order to 
ascertain the quality of the studies and therefore the reliability of the evidence on 
the effectiveness of the reported interventions. However, as the literature review 
was focussed upon interventions that improved both recruitment and retention the 
quality checklist for attrition bias was not the most appropriate tool and 
alternatives would need to be found.  
7.8 Conclusion 
Very few studies met the inclusion criteria and only two of these were RCTs. The 
interventions to improve recruitment and retention were diverse, which is 
expected given the complexity of barriers to participation which can differ by a 
combination of many factors, e.g. ethnic group, age, disease, country, healthcare 
system, history/past experiences. On the whole, the systematic review highlighted 
the lack of research in this area and emphasised the need for good quality studies 
in the future.  
All the included studies originated from the USA and, although they are of interest, 
not all interventions carried out would be feasible in the UK, e.g. the use of financial 
incentives in patients in particular. Payment is limited to subsistence cost, such as 
travel, parking fees, loss of earnings, carers cost if applicable or other costs that 
may preclude people from participating in research. Paying a patient in excess of 
this could be deemed coercion and would need to be approved by an ethics 
committee. Payment may affect the sampling process as patients who are 
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struggling financially may be more willing to participate than if the payment was 
not in place. This could therefore jeopardise the generalisability of the study. 
Financial incentives would also be an issue in other countries outside of the USA, 
such as Australia where, for similar reasons to the UK, it would violate ethical 
principles and be considered inducement (National Statement of Ethical Conduct in 
Human Research, 2007). 
Over half of the selected literature was dominated by building trust in African 
American communities; the effects of Tuskegee may not be as apparent in the UK. 
Although there was some evidence of interventions having a positive effect on 
recruitment, the evidence was not of sufficient quantity or quality to come to any 
definitive conclusions. However, this review has provided a basis for further work.  
Identifying effective strategies to facilitate the recruitment and retention of ethnic 
minorities in UK trials is needed given the ageing population structure of these 
groups. In the future, we expect to see more cancers as well as other diseases, just 
as we have witnessed the growing rates of diabetes and heart disease in ethnic 
minority populations. Kiernan et al (2000) states, “if suitable interventions are not 
identified, researchers may fail to recruit representative populations causing delays 
not only in recruitment time but also in progress into minority health”. The 
effectiveness of interventions may differ by ethnic minority group but I am unable 
to comment on this topic given the thin evidence obtained through this systematic 
review.  
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Based upon findings from the literature review above I would recommend future 
researchers wishing to trial interventions to improve the recruitment and retention 
of ethnic minority groups into RCTS in the UK to consider a cluster design with sites 
trialling different strategies coupled with a before and after comparison as 
demonstrated in the study by Cook et al (2010). Sites would be matched in terms of 
proportions of ethnic minority populations served by the site and the incidence of 
disease within ethnic minority groups e.g. diabetes more prevalent in South Asians 
compared to the Chinese population.  
Interventions I would consider for the UK, where payment beyond expenses 
incurred as a direct result of trial participation would be not considered acceptable, 
would include targeted mailshots in appropriate languages, adverts in local 
businesses and local radio stations. Ethnicity matched researchers, link workers or 
patient navigators who have knowledge of the study and/or disease area and can 
guide a potential participant through trial concepts, e.g. equipoise and 
randomisation, the study protocol and answer any questions.  Early consultations 
and input from representatives of ethnic minority community groups when devising 
strategies and securing funding in order to ensure sufficient resources, e.g. the link 
workers would be advised. 
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Chapter 8 Under-representation of ethnic 
minorities in cancer clinical trials: 
assessing the magnitude of the problem 
8.1 Introduction 
Randomised clinical trials are improving treatment in many disease areas, cancer 
being one of them. There are many benefits for patients who participate in an RCT 
which include access to new drugs or interventions before they are available on the 
NHS. There is also evidence to suggest that patients who participate in clinical trials 
have better outcomes (Braunholtz et al, 2001). This may be due to closer 
monitoring of their disease and general wellbeing as part of the trial protocol. 
However, the efficacy of treatments and toxicities suffered may vary between 
ethnic groups due to differences in pharmacokinetics (what the body does to the 
drug) and pharmacodynamics (what the drug does to the body). Ethnic factors can 
differ in two ways, intrinsically or extrinsically. Intrinsic factors include 
comorbidities and genetics, for example, the discovery of the salt sensitivity gene in 
African Americans (Johnson 1997, Xie et al, 2001, McGraw and Waller 2012). 
Extrinsic influences include environmentally factors such as diet, exercise and 
smoking habits.   
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Ethnic minorities have been shown to be poorly represented in clinical trials 
(Hussain-Gambles et al, 2003 and 2004, Mason et al, 2003, Murthy et al 2004, 
Godden et al, 2010), although there has been little recent evidence from the UK to 
support this. More recent research from the USA has been published which is of 
interest but not completely relevant to the UK (Hoel et al, 2009, Geller et al, 2011). 
The USA differs in several aspects:  
1) The proportion of ethnic minorities is much higher, in 2010 22% identified 
themselves as belonging to a ethnic minority group   (US Census bureau, 2010) 
2) The ethnic minority groups are different (the USA has a large proportion of 
Hispanic, Pacific Islanders and Alaskan Natives as well as African and Asian 
Americans)  
3) The healthcare system is privatised which makes receiving treatment 
difficult or impossible if you do not have adequate health insurance 
The importance of collecting ethnicity data has been increasingly recognised since 
the registration of this PhD. Cancer Research UK highlighted the importance of 
collecting ethnicity data in cancer patients and in 2006 commissioned a project to 
identify methods by which ethnicity data collection could be improved for cancer 
statistics.  
Cancer registration data is collected by 11 registries in the UK. The data is obtained 
from a range of sources, including hospitals, cancer centres, pathology laboratories, 
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private hospitals, general practice, hospices, nursing homes, screening programmes 
and death certificates. Data collected included tumour and patient characteristics 
but ethnicity was not included in the dataset until a few years ago.  
Data linkage was one possible means of obtaining ethnicity from Hospital Episode 
Statistics (HES) datasets that has been explored by cancer registries. The HES 
database holds information on every hospital encounter a patient has as either in- 
or outpatient. Ethnicity has been collected as part of HES data since 2004/5 and 
although collection has been patchy there have been improvements over recent 
years (HES online, 2004 and 2011). One of the main issues encountered during the 
linkage exercise was the occurrence of conflicting ethnicity codes where patients 
had multiple records. Methods using the ‘most frequently recorded ethnicity’ or the 
‘last recorded ethnicity’ were explored as well as multiple imputation to overcome 
this (Ryan et al, 2012).  
In 2009, the National Cancer Intelligence Network (NCIN) in collaboration with 
cancer registries published a report of cancer incidence figures using this newly 
collated data (NCIN, 2009). The report is the first of its kind, but is based upon 
incomplete data. Ethnicity was reported to be missing/unobtainable for 
approximately 25% of cancer registrations and the findings were limited to broad 
ethnic categories: White, Asian, Black, Chinese, Mixed and Other due to the small 
number of cancer registrations of patients in the ethnic minority groups. Three 
levels of sensitivity analyses were performed as a consequence of the missing 
ethnicity data, the first assuming patients with missing ethnicity were missing 
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completely at random therefore had the same distribution as the patients with 
recorded ethnicity. This was followed by extreme scenarios, firstly assuming all the 
unknowns were of White origin which produced the lowest rates of non-White 
incidence and secondly assuming they were non-White giving the highest rates. The 
results proved tricky to interpret.  
The aim of this chapter was to attempt to assess the size of the under-
representation problem by estimating how many ethnic minority patients would be 
expected to go into cancer trials using data from the following sources which were 
available for use in this thesis:  
1. 2001 and 2011 UK census  
2. Hospital Episode Statistics audit data from a large local teaching hospital 
3. Cancer Research Network trial recruitment data from one ethnic rich 
hospital 
These datasets were chosen to obtain rates of the ethnic minority populations in 
the UK, England and Wales and the local West Midlands area, and to examine 
ethnicity data collected in one local hospital and also to assess rates of cancer by 
ethnic group in this ethnic rich population. The local cancer research network 
recruitment dataset (also from the same ethnic-rich population) was chosen to 
enable assessment of the representation of ethnic minorities in cancer clinical trials.  
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8.2 Methods 
8.2.1 Census data 
8.2.1.1 Census 2001 
Population pyramids of the 2001 UK inhabitants exploring age, gender and country 
of birth across ethnic group were produced using Microsoft Excel to study the 
changing make-up of the UK population and the West Midlands population 
independently. The data presented here is from a table commissioned from the 
ONS in 2009. It included data from the Scottish and Northern Ireland censuses for 
the same period. The ethnic categories used by each census differed slightly (as 
explained in Chapter Two) and were harmonised to form 11 common groups for 
this analysis.  
8.2.1.2 Census 2011 
Data from the recent release of 2011 census was extracted from the ONS data table 
KS201EW which provides information split by local authority and also split by 
ethnicity. These data were used to compare the distribution of Coventry’s ethnic 
population to that of England and Wales. Only limited information was available for 
the 2011 census at the time of completing this thesis. As ethnicity was not broken 
down by age in census table KS201EW it was not possible to calculate age-specific 
incidence rates.  
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8.2.2 Hospital Episode Statistics 
Audit datasets for the period Jan 2007 to Dec 2012 were made available for use in 
this thesis. Completeness of ethnicity fields in both inpatient and outpatient 
datasets was assessed. Place of Birth, Religion and Language data were also 
compared across datasets.  
 Records meeting the following criteria were selected to create four datasets: 
8.2.2.1 Inpatients (dataset A) 
Patients with International Classification Disease codes for NEOPLASMS (ICD version 
10, codes C00 to D49) were identified and selected. Inpatient data were read into 
SAS statistical software. Patients had anything between 1 and 16 diagnoses, with 
many of these being non-cancer. However, some cancer codes referred to 
subsequent malignancies or disease metastasising to other areas of the body coded 
as ‘cancer of unknown or ill-defined origin’.  
These data were examined in the first instance looking purely at primary diagnosis 
(one row per patient format) followed by all diagnoses (multiple rows per patient). 
Non-cancer codes were re-coded to missing using SAS statistical software. I 
transposed this dataset in SAS in order to obtain the frequency of cancers suffered 
per patient. Cancer diagnoses were explored using frequency tables and cross-
tabulations. Scrutinizing all diagnoses provided a clearer picture of the prevalence 
rates of disease by site.  
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Incidence is a commonly used measure of the risk of developing a disease within a 
specified time frame. Precise incidence rates are very difficult to estimate even 
when not considering ethnic group. For this reason I have reported rates of cancer 
over a six year period (2007 to 2012) and one year period (Jan to Dec 2012).  
8.2.2.2 Outpatients (dataset B) 
The outpatient records originated from all oncology clinics held at a large local 
teaching hospital between 2007 and 2012. Data were provided in a one row per 
patient format with duplicates removed where possible. Further details relating to 
the clinic were not available. 
As it was possible for patients to be treated exclusively as inpatients, outpatients or 
indeed both then it was necessary to inspect these data in two additional 
permutations (datasets C and D below). 
8.2.2.3 Overlapping set (dataset C) 
Patients treated as both inpatient and outpatients presented an opportunity to 
compare reported ethnicities. The data were read into SAS statistical software and 
merged using a unique identifier. Rates of agreement for ethnic group across 
datasets were reported.  
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8.2.2.4 Final set (dataset D) 
Inpatient records were merged in SAS with the records of patients treated as 
outpatients only to form the final dataset of all records. For patients with 
missing/unknown ethnic group the record with most information was taken. This 
dataset was used to calculate the cancer rates for primary diagnoses and 
transposed using SAS to obtain all diagnoses.  
Exploration of the inpatient and outpatient data sets revealed two separate codes 
for ethnic origin, local and national (which is in keeping with the 2001 census 
categories). The codes were identical except for the inclusion of ‘not known’ and 
‘not specified’ in the local coding which is not offered in the national list. The local 
ethnicity coding was used for the entirety of this research. 
I examined these data over the full six year period and for 2012 exclusively to allow 
comparison with 2011 census data for Coventry and recruitment data from the 
selected Cancer Research Network. 
8.2.3 Cancer Research Network recruitment data 
Locally a Cancer Research Network (CRN) entered 35% of eligible patients into trials 
in 2005/6 (NCRN, 2006). In April 2012, the network changed software to a new 
database (EDGE) which gave them the ability to record information on all potential 
participants seen by the research team and their trial status (recruited, screened, 
declined). The database also had dedicated fields to record ethnicity and reason for 
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non-participation. Ethnicity was transferred from the HES database or medical 
notes to the recruitment database without consulting the patient. These data were 
available for April 2012 to April 2013 at the time of this write-up. Trial status was 
explored by ethnicity to gauge the numbers of patients invited to participate, those 
declining and numbers recruited.  
This dataset in conjunction with the final dataset derived from HES (dataset D) were 
used to crudely assess representiveness of cancer patients in clinical trials in the 
local area.  
8.2.4 Assessing representation 
In order to estimate the representativeness of the patients coming through the 
doors of the selected Cancer Research Network based within a large local teaching 
hospital, the total numbers of patients attending the hospital with cancer as 
reported above were used to form a denominator. The Cancer Research Network 
recruitment data were only available from April 2012 to April 2013 whereas HES 
data were available from Jan 2007 to Dec 2012. In order to assess 
representativeness over a year I chose to use HES data for 2012 (Jan-Dec) as it 
maximised crossover with the CRN recruitment data.  
In order to obtain a more accurate denominator I deleted patients meeting any of 
the following three criteria from the 2012 HES data. Firstly, patients dying in 
hospital as they may not have lived long enough to be identified by the research 
network, invited to participate in a trial or may have been filtered out at multi-
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disciplinary team (MDT) meetings because they were not fit enough to tolerate the 
treatment or did not meet other eligibility criteria. A patients’ treatment package is 
usually decided at these meetings and any potential trial candidates identified. The 
MDT may take a variety of criteria into consideration before making their decision, 
for example, co-morbidities or the ability to give informed consent. A list of open 
trials and their inclusion and exclusion criteria are usually available at these 
meetings which are frequently attended by a member of the research team.   
Secondly, patients who discharge themselves may not be interested in receiving 
treatment and so it could be assumed that there is a higher probability that they 
may not be in hospital long enough to be invited to participate in a trial, or would 
not participate if invited. This could also be true of those discharged by a relative. 
For this reason, these patients did not form part of the denominator. Thirdly, it was 
hypothesised some patients admitted for surgery may not be identified as possible 
candidates, e.g. cancer removed with no further treatment. These patients were 
also excluded from the denominator. 
8.3 Results 
8.3.1 City X’s ethnic population   
The population of City X is very diverse, with a higher proportion of non-white 
minorities than reflected in the overall census distribution (26.2% compared to 
14.1% respectively, see Table 8.1). This does not take into account the recent influx 
of Polish natives who would be placed within the ‘Other White’ category, which is 
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higher in City X than nationally (4.9% vs 4.4%). The largest non-white ethnic 
minority groups in 2011 England and Wales were Indian, Pakistani and Black African 
accounting for 2.5%, 2% and 1.8% respectively. Although the City X top three ethnic 
minority groups are the same as England and Wales, the proportions are different 
with Indians making up 8.8%, Black Africans now in second place with 4% and 
Pakistanis’ accounting for 3% of the population. 
Table 8.1 England and Wales and City X, 2011 census by ethnic group 
  England & Wales City X 
Category Ethnic group N % N % 
White: British, Scottish,  
Welsh, Northern Irish 
White British 
White Irish 
White Gypsy or Irish traveller 
Other White 
45,134,686 
531,087 
57,680 
2,485,942 
80.5 
0.9 
0.1 
4.4 
211,188 
7,305 
151 
15,385 
66.6 
2.3 
0.0 
4.9 
Mixed/Multiple  
Ethnicities 
White and Black Caribbean 
White and Black African 
White and Asian 
Other Mixed 
426,715 
165,974 
341,727 
289,984 
0.8 
0.3 
0.6 
0.5 
3,672 
943 
2,388 
1,227 
1.2 
0.3 
0.8 
0.4 
Asian/Asian British Indian 
Pakistani 
Bangladeshi 
Chinese 
Other Asian 
1,412,958 
1,124,511 
447,201 
393,141 
835,720 
2.5 
2 
0.8 
0.7 
1.5 
27,751 
9,510 
2,951 
3,728 
7,658 
8.8 
3.0 
0.9 
1.2 
2.4 
Black/African/ 
Caribbean/Black British 
African 
Caribbean 
Other Black 
989,628 
594,825 
280,437 
1.8 
1.1 
0.5 
12,836 
3,317 
1,611 
4.0 
1.0 
0.5 
Other ethnic group Arab 
Any other ethnic group 
230,600 
333,096 
0.4 
0.6 
2,020 
3,319 
0.6 
1.0 
Total All categories 56,075,912 100 316,960 100 
 Non-White 7,866,517 14.1 82,931 26.2 
Note: Data extracted from ONS 2011 census data table KS201EW. 
(http://www.ons.gov.uk/ons/search/index.html?newquery=ethnic+group) 
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8.3.2 Hospital Episode Statistics 
Analysis of ICD codes revealed 2278 patients with Non-Melanoma Skin Cancer 
(NMSC) and no further cancers. These patients were excluded from analysis as they 
are easily treated and are very common (usually abnormal moles and similar). They 
are slow growing and prognosis is very good hence the dearth of research in this 
area. This left 18,663 records remaining in the final inpatient dataset (dataset A, see 
Figure 8.1).  
Ninety four duplicate records were identified in the outpatient dataset and 
excluded leaving 18,322 records in the final outpatient dataset (dataset B). In terms 
of combined datasets, 10,251 patients were found to have a record in both in and 
outpatient sets (dataset C). The final dataset comprised of all inpatient records 
merged with patients who were treated as outpatients only (18663 + 8071=26,734, 
dataset D). 
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Figure 8.1 Process of HES dataset creation 
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8.3.3 Completeness of ethnicity in inpatients and outpatients 
The inpatient population (dataset A) 
The majority of inpatients were White British as expected making up 86.08% of the 
population (Table 8.2). The second largest group, although considerably smaller, 
were Indian (2.75%). Alarmingly, the third largest category were ‘not known’ 
comprising 2.44%, although ‘not specified’ and ‘not stated’ codes contributed a 
further 0.03% and 1.26%, respectively, resulting in total unknown ethnicity codes of 
3.73%. The Irish group contributed 2.34% whilst the Other White group was the 
next largest at 1.65% which included residents of Eastern European origin (e.g. 
Polish). The smallest groups were those who chose not to specify their ethnicity 
(0.03%), Chinese (0.14%), Bangladeshi (0.16%), Other Black (0.22%), Other Asian 
(0.33%), African (0.35%) and Pakistani (0.5%).   
The outpatient population (dataset B) 
There appeared to be a smaller proportion of White British outpatients compared 
to inpatients (78.17% vs 86.08%) see Table 8.2. Furthermore, All Whites accounted 
for 81.61% of outpatients yet 90.07% of inpatients. This anomaly may simply be due 
to the poorer collection of outpatient data. The outpatient ethnicity data contained 
a greater proportion of missing and not known, not specified and not stated codes 
accounting for 13.21% of outpatients compared to 3.73% for inpatients. The 
proportions of the remaining non-White ethnic minorities were similar across both 
datasets. 
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Table 8.2 : Datasets A and B-Ethnicity coding of the inpatient and all 
outpatient records 
 A=Inpatients B=Outpatients 
 N % N % 
A=White British 
B=Irish 
C=Other White 
16065 
436 
308 
86.08 
2.34 
1.65 
14322 
378 
253 
78.17 
2.06 
1.38 
D=Mix White+ Caribbean 
E=Mix White + African 
F=Mix White + Asian 
G=Mix Other 
22 
15 
4 
15 
0.12 
0.08 
0.02 
0.08 
27 
16 
8 
10 
0.15 
0.09 
0.04 
0.05 
H=Indian 
J=Pakistani 
K=Bangladeshi 
L=Other Asian 
514 
93 
30 
61 
2.75 
0.50 
0.16 
0.33 
437 
60 
18 
52 
2.39 
0.33 
0.10 
0.28 
M=Caribbean 
N=African 
P=Other Black 
131 
65 
41 
0.70 
0.35 
0.22 
106 
43 
37 
0.58 
0.23 
0.20 
R=Chinese 
S=Other ethnic 
26 
140 
0.14 
0.75 
26 
107 
0.14 
0.58 
NKN=Not known 
NSP=Not specified 
Z=Not stated 
456 
6 
235 
2.44 
0.03 
1.26 
1430 
42 
949 
7.80 
0.23 
5.18 
Total 18663 100 18322 100 
 
The split between males and females was roughly equal in the inpatient population 
with 49% being female (see Table 8.3). However, an imbalance was noted in the 
outpatient set, with 57% of patients being female. A large proportion of the 
patients were over 60 years of age (70% of inpatients vs 64% of outpatients) which 
was not unexpected in this cancer population. These data show a greater 
proportion of females than males being treated at a younger age in both sets 
(inpatients=35% females and 24% males, outpatients=42% females and 27% males), 
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possibly a reflection of breast cancer screening from the age of 47 years and over. 
Place of birth was largely incomplete, with outpatients having marginally poorer 
completion than inpatients (68% vs 70%); where completed most patients were 
born in the UK.  
Table 8.3 : Dataset A and B-Inpatient and all outpatient, age and place of 
birth by gender 
   Males Females Total 
Dataset Factor Grouping N % N % N % 
A=Inpatients Age <=60 
>60 
2315 
7148 
24 
76 
3252 
5948 
35 
65 
5567 
13096 
30 
70 
 Place of  
Birth 
UK 
Non-UK 
Blank 
3114 
109 
6240 
33 
1 
66 
2721 
102 
6377 
30 
1 
69 
5835 
211 
12617 
31 
1 
68 
B=Outpatients Age <=60 
>60 
2167 
5740 
27 
73 
4361 
6054 
42 
58 
6528 
11794 
36 
64 
 Place of  
Birth 
UK 
Non-UK 
2034 
70 
26 
1 
2310 
88 
22 
1 
4344 
158 
24 
1 
  Blank 5803 73 8017 77 13820 75 
 
A small proportion of in- and outpatients declined to provide data on religious 
beliefs (0.54% vs 0.36% respectively, see Table 8.4). Furthermore, large proportions 
in both in- and outpatients were coded as ‘not specified’ (37.16% and 41.23% 
respectively). Where reported, data on religion showed the majority of the 
population identified themselves as of Christian denomination, these were 
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combined into a new ‘Christian all denominations’ category (58.58% inpatients and 
55.28% of outpatients).  
Table 8.4 : Dataset A and B-Religious affiliation Inpatient and all 
outpatients 
Factor Grouping A=Inpatients 
N 
 
% 
B=Outpatients 
N 
 
% 
Religious  Agnosticism 59 0.32 38 0.21 
affiliation Atheist 48 0.26 38 0.21 
 Christian  
(all denominations) 
10932 58.58 10129 55.28 
 Declined to give 100 0.54 66 0.36 
 Hinduism 154 0.83 144 0.79 
 Islam 152 0.81 115 0.63 
 Judaism 6 0.03 6 0.03 
 Not Specified 
Other 
6936 
18 
37.16 
0.10 
7554 
13 
41.23 
0.07 
 Satanism - - 1 0.01 
 Sikhism 250 1.34 211 1.15 
 Buddhism 8 0.04 7 0.04 
 Total 18663 100 18322 100 
 
Language was completed well with all patients having entries in both datasets 
(Table 8.5). The overwhelmingly majority (99%) spoke English. The remaining 1% 
comprised of Panjabi, Polish, Urdu and Guajarati amongst others. This revealed that 
the vast majority of Coventry’s ethnic minority population had some level of 
English, which may be directly associated with country of birth and time in the UK. 
However, birthplace is poorly completed so I was not able to verify this (Table 8.3).  
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Table 8.5 : Dataset A and B-Inpatient and outpatient reported language 
Factor Grouping A=Inpatients 
N 
 
% 
B=Outpatients 
N 
 
% 
Language Albanian 1 0.01 1 0.01 
 Amharic 1 0.01 1 0.01 
 Arabic 1 0.01 1 0.01 
 Bengali 5 0.03 2 0.01 
 Bosnian 1 0.01 1 0.01 
 British Sign Language 
Chinese 
Croatian 
2 
2 
1 
0.01 
0.01 
0.01 
1 
1 
- 
0.01 
0.01 
0.01 
 Czech 3 0.02 2 0.01 
 Dutch, Flemish 2 0.01 1 0.01 
 English 18527 99.27 18228 99.49 
 French 
German 
Greek 
3 
2 
1 
0.02 
0.01 
0.01 
2 
1 
- 
0.01 
0.01 
0.01 
 Gujarati 10 0.05 9 0.05 
 Hindi 5 0.03 4 0.02 
 Italian 4 0.02 1 0.01 
 Kurdish 1 0.01 3 0.02 
 Latvian 1 0.01 1 0.01 
 Lingala 1 0.01 1 0.01 
 Malayalam 
Nepali 
Other 
1 
1 
1 
0.01 
0.01 
0.01 
- 
1 
2 
0.01 
0.01 
0.01 
 Panjabi 
Persian (farsi) 
39 
- 
0.21 
- 
26 
1 
0.14 
0.01 
 Polish 17 0.09 14 0.08 
 Portuguese 3 0.02 3 0.02 
 Romanian 1 0.01 1 0.01 
 Russian 
Shona 
2 
1 
0.01 
0.01 
1 
1 
0.01 
0.01 
 Tamil 
Thai 
Tigrinya 
Turkish 
2 
1 
1 
1 
0.01 
0.01 
0.01 
0.01 
1 
- 
- 
- 
0.01 
- 
- 
- 
 Urdu 
Vietnamese 
Total 
17 
1 
18663 
0.09 
0.01 
100 
10 
- 
18322 
0.05 
- 
100 
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By categorising ICD 10 codes, I was able to code cancer sites and present them split 
by gender, see Table 8.6. The most common primary malignancies in the female 
subset were breast (24.9%), ill-defined malignancies (11.7%) and cancers of the 
female genital organs (8.7%). Prostate, digestive and colorectal and lung were the 
most common in males (20.3%, 11.6%, 9.9% and 9.9% respectively).  
Table 8.6 : Dataset A-Inpatients by primary diagnosis and gender 
Disease site Females Males Total 
 N % N % N % 
Head and Neck                                                                                                239 2.6 547 5.8 786 4.2 
Bladder                                                                                              261 2.8 800 8.5 1061 5.7 
Brain/Eye                                                                                              215 2.3 375 4 590 3.2 
Breast                                                                                              2294 24.9 18 0.2 2312 12.4 
Colorectal                                                                                             776 8.4 935 9.9 1711 9.2 
Digestive                                                                                             720 7.8 1093 11.6 1813 9.7 
Female genital organs                                                                                              803 8.7 - - 803 4.3 
Ill defined                                                                                             1073 11.7 904 9.6 1977 10.6 
Leukaemia                                                                                              268 2.9 372 3.9 640 3.4 
Lung                                                                                               764 8.3 939 9.9 1703 9.1 
Lymphoma. 420 4.6 485 5.1 905 4.9 
Male genital organs - - 191 2 191 1 
Melanoma                                                                                              126 1.4 147 1.6 273 1.5 
Mesothelioma                                                                                              80 0.9 120 1.3 200 1 
Myeloma                                                                                              196 2.1 217 2.3 413 2.2 
Ovary                                                                                              550 6 - - 550 3 
Prostate                                                                                             - - 1917 20.3 1917 10.3 
Thyroid                                                                                              201 2.2 79 0.8 280 1.5 
Urinary tract                                                                                            185 2 279 2.6 464 2 
Other 29 0.3 45 0.5 74 0.4 
Total                                                                                              9200  9463  18663 100 
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When examining all diagnoses using the transposed copy of dataset A, cancers of ill-
defined origin were the most common diagnosis over the six year period (30.2%), 
followed by breast cancer (19.9%), with lung cancer overtaking malignancies of the 
females genital organs (6.9% vs 6.7%), see Table 8.7.  Similarly in males, ill-defined 
malignancies were the most common cancer over the six year period, followed by 
prostate and the addition of malignancies of the digestive organs (25.3%, 17.2% and 
9.3% respectively).  
Table 8.7 Dataset A-Inpatients, all diagnoses by gender (multiple patients 
from transposed dataset) 
Disease site Females Males Total 
 N % N % N % 
Head and Neck                                                                                                245 2 563 4.7 808 3.3 
Bladder                                                                                              267 2.2 828 6.9 1095 4.5 
Brain/Eye                                                                                              222 1.8 382 3.2 604 2.5 
Breast                                                                                              2427 19.9 21 0.2 2448 10.1 
Colorectal                                                                                             816 6.7 980 8.1 1796 7.4 
Digestive                                                                                             734 6 1123 9.3 1857 7.7 
Female genital organs                                                                                              817 6.7 - - 817 3.4 
Ill defined                                                                                             3677 30.2 3042 25.3 6719 27.7 
Leukaemia                                                                                              269 2.2 384 3.2 653 2.7 
Lung                                                                                               842 6.9 1032 8.6 1874 7.7 
Lymphoma. 432 3.6 497 4.1 929 3.8 
Male genital organs - - 193 1.6 193 0.8 
Melanoma                                                                                              132 1.1 156 1.3 288 1.2 
Mesothelioma                                                                                              88 0.7 121 1 209 0.9 
Myeloma                                                                                              200 1.6 221 1.8 421 1.7 
Ovary                                                                                              584 4.8 - - 584 2.4 
Prostate                                                                                             - - 2067 17.2 2067 8.5 
Thyroid                                                                                              204 1.7 83 0.7 287 1.2 
Urinary tract                                                                                            198 1.6 304 2.5 502 2.1 
Other 32 0.3 46 0.4 78 0.3 
Total                                                                                              12186 50.3 12043 49.7 24229 100 
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8.3.4 C=Overlapped dataset (in- and outpatients) 
10,251 patients were treated as both in- and outpatients. Ethnicity data were 
compared across the sets to check for agreement. Ethnicity was the same in 10,215 
of 10,251 patients (99.6%). In the 36 patients where there was disagreement, many 
were due to unknown codes recorded in one dataset, e.g. 12 patients were coded 
as not known and 12 as not stated in outpatients but were coded as White British in 
the inpatient set (Table 8.8).  A direct conflict of codes was detected in only three 
patients (in bold in Table 8.8). One patient was coded as an Irish inpatient but 
White British as an outpatient. Two other patients were coded as Indian as 
inpatients but Mixed in outpatients (possible error as Asian not selected from the 
Mixed categories). As inpatient data were generally better completed, I was more 
confident in the quality so took this to be the more accurate of the two datasets.  
Table 8.8 Dataset C-Inpatients and outpatient ethnicity comparison 
results for 36 patients with disagreement 
A=Inpatients B=Outpatients N 
White British Not known 
Not stated 
12 
12 
Irish White British 
Not known 
Not stated 
1 
1 
1 
Other White Not known 
Not stated 
1 
1 
Indian Mix-White & Caribbean 
Mix Other 
Not stated 
1 
1 
2 
Not known White British 1 
Not stated White British 2 
Total  36 
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8.3.5 D=Final dataset (all inpatients plus any additional 
outpatients) 
Ethnic groups were combined to eliminate groups with small numbers for the final 
analyses. The smallest groups with recorded ethnicity were those who chose not to 
specify, all mixed categories, Chinese, Bangladeshi, Pakistani, Other Asian, African 
and Other Black. For this reason, I combined Pakistani, Bangladeshi and Other Asian 
background together to form a new ‘Other Asian’ category and African and Other 
Black background into a ‘Other Black’ category, as well combining Chinese into the 
already existing ‘Other Ethnic’ (see Table 8.9). I also created a new ‘All Mixed’ 
category for all mixed groups.  
Table 8.9 Dataset D-Final ethnic group 
Factor Grouping n % 
Ethnic 
group 
A=White British 21570 81 
B=Irish 580 2 
C=Other White 390 1 
D-G=All Mixed ethnicities 78 0.3 
H=Indian 659 2 
J-L=Pakistani, Bangladeshi and Other Asian 219 0.8 
M=Caribbean 163 0.6 
N and P=African and Other Black 131 0.5 
S=Other ethnic 213 0.8 
Unknown ethnicity 2731 10 
Total 26734 100 
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Due to small numbers I also amalgamated cancer codes as shown below: 
1. Digestive organs: small intestine, oesophagus, stomach  
2. Female genital organs: Uterus, placenta, Vulva 
3. Male genital organs: Testis, penis 
4. Lymphoma: Hodgkins, Non-Hodgkins, Other Lymphoma 
Age and gender information was available for all 26,734 patients in the final set 
(Table 8.10). There were more females (53%) than males (47%) overall. The 
proportion of females aged 65 years and under was higher in comparison to males 
(38% vs 24% respectively). Place of birth was non-informative given the large 
proportion of missing data.   
Table 8.10 Dataset D-Final age group and place of birth by gender 
  Females 
(n=14103) 
Males 
(n=12631) 
Total 
(n=26734) 
Factor Grouping N % N % N % 
Age group <=65 years 
>65 years 
5308 
8795 
38 
62 
3081 
9550 
24 
76 
8389 
18345 
31 
69 
Place of birth UK 
Non-UK 
Missing 
Not known/stated 
3322 
127 
5 
10649 
24 
0.9 
0.04 
76 
3514 
125 
5 
8987 
28 
1 
0.04 
71 
6836 
252 
10 
19636 
26 
0.9 
0.04 
73 
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Forty per cent of patients did not specify any religious beliefs with a further 0.4% 
declining to provide this information (Table 8.11). 56% of patients were Christian 
(56%) with other religions accounting for 3.7%. Sikhism, Hinduism and Islam (1.2%, 
0.8% and 0.7% respectively) were the largest other groups in this population. 
Table 8.11 Dataset D-Final religion 
Religion N % 
Christian (all denominations) 14920 56 
Not Specified 10825 40 
Sikhism 319 1.2 
Hinduism 206 0.8 
Islam 186 0.7 
Declined to give 113 0.4 
Agnosticism 64 0.2 
Atheist 58 0.2 
Other 23 0.1 
Buddhism 10 0.04 
Judaism 9 0.03 
Satanism 1 0.004 
Total 26734 100 
 
An overwhelming majority of patients spoke English (99.4%) as shown in Table 8.12. 
The three most common languages other than English were Panjabi (0.18%), Polish 
(22%) and Urdu (0.07%). Information regarding proficiency was not available. 
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Table 8.12 Dataset D-Final language 
Factor Grouping N % 
Language Albanian 1 0.004 
 Amharic 1 0.004 
 Arabic 1 0.004 
 Bengali 5 0.02 
 Bosnian 1 0.004 
 British Sign Language 2 0.01 
 Chinese 2 0.01 
 Croatian 1 0.004 
 Czech 3 0.01 
 Dutch, Flemish 2 0.01 
 English 26574 99.4 
 French 3 0.01 
 German 2 0.01 
 Greek 1 0.004 
 Gujarati 13 0.05 
 Hindi 6 0.02 
 Italian 5 0.02 
 Kurdish 3 0.01 
 Latvian 1 0.004 
 Lingala 1 0.004 
 Malayalam 1 0.004 
 Nepali 1 0.004 
 Other 2 0.01 
 Panjabi 47 0.18 
 Persian (Farsi) 1 0.004 
 Polish 22 0.08 
 Portuguese 3 0.01 
 Romanian 1 0.004 
 Russian 3 0.01 
 Shona 1 0.004 
 Tamil 2 0.01 
 Thai 1 0.004 
 Tigrinya 1 0.004 
 Turkish 1 0.004 
 Urdu 18 0.07 
 Vietnamese 1 0.004 
 Total 26734 100 
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8.3.6 Primary cancer diagnosis by ethnic group (dataset D) 
ICD codes were only recorded for inpatient; disease site was unknown for the 8,071 
patients treated as outpatients only. Table 8.13 below shows the rates of cancer for 
the final dataset (daatset D). Data were not also presented split by gender due to 
the small number of ethnic minorities. Outpatients were included as a separate 
row.  
Tables 8.13 and 8.14 show figures for primary cancer site by ethnic group over the 
six year period (2007-2012). Figures for 2012 have also been presented in order to 
allow comparability between the HES and CRN recruitment data. Table 8.13 
presents column per cents which highlights the distribution of cancers within each 
ethnic group, whereas Table 8.14 presents row per cents to show the distribution of 
ethnic minorities across disease site.   
Overall, the numbers of ethnic minority patients was small. The proportion of 
patients with not known/not specified ethnicity data accounted for 10% of the six 
year data. However, looking at this category over the six year period it is possible to 
see a statistically significant trend showing an increase in unknown ethnicity codes 
from 5% in 2007 to 13% three years later in 2010 and 15% in 2012 (Mantel-
Haenszel Chi-Square p<0.0001). This may be a reflection of the increased strain on 
NHS resources.  
Based upon the available data it was possible to see that breast cancer was the 
most prevalent malignancy in six ethnic groups, White British (9%), Other White 
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(9.5%), Indian (13.5%), Pakistani/Bangladeshi/other Asians (11.9%), other ethnic 
group (11.3%) and unknown ethnicity (3.7%, see Table 8.13). Prostate cancer was 
the most common in three groups including Irish (12.6%), Caribbean (24.5%) and 
the new All mixed category (15.4%). The high proportion of prostate cancers in the 
Caribbean group confirms existing evidence of higher incidence in this population 
(National Cancer Intelligence Network, 2009).  Interestingly, the high proportion of 
prostate cancers in the Mixed group appeared to be due to the mixing of the 
African or Caribbean population with other ethnic groups (‘White and Caribbean’, 
‘White and African’ and ‘White and Other‘ patients in this dataset). Lymphoma was 
the most common in the African and Other Black group (10.7%).  
Table 8.14 shows White British patients unsurprisingly accounting for the bulk of 
patients in every disease site ranging from the lower 74.4% in cancers of the male 
genitals to a high of 90.5% in melanoma. Looking at ethnic minority disease aside 
from the White British population, the Irish group were shown to be the most 
afflicted by bladder (3%), lung (3.3%) and prostate (3.8%) cancers. The highest 
ethnic minority rates of eye/brain cancers (2.4%), leukaemia (3.6%), mesothelium 
(4.5%), myeloma (4.8%), thyroid (4.3%) and other malignancies (5.4%) were in the 
Indian group. However, sites such as head and neck (3.2%), breast (4.4%), colorectal 
(3.8%), digestive (3.6%), malignancies of the female genitals (9.3%), ill-defined 
cancers (3.1%), lymphoma (3.4%), male genitals (17.3%), melanoma (5.1%) and 
prostate (10%) were highest in the unknown ethnicity group.   
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As the inpatient dataset contained multiple diagnoses it was important to explore 
all malignancies. Tables 8.15 and 8.16 are in the same format as above but report 
all cancers suffered. Ill-defined malignancies were the most common across all 
ethnic groups with the exception of Caribbean patients where prostate cancer was 
slightly higher accounting for 25.2% (Table 8.15). The distribution of all 
malignancies across ethnic minorities group (i.e. excluding White British) was 
similar to that of the primary diagnosis. The ‘unknown ethnicity’ group suffered the 
largest proportion of disease across the majority of disease sites with the exception 
of eye/brain, leukaemia, lymphoma, mesothelium, myeloma, and other cancers 
where the Indian group were shown to carry greater burden (2.4, 3.6, 4, 4.5, 4.8 
and 5.4% respectively. The Irish population were seen to suffer the most bladder 
cancers (3%), lung cancers (3.3%) and prostate cancers (3.8%, see Table 8.16). 
Cancer rates in ethnic minority populations remained small even when considering 
all malignancies. 
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Table 8.13 Dataset D-Primary cancer diagnosis by ethnic group (column %) 
 White 
British 
Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
Caribbean Other 
Black 
Other  
Ethnicity 
Unknown 
ethnicity 
Total 
Head & Neck                                                                                                692 (3) 12 (2) 14 (3.6) 3 (3.9) 22 (3.3) 9 (4.1) 3 (1.8) 1 (0.8) 5 (2.4) 25 (0.9) 786 (2.9) 
Bladder 952 (4) 32 (5.5) 18 (4.7) 1 (1.3) 24 (3.6) 12 (5.5) 5 (3) 1 (0.8) 6 (2.8) 10 (0.4) 1061 (4.0) 
Breast 1959 (9) 44 (7.6) 37 (9.5) 9 (11.5) 89 (13.5) 26 (11.9) 9 (5.5) 13 (9.9) 24 (11.3) 102 (3.7) 2312 (8.6) 
Colorectal 1500 (7) 44 (7.6) 29 (7.4) 2 (2.6) 30 (4.6) 11 (5) 9 (5.5) 6 (4.6) 15 (7) 65 (2.4) 1711 (6.4) 
Digestive 1578 (7) 38 (6.6) 21 (5.4) 3 (3.9) 46 (7) 22 (10) 16 (9.8) 10 (7.6) 13 (6.1) 66 (2.4) 1813 (6.8) 
Eye/Brain                                                                                              530 (2) 6 (1) 8 (2) 1 (1.3) 14 (2.1) 8 (3.7) 2 (1.2) 2 (1.5) 6 (2.3) 13 (0.5) 590 (2.2) 
Female genitals 647 (3) 10 (1.7) 18 (4.6) 3 (3.9) 24 (3.6) 4 (1.8) 6 (3.7) 5 (3.8) 11 (5.2) 75 (2.6) 803 (3.0) 
Ill defined 1751 (8) 36 (6.2) 32 (8.2) 4 (5.1) 39 (5.9) 12 (5.5) 12(7.4) 11 (8.4) 18 (8.5) 62 (2.3) 1977 (7.4) 
Leukaemia                                                                                              543 (3) 19 (3.3) 6 (1.5) 1 (1.3) 23 (3.5) 13 (5.9) 2 (1.2) 9 (6.9) 9 (4.2) 15 (0.6) 640 (2.4) 
Lung 1503 (7) 56 (9.7) 28 (7.2) 4 (5.1) 21 (3.2) 13 (5.9) 5 (3.1) 4 (3) 16 (7.5) 53 (1.9) 1703 (6.4) 
Lymphoma 751 (3) 23 (4) 17 (4.4) 1 (1.3) 37 (5.6) 16 (7.3) 6 (3.7) 14 (10.7) 9 (4.2) 31 (1.1) 905 (3.4) 
Male genitals 142 (0.7) 1 (0.2) 5 (1.3) 0 6 (0.9) 3 (1.4) 0 0 1 (0.5) 33 (1.2) 191 (0.7) 
Melanoma 247 (1.2) 5 (0.9) 4 (1) 0 2 (0.3) 0 0 0 1 (0.5) 14 (0.5) 273 (1.0) 
Mesothelium 171 (0.8) 3 (0.5) 3 (0.8) 1 (1.3) 9 (1.4) 0 2 (1.2) 3 (2.3) 4 (1.9) 4 (0.2) 200 (0.7) 
Myeloma                                                                                               343 (1.6) 8 (1.4) 10 (2.6) 2 (2.6) 20 (3) 2 (0.9) 8 (4.9) 5 (3.8) 3 (1.4) 12 (0.4) 413 (1.5) 
Ovary                                                                                              447 (2) 9 (1.6) 8 (2.1) 4 (5.1) 16 (2.4) 4 (1.8) 2 (1.2) 0 5 (2.4) 55 (2) 550 (2.1) 
Prostate                                                                                             1631 (7.6) 73 (12.6) 28 (7.2) 12 (15.4) 62 (9.4) 16 (7.3) 40 (24.5) 13 (9.9) 10 (4.7) 32 (1.2) 1917 (7.2) 
Thyroid 219 (1) 3 (0.5) 10 (2.6) 4 (5.1) 12 (1.8) 5 (2.3) 0 5 (3.8) 6 (2.8) 16 (0.6) 280 (1.0) 
Urinary tract 396 (1.8) 14 (2.4) 9 (2.3) 1 (1.3) 14 (2.1) 8 (3.7) 3 (1.8) 3 (2.3) 3 (1.4) 13 (0.5) 464 (1.7) 
Other 63 (0.3) 0 3 (0.8) 0 4 (0.6) 0 1 (0.6) 1 (0.8) 1 (0.5) 1 (0.04) 74 (0.3) 
Outpatients  5505 (25.5) 144 (24.8) 82 (21) 22 (28.2) 145 (22) 35 (16) 32 (19.6) 25 (19.1) 47 (22.1) 2034 (74.5) 8071 (30.2) 
2007-12 21570 580 390 78 659 219 163 131 213 2731 26734 (100) 
2012 only 3205 (76) 73 (2) 81 (2) 10 (0.2) 105 (3) 35 (0.8) 26 (0.6) 20 (0.5) 29 (0.7) 629 (15) 4213 (100) 
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Table 8.14 : Dataset D-Primary cancer diagnosis by ethnic group (row %) 
 White 
British 
Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
Caribbean Other 
Black 
Other  
Ethnicity 
Unknown 
ethnicity 
Total 
Head & Neck                                                                                                692 (88) 12 (1.5) 14 (1.8) 3 (0.4) 22 (2.8) 9 (1.2) 3 (0.4) 1 (0.1) 5 (0.6) 25 (3.2) 786 
Bladder 952 (89.7) 32 (3) 18 (1.7) 1 (0.1) 24 (2.3) 12 (1.1) 5 (0.5) 1 (0.1) 6 (0.6) 10 (0.9) 1061 
Breast 1959 (84.7) 44 (1.9) 37 (1.6) 9 (0.4) 89 (3.9) 26 (1.1) 9 (0.4) 13 (0.6) 24 (1) 102 (4.4) 2312 
Colorectal 1500 (87.7) 44 (2.6) 29 (1.7) 2 (0.1) 30 (1.8) 11 (0.6) 9 (0.5) 6 (0.4) 15 (0.9) 65 (3.8) 1711 
Digestive 1578 (87) 38 (2.1) 21 (1.2) 3 (0.2) 46 (2.5) 22 (1.2) 16 (0.9) 10 (0.6) 13 (0.7) 66 (3.6) 1813 
Eye/Brain                                                                                              530 (89.8) 6 (1) 8 (1.4) 1 (0.2) 14 (2.4) 8 (1.4) 2 (0.3) 2 (0.3) 6 (1) 13 (2.2) 590 
Female genitals 647 (80.1) 10 (1.3) 18 (2.2) 3 (0.4) 24 (3) 4 (0.5) 6 (0.8) 5 (0.6) 11 (1.4) 75 (9.3) 803 
Ill defined 1751 (88.6) 36 (1.8) 32 (1.6) 4 (0.2) 39 (2) 12 (0.6) 12(0.6) 11 (0.6) 18 (0.9) 62 (3.1) 1977 
Leukaemia                                                                                              543 (84.8) 19 (3) 6 (0.9) 1 (0.2) 23 (3.6) 13 (2) 2 (0.3) 9 (1.4) 9 (1.4) 15 (2.3) 640 
Lung 1503 (88.3) 56 (3.3) 28 (1.6) 4 (0.2) 21 (1.2) 13 (0.8) 5 (0.3) 4 (0.2) 16 (0.9) 53 (3.1) 1703 
Lymphoma 751 (83) 23 (2.5) 17 (1.9) 1 (0.1) 37 (4) 16 (1.8) 6 (0.7) 14 (1.6) 9 (1) 31 (3.4) 905 
Male genitals 142 (74.4) 1 (0.52) 5 (2.6) 0 6 (3) 3 (1.6) 0 0 1 (0.5) 33 (17.3) 191 
Melanoma 247 (90.5) 5 (1.8) 4 (1.5) 0 2 (0.7) 0 0 0 1 (0.4) 14 (5.1) 273 
Mesothelium 171 (85.5) 3 (1.5) 3 (1.5) 1 (0.5) 9 (4.5) 0 2 (1) 3 (1.5) 4 (2) 4 (2) 200 
Myeloma                                                                                               343 (83.1) 8 (1.9) 10 (2.4) 2 (0.5) 20 (4.8) 2 (0.5) 8 (1.9) 5 (1.2) 3 (0.7) 12 (2.9) 413 
Ovary                                                                                              447 (81.3) 9 (1.6) 8 (1.5) 4 (0.7) 16 (2.9) 4 (0.7) 2 (0.4) 0 5 (0.9) 55 (10) 550 
Prostate                                                                                             1631 (85.1) 73 (3.8) 28 (1.5) 12 (0.6) 62 (3.2) 16 (0.8) 40 (2.1) 13 (0.7) 10 (0.5) 32 (1.7) 1917 
Thyroid 219 (78.2) 3 (1.1) 10 (3.6) 4 (1.4) 12 (4.3) 5 (1.8) 0 5 (1.8) 6 (2) 16 (5.7) 280 
Urinary tract 396 (85.3) 14 (3) 9 (1.9) 1 (0.2) 14 (3) 8 (1.7) 3 (0.7) 3 (0.7) 3 (0.7) 13 (2.8) 464 
Other 63 (85.1) 0 3 (4) 0 4 (5.4) 0 1 (1.4) 1 (1.4) 1 (1.4) 1 (1.4) 74 
Outpatients 5505 (68.2) 144 (1.8) 82 (1) 22 (0.3) 145 (1.8) 35 (0.4) 32 (0.4) 25 (0.3) 47 (0.6) 2034 (25.2) 8071 
2007-12 21570 (81) 580 (2.2) 390 (1.5) 78 (0.3) 659 (2.5) 219 (0.8) 163 (0.6) 131 (0.5) 213 (0.8) 2731 (10) 26734 
2012 only 3205 (76) 73 (2) 81 (2) 10 (0.2) 105 (3) 35 (0.8) 26 (0.6) 20 (0.5) 29 (0.7) 629 (15) 4213 (100) 
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Table 8.15 Dataset D-All cancer diagnoses by ethnic group (multiple rows per patient, column %) 
 White 
British 
Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
Caribbean Other 
Black 
Other  
Ethnicity 
Unknown 
ethnicity 
Total 
Head & Neck                                                                                                712 (3.4) 12 (2,2) 15 (3.8) 3 (4.2) 23 (3.6) 9 (3.8) 3 (1.9) 1 (0.8) 5 (2.5) 25 (2.7) 808 (3.3) 
Bladder 982 (4.7) 33 (6) 18 (4.6) 1 (1.4) 24 (3.7) 12 (5) 5 (3.1) 1 (0.8) 6 (2.7) 13 (1.4) 1095 (4.5) 
Breast 2081 (10) 45 (8.2) 38 (9.6) 10 (14.1) 94 (14.6) 26 (10.8) 9 (5.7) 13 (9.9) 25 (12.3) 107 (11.6) 2448 (10.1) 
Colorectal 1572 (7,5) 47 (8.6) 33 (8.4) 2 (2.8) 32 (5) 12 (5) 9 (5.7) 6 (4.6) 15 (7.4) 68 (7.4) 1796 (7.4) 
Digestive 1619 (7.7) 38 (7) 21(5.3) 4 (5.6) 46 (7) 23 (9.6) 17 (10.7) 10 (7.6) 13 (6.4) 66 (7.2) 1857 (7.7) 
Eye/Brain                                                                                              541 (2.6) 6 (1.1) 9 (2.3) 1 (1.4) 14 (2.2) 8 (3.3) 2 (1.3) 3 (2.3) 6 (3) 14 (1.5) 604 (2.5) 
Female genitals 658 (3.2) 10 (1.8) 19 (4.8) 3 (4.2) 24 (3.4) 4 (1.7) 6 (3.8) 5 (3.8) 11 (5.4) 77 (8.4) 817 (3.4) 
Ill defined 5870 (28) 135 (24.6) 103 (26) 17 (23.9) 153 (24) 63 (26.3) 38 (24) 32 (24.4) 51 (25) 257 (28) 6719 (27.7) 
Leukaemia                                                                                              554 (2.7) 19 (3.5) 7 ()1.8 1 (1.4) 24 (3.7) 13 (5.4) 2 (1.3) 9 (6.9) 9 (4.4) 15 (1.6) 653 (2.7) 
Lung 1654 (8) 59 (10.7) 30 (7.6) 4 (5.6) 23 (3.6) 14 (5.8) 6 (3.8) 5 (3.8) 17 (8.4) 62 (6.4) 1874 (7.7) 
Lymphoma 773 (3.7) 23 (4.2) 18 (4.6) 1 (1.4) 37 (5.8) 16 (6.7) 6 (3.8) 14 (10.7) 9 (4.4) 32 (3.5) 929 (3.8) 
Male genitals 144 (0.7) 1 (0.2) 5 (1.3) 0 6 (0.9) 3 (1.3) 0 0 1 (0.5) 33 (3.6) 193 (0.8) 
Melanoma 262 (1.3) 5 (0.9) 4 (1) 0 2 (0.3) 0 0 0 1 (0.5) 14 (1.5) 288 (1.2) 
Mesothelium 180 (0.9) 3 (0.6) 3 (0.8) 1 (1.4) 9 (1.4) 0 2 (1.3) 3 (2.3) 4 (2) 4 (0.4) 209 (0.9) 
Myeloma                                                                                               351 (1.7) 8 (1.5) 10 (2.5) 2 (2.8) 20 (3.1) 2 (0.8) 8 (5.0) 5 (3.8) 3 (1.5) 12 (1.3) 421 (1.7) 
Ovary                                                                                              478 (2.3) 10 (1.8) 8 (2) 4 (5.6) 16 (2.5) 4 (1.7) 2 (1.3) 0 5 (2.5) 57 (6.2) 584 (2.4) 
Prostate                                                                                             1765 (8.4) 79 (14.4) 30 (7.6) 12 (16.9) 65 (10.1) 16 (6.7) 40 (25.2) 14 (10.7) 11 (5.4) 35 (3.8) 2067 (8.5) 
Thyroid 224 (1.1) 3 (0.6) 11 (2.8) 4 (5.6) 12 (1.9) 6 (2.5) 0 5 (3.8) 6 (3) 16 (1.7) 287 (1.2) 
Urinary tract 431 (2.1) 14 (2.6) 9 (2.3) 1 (1.4) 15 (2.3) 8 (3.3) 3 (1.9) 4 (3) 4 (2) 13 (1.4) 502 (2.1) 
Other 66 (0.3) 0 3 (0.8) 0 4 (0.6) 1 (0.4) 1 (0.6) 1 (0.8) 1 (0.5) 1 (0.1) 78 (0.3) 
Total 2007-12 20917  
(86.3) 
550  
(2.3) 
394  
(1.6) 
71  
(0.3) 
643  
(2.7) 
240  
(1.0) 
159  
(0.7) 
131  
(0.5) 
203  
(0.8) 
921  
(3.8) 
24229  
(100) 
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Table 8.16 Dataset D-All cancer diagnoses by ethnic group (multiple rows per patient, row%) 
 White 
British 
Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
Caribbean Other 
Black 
Other  
Ethnicity 
Unknown 
ethnicity 
Total 
Head & Neck                                                                                                712 (88.1) 12 (1.5) 15 (1.9) 3 (0.4) 23 (2.9) 9 (1.1) 3 (0.4) 1 (0.1) 5 (0.6) 25 (3.1) 808 (3.3) 
Bladder 982 (89.7) 33 (3) 18 (1.6) 1 (0.1) 24 (2.2) 12 (1.1) 5 (0.5) 1 (0.1) 6 (0.6) 13 (1.2) 1095 (4.5) 
Breast 2081 (85) 45 (1.8) 38 (1.6) 10 (0.4) 94 (3.8) 26 (1.1) 9 (0.4) 13 (0.6) 25(1) 107 (4.4) 2448 (10.1) 
Colorectal 1572 (87.5) 47 (2.6) 33 (1.8) 2 (0.1) 32 (1.8) 12 (0.7) 9 (0.5) 6 (0.3) 15 (0.8) 68 (3.8) 1796 (7.4) 
Digestive 1619 (87.2) 38 (2.1) 21(1.1) 4 (0.2) 46 (2.5) 23 (1.2) 17 (0.9) 10 (0.5) 13 (0.7) 66 (3.6) 1857 (7.7) 
Eye/Brain                                                                                              541 (89.6) 6 (1) 9 (1.5) 1 (0.2) 14 (2.3) 8 (1.3) 2 (0.3) 3 (0.5) 6 (1) 14 (2.3) 604 (2.5) 
Female genitals 658 (80.5) 10 (1.2) 19 (2.3) 3 (0.4) 24 (2.9) 4 (0.5) 6 (0.7) 5 (0.6) 11 (1.4) 77 (9.4) 817 (3.4) 
Ill defined 5870 (87.4) 135 (2) 103 (1.5) 17 (0.3) 153 (2.3) 63 (0.9) 38 (0.6) 32 (0.5) 51 (0.8) 257 (3.8) 6719 (27.7) 
Leukaemia                                                                                              554 (84.8) 19 (2.9) 7 (1.1) 1 (0.2) 24 (3.7) 13 (2.0) 2 (0.3) 9 (1.4) 9 (1.4) 15 (2.3) 653 (2.7) 
Lung 1654 (88.3) 59 (3.2) 30 (1.6) 4 (0.2) 23 (1.2) 14 (0.8) 6 (0.3) 5 (0.3) 17 (0.9) 62 (3.3) 1874 (7.7) 
Lymphoma 773 (83.2) 23 (2.5) 18 (1.9) 1 (0.1) 37 (4.0) 16 (1.7) 6 (0.7) 14 (1.5) 9 (1) 32 (3.4) 929 (3.8) 
Male genitals 144 (75) 1 (0.5) 5 (2.6) 0 6 (3.1) 3 (1.6) 0 0 1 (0.5) 33 (17.1) 193 (0.8) 
Melanoma 262 (91) 5 (1.7) 4 (1.4) 0 2 (0.7) 0 0 0 1 (0.4) 14 (4.9) 288 (1.2) 
Mesothelium 180 (86) 3 (1.4) 3 (1.4) 1 (0.5) 9 (4.3) 0 2 (1.0) 3 (1.4) 4 (1.9) 4 (1.9) 209 (0.9) 
Myeloma                                                                                               351 (83.4) 8 (1.9) 10 (2.4) 2 (0.5) 20 (4.8) 2 (0.5) 8 (1.9) 5 (1.2) 3 (0.7) 12 (2.6) 421 (1.7) 
Ovary                                                                                              478 (82) 10 (1.7) 8 (1.4) 4 (0.7) 16 (2.7) 4 (0.7) 2 (0.3) 0 5 (0.9) 57 (9.8) 584 (2.4) 
Prostate                                                                                             1765 (85.4) 79 (3.8) 30 (1.4) 12 (0.6) 65 (3.1) 16 (0.8) 40 (1.9) 14 (0.7) 11 (0.5) 35 (1.7) 2067 (8.5) 
Thyroid 224 (78.1) 3 (1) 11 (0.2) 4 (1.4) 12 (4.2) 6 (2.1) 0 5 (1.7) 6 (2.1) 16 (5.6) 287 (1.2) 
Urinary tract 431 (86) 14 (2.8) 9 (1.8) 1 (0.2) 15 (3.0) 8 (1.6) 3 (0.6) 4 (0.8) 4 (0.8) 13 (2.6) 502 (2.1) 
Other 66 (85) 0 3 (0.1) 0 4 (5.1) 1 (1.3) 1 (1.3) 1 (1.3) 1 (1.3) 1 (1.3) 78 (0.3) 
2007-12 20917 (86) 550 (2.3) 394 (1.6) 71 (0.3) 643 (2.6) 240 (1.0) 159 (0.7) 131 (0.5) 203 (0.8) 921 (3.8) 24229 
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8.3.7 Activity type 
Inpatients were admitted for either elective or non-elective treatment. Elective 
included patients being treated as day cases as well as those staying overnight. 
Overall, 66% of patients were admitted to hospital for elective treatment. Table 
8.17 below shows no differences in the type of activity by ethnic group over the six 
year period. The proportion of patients having elective surgery was highest in the 
unknown ethnicity category (81%). For the remaining ethnic groups, the numbers 
having elective treatment were similar. Table 8.18 shows the same to be true when 
examining data for 2012 independently, where 68% were admitted for elective 
treatment. Any variations can be explained by the small sample. 
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Table 8.17 Activity type by ethnic group 2007-2012 
Activity type White 
British 
Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
Caribbean Other 
Black 
Other  
Ethnic 
Unknown 
ethnicity 
Total 
Elective 10487 (65) 281 (64) 197 (64) 39 (70) 331 (64) 101 (55) 77 (59) 66 (62) 100 (60) 563 (81) 12242 (66) 
Non-Elective 5578 (35) 155 (36) 111 (36) 17 (30) 183 (36) 83 (45) 54 (41) 40 (38) 66 (40) 134 (19) 6421 (44) 
2007-12 16065 436 308 56 514 184 131 106 166 697 18663 
 
 
 
Table 8.18 Activity type by ethnic group for 2012 
Activity type White 
British 
Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
Caribbean Other 
Black 
Other  
Ethnic 
Unknown 
Ethnicity 
Total 
Elective 1785 (68) 37 (67) 52 (74) 6 (67) 61 (67) 13 (43) 18(72) 13 (87) 18 (75) 118(81) 2121 (68) 
Non-Elective 852 (32) 18 (33) 18 (26) 3(33) 30(33) 17 (57) 7(28) 2 (13) 6 (25) 27(19) 980 (32) 
2012 only 2637 55 70 9 91 30 25 15 24 145 3101 
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8.3.8 Surgery 
Of the 18,663 patients admitted to hospital 13,713 (73%) did not have surgery 
(Table 8.19). The most common treatments for these non-surgery patients were 
general medicine (28%), clinical oncology (18%) and urology (16%). In the 4,950 
(27%) that had surgery, 31% were coded as general surgery and 28% as having 
breast surgery. No differences in surgery were detected by ethnic group when 
examining the six year data or 2012 data (Table 8.20). Again any fluctuations can be 
explained by the small samples.  
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Table 8.19 Surgery by ethnic group 2007-2012 
Surgery White 
British 
Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
Caribbean Other 
Black 
Other  
Ethnic 
Unknown 
ethnicity 
Total 
Yes 4335 (27) 110 (25) 80 (26) 13 (23) 146 (28) 45 (24) 26 (20) 22 (21) 48 (29) 125 (18) 4950 (27) 
No 11730 (73) 326 (75) 228 (74)  43 (77) 368(72)  139(76) 105 (80) 84 (79) 118 (71)  572(82) 13713 (73) 
2007-12 16065 436 308 56 514 184 131 106 166 697 18663 
 
Table 8.20 Surgery by ethnic group 2012 
Surgery White 
British 
Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
Caribbean Other 
Black 
Other  
Ethnic 
Unknown 
ethnicity 
Total 
Yes 708 (27) 14 (25) 26 (37) 1(11) 20(22) 7 (23) 3 (12) 3 (20) 7 (29) 19 (13) 808 (26) 
No 1929 (73) 41 (75) 44 (63) 8 (89) 71 (78) 23 (77) 22 (88) 12 (80) 17 (71) 126 (87)  2293(74) 
2012 2637 55 70 9 91 30 25 15 24 145 3101 
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8.3.9 Episode outcome 
 
Episode outcome data were missing for three patients (two being White British and 
one of Indian origin) bringing the total down to 18,660. The majority of inpatients 
were discharged on clinical advice (94%, Table 8.21). A small proportion self-
discharged or were discharged by a relative (0.2%), the remaining 6% died whist in 
hospital. The data were very similar across the board with no differences detected 
by ethnicity. The picture was very similar when examining 2012 data independently 
(Table 8.22). Based upon these data, there was no evidence to show a difference in 
activity type or outcome by ethnic group. However, it is important to note the large 
proportion of missing ethnicity data, the unknown ethnicity group was the second 
largest preceded only by the White British group. 
To summarise, the data shown above were too limited to permit any conclusions. 
The high proportion of missing data limits interpretation further as we do not know 
if the data were missing at random across all ethnic groups or for restricted to 
particular ethnic groups, e.g. non-English speaking.  
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Table 8.21 Episode outcome by ethnic group 2007-2012 
Activity type White 
British 
Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
Caribbean Other 
Black 
Other  
Ethnic 
Unknown 
ethnicity 
Total 
Self/ relative 29 (0.2) 0 0 0 1 (0.2) 0 0 0 0 1 (0.1) 31 (0.2) 
On clinical advice 15021 (94) 404 (93) 292 (95) 53 (95) 483 (94) 177 (96) 126 (96) 101 (95) 153 (92) 653 (94) 17463 (94) 
Patient died 1013 (6) 32 (7) 16 (5) 3 (5) 29 (6) 7 (4) 5 (4) 5 (5) 13 (8) 43 (6) 1166 (6) 
2007-12 16063 436 308 56 513 184 131 106 166 697 18660 
 
Table 8.22 Episode outcome by ethnic group 2012 
Activity type White 
British 
Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
Caribbean Other 
Black 
Other  
Ethnic 
Unknown 
ethnicity 
Total 
Self/ relative 6 (0.2) 0 0 0 0 0 0 0 0 1 (0.7) 7 (0.2) 
On clinical advice 2514 (94) 53(96) 68(97) 8 (89) 89 (98) 29 (97) 24 (96) 15 (100) 23 (96) 141(97) 2964 (96) 
Patient died 117 (5) 2 (4) 2 (3) 1 (11) 2 (2) 1 (3) 1 (4) 0 1 (4) 3 (2) 130 (4) 
2012 2637 55 70 9 91 30 25 15 24 145 3101 
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8.3.10 Representation of ethnic minorities in clinical trials  
In order to assess the representation of ethnic minorities in clinical trials on a local 
level I used data from HES as presented above and data from a cancer research 
network. The total number of patients identified by healthcare professionals as 
potential participants in clinical trials across the entire cancer network was 1271 for 
2012/2013 spanning across five trusts. Of the 1271, 897 were treated at the large 
local teaching hospital, with 618 (69%) of these being successfully recruited to a 
trial (Table 8.23). On the whole, only a small proportion were not invited to 
participate due to clinician decision (4%). At the time of the analysis 7% of patients 
were still being screened and a further 20% had refused to participate. Ethnicity 
was not known in 15% of the 897 patients identified at the local hospital.  
Only the ethnic groups of White British, Indian and unknown ethnicity had counts 
greater than 20. Similar proportions of patients from these three groups were 
recruited into clinical trials (69%, 71% and 63% respectively). Early indications 
suggest that ethnic minority patients may be more likely to decline participation 
(e.g. 33% Mixed, 29% Indian, 40% Other Asian, 33% Other Ethnicity group and 28% 
Not known) compared to white groups (18% White British, 15% Irish and 19% other 
White).   
HES data from 2012 was used to form a crude denominator to estimate the 
representativeness of ethnic minority patients in trials. However, patients having 
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surgery, dying whilst in hospital and those self-discharging or being discharged by a 
relative were deducted from the denominator as shown in Table 8.24.    
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Table 8.23: Trial status for potential participants identified by the Cancer Research Network 
 White 
British 
Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
All 
Black 
Other  
Ethnic 
Unknown 
ethnicity 
Total 
Clinician decision 47 (7) - 3 (19) 1 (33) 2 (10) 1 (10) 1 (12) - 8 (6) 63 (4) 
Patient declined 105 (15) 2 (15)  1 (33) 4 (19) 3 (30) - 2 (33) 32 (24) 149 (20) 
Screened 59 (9) - - - - - - - 8 (6) 67 (7) 
Recruited 477 (69) 11 (85) 13 (81) 1 (33) 15 (71) 6 (60) 7 (88) 4 (67) 84 (64) 618 (69) 
Total 688 (77) 13 (1) 16 (2) 3 (0.3) 21 (2) 10 (1) 8 (0.9) 6 (0.7) 132 (15) 897 (100) 
 
Table 8.24: Calculating the denominator (excluding patients dying in hospital and those discharging themselves or being 
discharged by a relative) 
 White 
British 
Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
All 
Black 
Other  
Ethnic 
Unknown 
ethnicity 
Total 
Denominator 3082 (75) 71 (2) 79 (2) 9 (0.2) 103 (3) 34 (0.8) 45 (1.1) 28 (0.7) 625 (15) 4076 (100) 
HES 2012 3205 73 81 10 105 35 46 29 629 4213 
Died in hospital 117 2 2 1 2 1 1 1 3 130 
Discharged  
by Self/relative 
6 0 0 0 0 0 0 0 1 7 
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Numbers of cancer patients from ethnic minority groups attending the selected 
hospital were small as were the numbers of potential participants identified by the 
CRN. However, there were a large number of potential participants with unknown 
ethnicity which hinders interpretation. Fluctuations in proportions of ethnic 
minority groups can be explained by the small numbers which are not substantial 
enough to draw any conclusions from. Potential participants identified by ethnic 
groups ranged from 18% to 33% (see Table 8.25). 
Table 8.26 reveals a large proportion of patients labelled as ‘unaccounted’ (78% in 
total). These patients received cancer treatment at the selected hospital but were 
not considered for trials. This may have been because there were no trials open to 
recruitment for their condition at the time of their diagnosis or they did not meet 
eligibility criteria. This information may be recorded in MDT data logs to which I did 
not have access. However, the proportions of unaccounted for patients did not 
differ by ethnicity. The White British and Irish groups had the lowest proportion of 
patients declining to participate in a clinical trial (3%) compared to 9% in the Other 
Asian group. Other Asians were the highest recruited (18%) compared to the lowest 
recruited Mixed group (11%). However, given the small sample, these findings must 
be treated with caution and should be subjected to further investigation in the 
future once more data are available.  
All in all, based upon the short period of time for which trial recruitment data were 
available and the incompleteness of ethnicity across all datasets, it was not possible 
to assess the under-representation of ethnic minorities into RCTs. Improving the 
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collection of ethnicity data in healthcare generally as well as establishing routine 
collection of ethnicity data within trials themselves as well as research network trial 
recruitment databases, e.g. CRN recruitment data as will be demonstrated in the 
next chapter, would be required to answer this question in the future.  
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Table 8.25: Representation of potential participants identified by the Cancer Research Network of patients from the large local 
teaching hospital (% of denominator)  
 
 White British Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
All 
Black 
Other  
Ethnic 
Unknown 
Ethnicity 
Total 
Potential participants   
identified 
688 (22) 13 (18) 16 (20) 3 (33) 21 (20) 10 (29) 8 (18) 6 (21) 132 (21) 897 (22) 
Denominator 3082 71 79 9 103 34 45 28 625 4076 
 
Table 8.26: Representation of potential participants from all patients attending the local teaching hospital with a cancer 
diagnosis by trial status 
 White British Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
All 
Black 
Other  
Ethnic 
Unknown 
Ethnicity 
Total 
Clinician decision 47 (2) - 3 (4) 1 (11) 2 (2) 1 (3) 1 (2) - 8 (1) 63 (2) 
Patient declined 105 (3) 2 (3)  1 (11) 4 (4) 3 (9) - 2 (7) 32 (5) 149 (4) 
Being screened 59 (2) - - - - - - - 8 (1) 67 (2) 
Recruited 477 (15) 11 (15) 13 (16) 1 (11) 15 (15) 6 (18) 7 (16) 4 (14) 84 (13) 618 (15) 
Unaccounted 2394 (78) 58 (82) 63 (80) 6 (67) 82 (80) 24 (71) 14 (31) 22 (79) 492 (79) 3177 (78) 
Denominator 3082 71 79 9 103 34 45 28 625 4076 
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8.4 Discussion 
As reported in the results section, City X has a higher proportion of ethnic 
minorities compared to the national average. However, data shows low proportions 
of these patients being treated for cancer at the local hospital in the past six years 
and consequently few cases being identified as potential trial participants by the 
cancer research network. This was not entirely unexpected given the younger age 
structure of ethnic minority groups in the local area. The data showed no 
differences by ethnicity in the proportions of patients being admitted for surgery, 
or dying whilst in hospital or self-discharging which may partly explain the lack of 
ethnic minority patients being identified as potential clinical trial participants by the 
research team.  
There could be a number of explanations for the small number of malignancies 
observed in the ethnic minority groups, one of them being ethnic minorities are less 
susceptible to certain cancers, such as the lower rates of breast cancer in South 
Asians (Farooq et al, 2005). The data confirmed existing evidence of higher 
incidences of prostate cancers in Caribbean males (National Cancer Intelligence 
Network, 2009) and indicated that this increased risk may also be present in the 
Mixed population where one of the ethnic groups is Caribbean, African or of Other 
Black background.  
A closer examination of the ethnic minority population structure by age and sex 
may shed further light onto the under-presentation problem. It is reported that 
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three-quarters of all newly diagnosed cancers occur in people aged 60 or over 
(Macmillan, 2012). However, as age and sex data by ethnic group for the 2011 
census were not available at the time of this analysis, I could not assess this in the 
population as a whole. However, age and sex data by ethnic group at a local 
authority level was available in the table commissioned of the 2001 census which 
was used as a surrogate. I identified the population aged 50 and above in 2001 who 
would have been 60 years plus by 2011. The downside to using these data was that 
it would not include movements in and out of the West Midlands or births and 
deaths occurring during the period between the surveys.  
The population pyramids below show the difference in the White West Midlands 
population to the non-White ethnic minority groups (Figure 8.2). The smaller 
apexes of the ethnic minority populations compared to the White population are 
striking but not unexpected. The shapes of the pyramids are consistent with that of 
the UK presented earlier in Chapter Three. 
The shape of the pyramid for the White group is typical of an established 
population with slow growth (Figure 8.2, b). Longer life expectancy is highlighted by 
the broad bands in the top tertile. The ethnic minorities have a much more pyramid 
like shape with a broad base indicating a larger proportion of younger people and 
children narrowing to a small apex exposing a much smaller older population 
(Figure 8.2c-l).  
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Looking in more detail at the subset with the highest risk of cancer by ethnic group 
(>=60 or 50 years as it is here) this proportion was 36% in the White population 
(Figure 8.2b). In contrast, the Caribbean group who had the largest elder population 
of all the ethnic minority groups comprised 26% in this age group (Figure 8.2g). The 
Indian group had the second largest older ethnic minority population with 19% in 
this group (Figure 8.2c). As these groups were earlier migrants this was not 
unexpected. Later migrants from the Indian subcontinent were much younger, e.g. 
only 11% and 10% of Pakistanis and Bangladeshis being >=60years (Figure 8.2d and 
e, migration patterns were discussed earlier in Chapter One).  The youngest 
population by far was the mixed group with only 5% aged 60 years plus (Figure 
8.2l).  
The Caribbean and Other Black background groups experienced a baby boom 
between the 1950s-1970s which means in the next ten years the over 60s 
population in this group will increase significantly (Figure 8.2g and i). This bulge in 
the 40-50 year olds in the Caribbean and other Black background groups may also 
result in an increase in prostate cancers in this more susceptible group in the near 
future. The African group also displays a similar bulge but the majority were born 
outside of the UK suggesting a period of mass migration (Figure 8.2h). This 
information could help policy makers plan future resources and drive research in 
this area.  
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Figure 8.2: Age and sex populations pyramids by ethnicity for the West 
Midlands using data from the 2001 census  
(darker shading indicates births outside of the UK, line across the chart indicates 
the population aged 50 years plus and those under)   
 
a) All (total aged 50+=34%)  b) White (total aged 50+=36%) 
 
c) Indian (total aged 50+=19%)  d) Pakistani (total aged 50+=11%)
 
 
e) Bangladeshi (total aged 50+=10%) f) Other Asian background (total aged  
50+=17%)
 
  
32% aged 50+ 35% aged 50+ 34% aged 50+ 38% aged 50+
18% aged 50+ 19% aged 50+ 11% aged 50+ 11% aged 50+
17% aged 50+ 17% aged 50+
10% aged 50+ 10% aged 50+
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g) Caribbean (total aged 50+=26%) h) African (total aged 50+=11%)
 
 
i) Other Black background   j) Mixed (total aged 50+=5%) 
(total aged 50+=7%) 
 
 
k) Chinese (total aged 50+=15%)  l) Other ethnic group (total aged  
50+=10%)
 
  
12% aged 50+ 11% aged 50+27% aged 50+ 25% aged 50+
5% aged 50+ 5% aged 50+8% aged 50+ 7% aged 50+
10% aged 50+ 10% aged 50+13% aged 50+ 16% aged 50+
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A lack of awareness of symptoms could lead to later presentation and delays in 
treatment. Ethnic minorities and people from low socio-economic backgrounds 
were found to have a lower awareness of cancer warning signs in a study of 2208 
British participants (of which 144 (6.5%) were of non-White ethnicity) (Robb et al, 
2009). The most commonly cited barriers to seeking medical treatment were: 1) 
difficulty getting an appointment, 2) worry about wasting the doctors time and 3) 
fear of what might be found. The authors recommended a campaign to raise 
awareness of cancer warning signs. The ‘Ethnic Minority Cancer Awareness Week’ 
has being seeking to do just that by hosting events around the UK to raise 
awareness of risk factors, cancer symptoms and to promote the importance of 
screening (EMCAW, 2008). 
Language barriers may have contributed to the small number of cancers observed 
in ethnic minority populations. Data from the 2011 census showed 49.8 million 
(92.3%) of the population aged three years and over reporting English as their main 
language. The remaining 4.2million (7.7%) reported a language other than English 
as their main language, the most common of these was Polish. When asked about 
their ability to speak English 726,000 people (1.3%) reported not being able to 
speak English ‘well’ and a further 138,000 (0.3%) reported no ability to speak 
English at all (Office for National Statistics, 2011). Ethnic minorities not proficient in 
English and not being able to communicate their symptoms fully may experience 
delay in diagnosis and/or referral to hospital.   
231 
 
Other explanations could include ethnic minorities migrating back to their countries 
of origin for treatment. Medical pluralism (where a community consults more than 
one type of therapy or medical system) is not uncommon in certain ethnic minority 
groups. For example, there is widespread use of Chinese medicine in conjunction 
with western medicine in the Chinese community (Green et al, 2006). There may 
also be cultural issues surrounding perceptions of disease and treatment or faith 
rooted perceptions (e.g. adopting a fatalistic attitude) (Austin et al, 2002; Dein, 
2002; Helman, 2007). However, there is a paucity of good quality evidence from the 
UK to support this. 
8.4.1 Limitations 
The work reported in this chapter was limited by the lack of data and the difficulties 
in obtaining a denominator in order to assess whether under-representation of 
ethnic minorities in RCTs was a problem. The data obtained from HES contained a 
large proportion of missing and not specified/not known codes. Similarly, trials 
recruitment data from the Cancer Research Network was available for a one year 
period only and also contained a large amount of missing data. Many patients were 
present in the HES data having been diagnosed with cancer but were not accounted 
for in either the surgery, discharge or Cancer research network data which held 
information on all potential participants. It is not known why these patients were 
not identified but it may have been largely due to a lack of trial availability or 
ineligibility. Accessing data from multi-disciplinary team meetings could shed light 
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on this issue and allow us to gauge the proportions of patients for whom no trials 
are available.  
At the time of writing, only preliminary data from the 2011 census had been 
released, data by age and gender by ethnic group were not available.  
8.5 Conclusion 
Population structures of ethnic minority groups are without a doubt rapidly 
changing within the UK. The 1991 census reported over 3 million people (5.5%) of 
the UK population identifying themselves as belonging to a non-white ethnic group. 
By 2001, this had increased to 4.6 million (7.9%) and in 2011 this increased again to 
14.1% in England and Wales (UK figure not yet available) (Office for National 
Statistics, 2011). These changes could have been influenced by a number of factors, 
such as new migrants, second and third generation UK born offspring of the original 
migrants, as well as the numbers of people self-reporting as belonging to an ethnic 
minority group increasing, possibly due to the availability of more sensitive 
categorisations, e.g. introduction of Mixed, Arab, Traveller categories and the 
ability to write-in responses.    
Despite the increasing proportion of ethnic minorities, I was not able to confirm the 
under-representation of these groups in clinical trials at a local level. However, the 
under-representation of ethnic minority groups in RCTs continues to be observed in 
ad hoc studies, such as that reported by Godden et al (2010) who found, when 
comparing patients admitted with cancer after adjusting for age, disease and 
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gender the odds of being in a trial 30% lower in ethnic minority cancer patients 
compared to White cancer patients. However, there is evidence to suggest ethnic 
minorities are better represented in trials of other disease areas such as heart 
disease (Jolly et al, 2005, Cooper et al, 2003). Jolly et al (2005) reported exclusion 
rates and reasons for exclusion in a study of cardiac rehabilitation conducted in 
ethnic-rich Birmingham. Results revealed patients of South Asian background to be 
the most likely to be excluded and for the exclusion to be language based. 
Reassuringly, recruitment of eligible patients was similar across ethnic groups with 
South Asians accounting for 17% of the final sample. The external validity of RCTs 
becomes questionable when certain groups have been excluded from a trial 
(Rothwell, 2005). Ethnic minority patients need to be represented in RCTs in order 
to ensure generalisability to the wider UK population.  
The biggest challenge in assessing under-representation remains the 
incompleteness and questionable quality of ethnicity data. Ethnicity data must 
continue to be prospectively collected by Cancer registries across the UK in order to 
obtain a more accurate picture of cancer incidence. Ethnicity in HES databases also 
requires improvement in both inpatient and outpatient records. The current data 
contains large numbers of unknown ethnicities. Some suggestions as to how this 
could be remedied were made earlier in the literature review of improving ethnicity 
data collection (see Chapter Four). Lastly, the importance of recording ethnicity at 
research network level as well as in RCTs themselves needs to be recognised in 
order to assess under-representation accurately in the future.  
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8.6 Summary 
In this chapter, I assessed the completion of ethnicity data in local HES datasets. I 
explored the population structure of ethnic minorities on a national level and for 
the West Midlands and identified proportions >=60 who are most at risk of 
developing cancer. I also scrutinised the Cancer Research Network recruitment data 
and used this information to assess representativeness of ethnic minority patients 
entering cancer trials.  
In the next chapter, I describe my journey towards establishing ethnicity data 
collection at a local CRN and describe the problems I encounter along the way. I 
then attempt to use the collected ethnicity data to assess the representation of 
ethnic minorities in clinical trials and explore barriers to clinical trial participation by 
ethnicity using data from the selected Cancer Research Network recruitment 
database.  
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Chapter 9 Ethnicity data collection and 
participation in clinical trials 
9.1 Introduction 
As discussed in Chapters One and Seven, it has been reported that ethnic minorities 
are under-represented in clinical trials. This is based on the known size of the ethnic 
minority population and the reported incidence of disease in that population.  
(Mason et al, 2003, Hussain-Gambles, 2004 and Goddard et al, 2012). Two 
systematic reviews carried out prior to the formation of the NCRN suggested that 
clinicians may be reluctant to approach ethnic minority patients for inclusion in 
clinical trials due to time restrictions and a lack of resources (Ross et al, 1999, Ward 
et al, 2000). Ward et al (2000) and Hussain-Gambles et al (2004) reported the 
problem of under-representation stemming from a fear of authority and lack of 
faith in the medical profession. 
The Equality Act 2010 holds organisations such as the Health Service responsible for 
ensuring there is no discrimination in access to health care on the grounds of any of 
its nine protected characteristics, one of which is race (Home Office, 2010). As 
patients who enter clinical trials are reported to have better outcomes, there is 
therefore an urgent need for evidence on barriers to recruitment into RCTs by 
ethnic group before strategies can be developed to address these barriers and 
improve uptake into trials (Braunholtz et al, 2001). Ethnicity data collection within 
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the context of the clinical trial recruitment network is also needed in order to 
address this problem.  
One of the problems which I encountered and only partially solved was the 
reluctance of healthcare professionals to collect ethnicity data. Focus groups with 
healthy participants reported in Chapter Five revealed ethnic minority groups, more 
specifically South Asians, were willing to provide their ethnicity data for healthcare 
purposes, provided they are given an explanation as to why the data are being 
collected and how it will be used to improve services.  
Part of my research included establishing ethnicity data collection at a local Cancer 
Research Network (CRN). The selected CRN was established in 2001 and is 
committed to entering patients into trials. By 2006, it had exceeded the NCRN 
recruitment target of entering 7.5% of cancer patients into clinical trials by 
successfully recruiting 35% of all cancer patients treated through their network 
(NCRN, 2006). The CRN routinely collects trial recruitment data for monitoring and 
reporting purposes as part of their recruitment strategy. Once a patient has been 
identified as a potential participant, they are screened by a member of the research 
network team operating in that particular disease site and offered a trial if suitable. 
The reason why a patient may be considered unsuitable by the clinician is recorded 
in a recruitment database. In circumstances where eligible patients choose not to 
participate in a trial, the reasons they give for deciding so are recorded in an 
independent anonymised ‘Reasons for refusal’ database.   
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This chapter provides a narrative of my journey towards establishing ethnicity data 
collection at a local cancer research network and was broken down into two 
sections; the first being the establishment of ethnicity data collection as part of the 
‘reasons for refusal’ dataset at the selected CRN. In the second part, I attempt to 
use the data collected in part one to investigate the representation of ethnic 
minorities in clinical trials and reasons for non-participation by ethnic group.  
9.2 Timeline of establishing ethnicity data collection 
In order to achieve ethnicity data collection on all patients identified by the CRN as 
potential participants, I proposed obtaining prospective self-reported data from 
patients. The process of my efforts to supplement the ‘reasons for refusals’ 
database with ethnicity is summarised as milestones in chronological order below 
and is described in further detail in each of the relevant sections: 
 Jan 2008 - I had an initial meeting with the cancer research network lead 
and managers 
 Oct 2008 - I identified items of interest and developed ethnicity 
questionnaire  
 Dec 2008-I finalised ethnicity questionnaire with network lead and 
managers, received approval to collect ethnicity data from the Caldicott 
Guardians 
 Apr 2009 - I met with Comprehensive Local Research Network (CLRN) to 
discuss ethnicity data collection through their network 
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 May 2009 - I received confirmation that ethics approval was not required to 
add ethnicity questions to existing data collection from the local ethics 
committee chair who the deemed the exercise to be service evaluation 
 Jun 2009 - I met with database administrative staff (clinical trials officers) to 
discuss practicalities of adding ethnicity fields to the existing database to 
capture data from completed questionnaire and data entry 
 Jul 2009 - I met with clinical trials officers, network manager & research 
nurses to discuss the questionnaire and point of administration. Concerns 
were raised resulting in the proposal to collect prospective self-reported 
ethnicity data via nurse administered questionnaire being rejected.  
 Jul 2009 –Questionnaire adapted to be suitable to be posting to patients 
 Jan 2010 - Obtained relevant approval from the selected hospital and its 
peripheral sites 
 Feb 2010 – I provided first batch of 40 questionnaire packs to CRN 
 Mar 2010 - 100 further packs provided 
 Apr 2010 – A questionnaire was sent out to non-declining patient in error 
 Feb 2012 - Exercise terminated due to upcoming change of CRN database 
 Apr 2012 - Change of CRN software. Staff now have ability to record 
ethnicity data and reasons for non-participation recorded directly on 
database 
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9.3 Proposed method 1: Ethnicity data collection by 
research nurses at point of refusal 
Once a patient has declined to participate in a trial they are routinely asked by the 
CRN if they would be willing to provide a reason for their decision. I proposed that 
ethnicity data were requested at this time through a short nurse administered 
questionnaire. The work was deemed service evaluation so did not require ethics 
approval, and as no patient identifiers were included in the questionnaire I did not 
require Ethics and Confidentiality Committee (ECC) approval. 
 
I developed the ethnicity questionnaire in conjunction with the CRN, it comprised of 
six ethnicity questions, 1) ethnic group, 2) religion, 3) country of birth, 4) first 
language or mother tongue, 5) language in which the patient feels most 
comfortable speaking with healthcare professionals and 6) ability to speak and 
understand English (see Appendix 3). Responses to questions on ethnic group, 
religion and country of birth were categorised tick boxes with space provided for 
the entry of free text should the categories be inadequate. In addition, where 
country of birth was outside of the UK or Republic of Ireland the number of years 
residing in the UK were requested. Data on first language and the choice of 
language a patient feels most comfortable speaking with their doctor or nurse 
captured free text only. Patients were also asked to rate their ability to speak 
English using a Likert scale with responses available of Excellent, Good, Fair, Poor 
and Not at all.   
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The ethnicity questions and offered response categories were based upon the 
findings of the ethnicity data collection literature review reported in Chapter Four. 
Both the questions and response categories conformed to the Department of 
Health (2005) guidelines for ethnicity data collection in the NHS. Ethnic group was 
collected using the 16+1 categories which map directly onto the 2001 census data. 
A question on the reason for declining a trial with a free text response was included 
at a later date (details below). 
9.3.1 How the proposal was received 
I had an initial meeting with the CRN lead and network manager to discuss 
incorporating ethnicity data collection to enhance the existing anonymised ‘reasons 
for refusal’ database. The idea was well received and of great interest to the 
network lead. The CRN spans across five NHS trusts with the selected hospital 
hosting the main site. Authorisation from the research and development managers 
was needed for each of the four peripheral hospital sites. I gave an initiation 
presentation explaining the problem of ethnic minority under-representation and 
the need for the collection of ethnicity data in conjunction with reasons for refusal 
to the research team prior to commencement.  
I discussed the practical issues of data collection, primarily data entry and database 
issues with the administrative staff or Clinical Trials Officers who would be 
responsible for processing the data. Both Clinical Trials Officers were reluctant to 
add items to the database and suggested a separate data file for ethnicity. This was 
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not feasible as the database that held the reasons for refusal was anonymised, and 
ethnicity would need to be stored in the same database in order to maintain the 
link between the two data items. The Clinical Trials Officers also expressed concerns 
about how this would fit into their already busy work schedule. Their concerns were 
discussed with the Network Manager and both issues were addressed through 
agreement to add a ‘reason for refusal’ question to the questionnaire and I 
volunteered to take on the task of data entry.  
The ethnicity and reason for refusal questionnaire was reviewed by research nurses 
and clinical trials officers and I met with them to obtain feedback. Concerns relating 
to an ethnicity question and the administration were voiced. One individual 
strongly disliked the idea of asking patients how long they have lived in the UK 
(where country of birth was non-UK/ROI).  The individual strongly felt this would 
alienate patients and invoke feelings of being singled out, particularly if they were 
recent immigrants. The individual raising the concern was a non-UK born resident 
and spoke from personal experience. No other objections to the individual 
questions were raised. However, strong feelings were expressed by two research 
nurses regarding the administration of the questionnaire. They felt that asking for 
ethnicity data would be too much for patients who were already overwhelmed and 
vulnerable. Most would be trying to come to terms with a recent cancer diagnosis 
or relapse. Patients would also be trying to digest possible treatment options 
and/or trial options or, at the very least, given study material to take away and 
read/digest.  
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The Research Nurses spoke of patients’ struggle to process study information and 
the frequency with which they were confronted with blank looks and knew the 
information had not been retained. A proportion of patients rejected the idea of 
going into a study immediately and therefore were never approached by the 
research network. Others were approached, but did not wish to go into a study or 
even take the information home to read and consider later. In this situation the 
patient is not asked any further questions, including reason for refusal.  
The nurses also spoke of the guilt expressed by patients who, having spent time 
with the consultant or research nurse felt as though they were letting them down 
by declining to participate. Patients were overly apologetic and sometimes asked if 
there was anything else they could do to help. However, the nurses on seeing the 
patients were feeling needlessly guilty and not wishing to put them through 
anymore anxiety, felt asking ethnicity at this point would be taking advantage of 
their fragility. 
 All in all, the nurses did not feel the timing of the questionnaire was appropriate 
nor felt comfortable asking the patients for this information verbally. Obtaining 
such data from patients using a research nurse administered questionnaire was 
rejected. 
9.4 Proposed method 2: The postal questionnaire 
Research nurses at the CRN rejected my proposal to administer the ethnicity 
questionnaire at the point of refusal, but believed posting the ethnicity 
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questionnaire to patients declining the offer to participate in a clinical trial to be 
more acceptable. Cancer patients of all ethnic groups (including white) attending 
the CRN and who were eligible to enter a clinical trial and declined were mailed a 
questionnaire post trial refusal.  
The ethnicity questionnaire I developed was amended to include basic patient 
information, such as age group, gender, and type of cancer and name of the trial 
which they were offered. All patients were encouraged to return the questionnaire 
with an additional tick box provided for patients’ not wishing to complete the 
information included as the first item appearing at the top of the questionnaire. 
Questionnaires were mailed to patients by research nurses with a covering letter 
from the nurse who originally discussed the trial with the patient. The pack 
contained a copy of the questionnaire, the cover letter introducing the 
questionnaire, the need for it and how it will be used, and a pre-addressed postage 
paid envelope. In total, 160 packs were supplied to the CRN.  
9.4.1 Implementation of the postal questionnaire exercise 
Questionnaires were posted to cancer patients declining to participate in clinical 
trials by the research nurses. It was assumed the accompanying cover letter from 
the nurse who had personal contact with the patient would have a positive effect 
on the response rate. 
 I was able to keep tally of the numbers of questionnaires sent out through regular 
reports from the CRN and compare this with the numbers of completed forms 
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returned to me in the pre-addressed envelopes and therefore calculate a response 
rate.  
After receiving 11 completed questionnaires, I was contacted by telephone and 
letter by a patient (referred to as Mrs X from this point onward) regarding a 
questionnaire she had been posted. Mrs X had not refused to participate in a trial 
and, in fact, was already participating in a clinical trial when she received 
information about a second trial. Prior to making a decision on whether to 
participate in the second trial she received a phone call from the network 
apologising as a mistake had been made and she wasn’t in fact eligible for the 
second trial. She subsequently received one of my questionnaires. Mrs X did not 
understand why she had been sent the questionnaire and felt she has been labelled 
negatively as a ‘refuser’ which as a participant in another trial she was not. Mrs X 
disapproved of the term ’refusal’ stating that the choice of word ‘refusal’ was 
unfortunate as patients are neither asked nor told to enter a trial. She explained 
patients are given the opportunity to participate in a trial. It is explained to them; 
they take the information away, weigh the pros and cons and then make a choice. 
Mrs X pointed out that, had she been eligible for the second trial, she would not 
have participated after her experiences with the first clinical trial in which she was 
participating.  This was mainly due to the burden of extra visits to the hospital 
which were time-consuming and strenuous.  
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The research network was alerted and the incident investigated. It was raised at 
team meetings to ensure questionnaires were only sent out once a patient had 
declined to participate.  
A total of 13 nurses took part in the postal questionnaire survey, with one taking 
maternity leave during the course of the exercise.  Three of the remaining 12 
nurses, posted out questionnaires to declining cancer patients (25%).  In total, 16 
questionnaires were mailed out to patients. Ten completed questionnaires were 
received in total and a further one where the patient did not agree to complete the 
form, resulting in a response rate of 69%. No further questionnaires were received 
after the incident with Mrs X. 
Feedback from the CRN manager suggested the main reason for the low rate of 
questionnaires being posted out was because the nurses forgot as it was not part of 
their usual routine. However, some nurses felt that once a patient refused to 
participate in a clinical trial, that no other surveys or studies should be offered or 
entered into. The postal questionnaire exercise was terminated after a running for 
a period of two years (Feb 2010 to Feb 2012). Although severely limited, data 
collect from the completed ethnicity and reason for refusal questionnaires are 
presented below. 
9.4.2 Postal questionnaire results 
Ten patients of the 16 who were posted a questionnaire returned a completed form 
in the two year timeframe. One further patient returned an incomplete 
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questionnaire having ticked the box to say he/she was not happy to provide the 
requested information, and one non-declining patient was posted a questionnaire 
in error.  
Respondents were balanced across the age groups and half did not provide gender 
(n=5). All bar one were of White ethnicity, including White British (6), White Irish (2) 
and White Other (1). The majority were of Christian faith, were born in England and 
spoke fluent English.  
Eight patients suffered with cancers of the head and neck, the remaining two had 
ovarian and prostate cancer (Table 9.1). The reasons for refusing a trial were varied. 
Five themes were identified (the patient ID to which it relates is listed in brackets):  
 Treatment preference (1, 3, 5, 10) 
 Patient does not wish to be randomised (2) 
 Patient has been through enough/already stressed (4, 9) 
 Burden of extra hospital visits (6, 8) 
 Burden of trial related activity (7) 
The most common reason for non-participation in this small set was the preference 
for a particular treatment. Eight patients were diagnosed with head and neck 
cancers and were offered the PET-NECK trial (based at Warwick). This trial aimed to 
compare the efficacy of a PET-CT guided watch and wait policy with the current 
practice of planned neck dissection. Patients were opposed to the option of 
watching and waiting and therefore chose not to be randomised. 
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Three patients rejected a trial based upon the number of extra hospital visits 
involved. One patient with a needle phobia rejected the trial as it would involve 
injections/blood draws. One patient felt they had been through enough already and 
another was too stressed following diagnosis to consider a trial.  
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Table 9.1 Ethnicity, cancer type, and reasons for refusal per patient 
ID Ethnicity Type of 
cancer 
Reason for refusal 
1 White British Tongue and 
throat 
I wanted surgery on my lymph glands 
before radio/chemo therapy and the 
trial would have randomised this 
decision. 
2 White British Tongue It was recommended by the oncologist 
that I go straight to radio/chemo 
therapies. The trial was random and 
surgery first would have delayed 
treatment. 
3 White other Prostate I prefer to have regular blood tests and 
if my PSA  increase then I will have 
radiotherapy 
4 White British Left 
paratoid 
gland 
I had concerns that it may not be as 
effective as the original radiotherapy 
treatment I along with my family 
researched on the internet and also 
consulted an independent doctor for 
advice all of which made up my mind 
that it was too much of a risk. Having 
gone through an operation lasting over 
6 hours I feel it is time to think of myself 
and my family after having a traumatic 
few months. 
5 White British Paratoid Risk of all areas not being treated by 
radiotherapy 
6 White Irish Thyroid Distance and time to Coventry 25 miles 
each way 
7 White British Thyroid I am extremely needle phobic and don’t 
want to have any more injections than 
necessary. That is sole reason. 
8 White Irish Ovarian Too many extra trips to  hospital which 
would be stressful 
9 Asian Indian Thyroid Already stressed about my condition 
10 White British Throat I have gone for surgery straight away 
then Chemo therapy /radio therapy. You 
can use any of my notes for research. 
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9.5 Proposed method 3: Transfer of ethnicity data from 
other sources 
Old software at the selected CRN which prohibited the collection of ethnicity data 
was phased out in April 2012 and replaced with new database (EDGE) which 
included a dedicated field for ethnicity and a coded list for ‘reasons for non-
participation’. This presented me with a new opportunity to initiate the prospective 
collection of ethnicity data. The CRN proposed transferring ethnicity data from 
Hospital Episode Statistics (HES) or medical notes (where recorded) into the new 
database. The exercise commenced in April 2012 at which time the new database 
was activated.  
The second section of this chapter involved utilising the collected ethnicity data to 
assess the representation of ethnic minorities recruited into clinical trials across the 
selected CRN and explore barriers to participation by ethnic group.  
Once a patient has been identified by the CRN as a potential participant, they either 
fail to meet the eligibility criteria and are not offered the trial and the ‘recruitment 
status’ field on the database is coded as  ‘clinician decision’, decline to participate 
which is recorded as ‘patient decision’ or are ‘recruited’. Patients undergoing tests 
for eligibility are recorded as ‘screening’. Trial status by ethnic group is presented in 
this chapter. In addition, reasons given by patients for choosing not to participate in 
a trial and the reasons why clinicians deemed them unsuitable is explored with and 
without ethnic group.  
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Reasons for non-participation were analysed using a qualitative thematic approach. 
Responses were coded and categorised into themes and subthemes. Analysis in the 
first instance was blind to ethnic group. Further analysis by ethnicity was performed 
once themes had been established. Ethnic groups were combined due to small 
numbers into Whites and non-Whites.  
9.5.1 Results from method 3 
Data on a total of 1271 potential participants were collected from April 2012 to 
April 2013 (Table 9.2). Three of the 1271 patients had missing recruitment data. 
Reasons for non-participation were collected for 331 patients who did not enter a 
clinical trial with 283 of these being patient decision and the remaining 48 clinician 
decision. 
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Table 9.2 Trial status for potential participants identified by the selected Cancer Research Network across all sites 
Recruitment  
status 
White 
British 
Irish Other 
White 
All  
Mixed 
Indian Other 
Asian 
Caribbean Other 
Black 
Other  
Ethnic 
Unknown 
Ethnicity 
Total 
Clinician decision 38 (4) 1 (7) - 1 (33) - - - 1 (17) - 7 (3) 48 (4) 
Patient declined 204 (22) 2 (13) 7 (28) 1 (33) 6 (29) 5 (42) - - 2 (33) 56 (24) 283 (22) 
Screened* 96 (10) - - - - - - - - 20 (9) 116 (9) 
Recruited 605 (64) 12 (80) 18 (72) 1 (33) 15 (71) 7 (58) 2 (100) 5 (83) 4 (67) 152 (65) 821 (65) 
Total 943 (74) 15 
(1.2) 
25 (2) 3 (0.2) 21 (2) 12 (1) 2 (0.2) 6 (0.5) 6 (0.5) 235 (19) 1268 
(100) 
Note * =‘Screened’ represents patients who were being screened for eligibility at the time of data lock 
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Reasons for non-participation were selected from a drop down list (predefined by 
database developers) and did not allow the entry of free text. The reasons given 
were categorised into themes based upon whether it was the patients or the 
clinician’s decision not to participate, or other reason. A large proportion of 
patients (n=114, 34%) did not participate in trials but did not provide a reason or 
were not asked to provide a reason, leaving 217 patients with data. Patient decision 
accounted for 47.5% of non-participants with reason for non-participation data, 
clinician decision for 38.7% and other reasons 13.8% (Table 9.3). Patients not put 
forward for trials by the clinicians were mainly due to ineligibility (31.8%). Clinicians 
decided 3.7% of patients had been through enough, a further 3.2% were coded as 
‘inappropriate for approach’, but no further information was available. The most 
common ‘other reason’ for non-participation simply stated ‘Other’ indicating a 
suitable match from the drop down list had not been found. Two patients died 
between being identified and approached and one patient was already participating 
in one trial, but it is not clear who made the decision not to participate in the 
second trial. It may have been the patient not wishing to partake in another trial or 
clinician decision if the two trials were incompatible.  
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Table 9.3 Reasons for non-participation 
 
Reason for non-participation 
 
All patients 
Patients with 
reasons data 
 N=331 % N=217 % 
No reason reported 114 34.2 - - 
Patient decision 103 31.2 103 47.5 
Cannot cope with thinking about a trial and 
making another decision 
Does not want extra visits to hospital 
Does not want extra blood tests 
Inconvenience of trial treatment 
Treatment too long 
Put off by toxicities 
Patient has treatment preference 
Patient doesn't wish to be randomised 
Wants the gold standard treatment & doesn’t 
want to be a guinea pig 
Wants treatment elsewhere 
Not satisfied with care services 
Patient doesn't want treatment 
39 
 
10 
2 
5 
1 
10 
7 
6 
13 
 
4 
1 
5 
11.8 
 
3.0 
0.6 
1.5 
0.3 
3.0 
2.1 
1.8 
3.9 
 
1.2 
0.3 
1.5 
39 
 
10 
2 
5 
1 
10 
7 
6 
13 
 
4 
1 
5 
18.0 
 
4.6 
0.9 
2.3 
0.5 
4.6 
3.2 
2.8 
6.0 
 
1.8 
0.5 
2.3 
Clinician decision 84 25.5 84 38.7 
Clinical decision patient has been through 
enough 
Inappropriate for approach 
Ineligible 
8 
 
7 
69 
2.4 
 
2.1 
20.9 
8 
 
7 
69 
3.7 
 
3.2 
31.8 
Other reason 30 9.1 30 13.8 
Death 
Already participating in another trial 
Other reason, not specified 
2 
1 
27 
0.6 
0.3 
8.2 
2 
1 
27 
0.9 
0.5 
12.4 
 
The most common reason given by patients choosing not to participate was the 
inability to cope with thinking about a trial or being faced with another decision 
(18%).  Other patients refused on account of the burden of extra visits to the 
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hospital (4.6%) or extra blood draws (0.9%), one patient stated that the treatment 
period was too long (0.5%). Five patients declined because of the inconvenience of 
the trial treatment (2.3%). As all of the above related to the inconvenience aspect 
of the trial, they were grouped together to form a subtheme which accounted 8.3% 
of patient decisions. Further subthemes were identified by grouping similar reasons 
as follows (also see Table 9.4): 
1. Feeling overwhelmed 
2. Inconvenience 
3. Toxicity 
4. Treatment preference 
5. Does not wish to be experimented upon/randomised 
6. Changing hospital 
7. No treatment 
Patients ‘not wanting to be experimented on’ or ‘randomised’ was the second most 
common theme accounting for 8.8%. The list of treatment toxicities put off a 4.6% 
of patients, with a further 3.2% having a treatment preference, and 2.3% declining 
all treatment. Changing of hospital accounted for 2.4% with one patient reporting 
this to be due to unsatisfactory care services.    
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Table 9.4 Patient decision subthemes and their components 
Subtheme N=103 % 
1. Feeling overwhelmed 
Cannot cope with thinking about a trial and making another 
decision 
39 
39 
18.1 
18.1 
2. Inconvenience of trial 
Does not want extra visits to hospital 
Does not want extra blood tests 
Inconvenience of trial treatment 
Treatment too long 
18 
10 
2 
5 
1 
8.3 
4.6 
0.9 
2.3 
0.5 
3. Treatment toxicity 
Put off by toxicities 
10 
10 
4.6 
4.6 
4. Treatment preference 
Patient has treatment preference 
7 
7 
3.2 
3.2 
5. Does not wish to be experimented upon/randomised 
Patient doesn't wish to be randomised 
Wants the gold standard treatment & doesn’t want to be a 
guinea pig 
19 
6 
13 
8.8 
2.8 
6.0 
6. Changing hospital 
Wants treatment elsewhere 
Not satisfied with care services 
5 
4 
1 
2.4 
1.9 
0.5 
7. No treatment 
Patient doesn't want treatment 
5 
5 
2.3 
2.3 
 
The data were weak, with the majority of cases being of White British origin and 
unknown ethnicity and with insufficient numbers from ethnic minority groups to 
derive any conclusions. 
The most common reason for clinicians not offering a patient a trial was ineligibility 
(Table 9.5). However, seven patients (6 of White British or Irish origin and one with 
unknown ethnicity) were considered inappropriate for approach.  
256 
 
 
Table 9.5 Clinician decision or other reason for non-participation by 
combined ethnic group 
Clinician decision White  
Non-
White   Unknown Total 
Patient has been through enough 7  1 8 
Inappropriate for approach 6  1 7 
Ineligible 54 5 10 69 
Subtotal 67 5 12 84 
Other reasons     
Death 2   2 
Already participating in another trial   1 1 
Other reason, not specified 15  12 27 
Subtotal 17 0 13 30 
 
Investigating patient decision by ethnic group revealed the most common reason 
provided for the non-participation of White patients was found to be the feeling of 
being overwhelmed and not being able to think about a trial or make a decision 
(Table 9.6). Although, seven patients with unknown ethnicity gave the same reason, 
no non-White ethnic minority patients in this extremely small sample offered this 
reason. Three patients from ethnic minorities had a treatment preference, three 
did not wish to be randomised or experimented upon, and two patients were put 
off by treatment toxicities listed in the patient information leaflet.  
257 
 
Table 9.6 Patient decision by combined ethnic group 
Patient decision themes White Non -White Unknown Total 
Declined to take part, no reason reported 93 4 16 113 
1. Feeling overwhelmed    39 
Cannot cope with thinking about a trial and making another 
decision 
32  7 39 
2. Inconvenience of trial treatment    18 
Does not want extra visits to hospital 
Does not want extra blood tests 
Inconvenience of trial treatment 
Treatment too long 
7 
2 
4 
0 
 3 
1 
1 
10 
2 
5 
1 
3. Treatment toxicity    10 
Put off by toxicities 4 1 5 10 
4. Treatment preference    7 
Patient has treatment preference 4 3  7 
5. Does not wish to be experimented upon/randomised    19 
Patient doesn't wish to be randomised 
Wants the gold standard treatment & doesn’t want to be a guinea 
pig 
5 
9 
2 1 
2 
6 
13 
6. Changing hospital    5 
Wants treatment elsewhere 
Not satisfied with care services 
4 
1 
  4 
1 
7. No treatment    5 
Patient doesn't want treatment 4  1 5 
Subtotal 169 10 37 216 
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9.6 Limitations 
I conducted a practical exercise to collect data prospectively in a set timeframe of a 
year with a team of trial staff who were inexperienced in ethnicity data collection. 
The exercise demonstrated the difficulty of collecting ethnicity data particularly due 
to staff perceptions and the perceived usefulness of the data, and the extent to 
which staff felt comfortable in collecting these data. Similar issues were apparent in 
the survey of healthcare professionals (Chapter Six). One problem was that the 
database in use did not allow the capture of ethnicity data. Changeover to a new 
database, which came with dedicated ethnicity and reason for non-participation 
fields was the most effective method in changing staff behaviour and resulted in 
the recording of ethnicity data.  
The postal ethnicity questionnaire was unsuccessful not because patients did not 
complete and return the questionnaire but because very few members of staff 
remembered to send the questionnaire out, whilst others actively declined to send 
it out because they believed once a patient says no to research they should not be 
contacted any further. Conducting research on people who have decided not to 
participate in research was a difficult subject to explain and cropped up often 
throughout my research journey. 
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9.7 Summary 
The biggest barrier that I encountered in attempting to collect data on ethnic 
minority representation in clinical trials was the research nurses reluctance to ask 
patients to provide ethnicity data. This confirms the findings of the ethnicity data 
collection literature review reported in Chapter Four and the survey of healthcare 
professional (HCP) perceptions of ethnicity data collection reported in Chapter Six. 
Fear of offending patients and a lack of understanding of the importance of these 
data were identified in both of these pieces of research  
The research nurse administered questionnaire proposed in method 1 was rejected 
outright as the nurses were not comfortable asking patients for this data although 
there was no objection to the questions themselves except for that raised by the 
Clinical Trials Officer regarding the numbers of years lived in the UK for non-UK 
born ethnic minorities. The postal questionnaire, although proposed by the 
research nurses as an alternative to asking patients for these data, was unsuccessful 
with only 16 questionnaires sent out over a two year period. The response rate 
however was 73% (11 of 15 were returned excluding one sent out in error), 
indicating patients were generally happy to provide such information with only one 
patient returning the form uncompleted. It is my belief that no further 
questionnaires were posted out following the incident with Mrs X.  
The restrictions imposed by the database used at the time of the start of this 
exercise did not have fields within which to record ethnicity, if collected it would 
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have been held on an independent datasheet. A new replacement database 
allowed the transfer of ethnicity data from other hospital sources to the new 
database, and this was the most effective solution. However, this system for 
collecting ethnicity data is dependent on other healthcare professionals collecting 
ethnicity data and does not address the barriers preventing research nurses 
collecting this information. In order for improvement this method requires full 
collection of ethnicity data and the barriers to participation. Over, 34% of patients 
not participating in a trial had no reason recorded.  
The network manager stated time restrictions and a lack of resources to be the 
main reasons why ethnic minority patients are not offered a trial. Additionally, the 
network manger believed Multi-Disciplinary Team (MDTs) where potential trial 
participants are usually identified is where they were missed. The manager did not 
perceive patient barriers to be the main barrier to trial recruitment, instead 
believing the problem lay with healthcare professionals and a lack of resources. It 
can take a long time to get an interpreter so staff at the CRN actively encouraged 
patients to bring an English speaking relative to appointments, believing this to be 
the best option at the moment.  
Identifying and addressing HCP barriers to ethnicity data collection, e.g. raising 
awareness of the importance of collecting these data and using the data collected 
in reports to demonstrate equality in access to clinical trials is needed. Improved 
collection of ethnicity data will enable policymakers, researchers and healthcare 
providers to identify vulnerable groups and allocate resources appropriately to 
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target barriers effecting ethnic minority access to and participation in clinical trials, 
e.g. help consenting patients into studies. 
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Chapter 10 Discussion and conclusions 
The aim of this thesis was to investigate the collection of data on ethnicity and the 
recruitment of ethnic minorities into clinical trials and also to determine whether 
ethnic minorities are under-represented in trials. I have not found evidence that 
ethnic minorities are under-represented, but there is insufficient evidence to 
demonstrate adequate representation or equality in access to RCTs. Inequalities in 
access to clinical trials would be in direct violation of the Equality Act 2010 and the 
goals set by the NHS plan to tackle inequalities and provide culturally appropriate 
care (Home Office, 2010; Department of Health, 2011). The inclusion of ethnic 
minorities in trials is important for ensuring that the trials have external validity and 
that the results can be extrapolated to the whole British population. 
The age structure of the UK ethnic minority population is changing and ageing. The 
Mixed group is reported to be the fastest growing (Pinnock, 2009 and Office for 
National Statistics, 2011). The health service needs to adapt in order to meet the 
needs of an ageing ethnic minority population and subsequent increase in the 
burden of disease amongst ethnic minorities who were largely born outside of the 
UK. Future generations of current immigrants will speak English and may be more 
aware of health research than their parents and grandparents. People may also 
have more ownership of the NHS especially with non-White people coming into the 
NHS as professionals. Although the need for interpreters and translated trial 
material may decrease for the established ethnic minority groups, this will not 
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necessarily affect non-language specific barriers to accessing clinical trials, such as 
lack of trust, lack of resources and institutional racism (Macpherson, 1999).  In 
addition, patient perceptions of research, clinical trials and what it means to 
participate in a clinical trial as well poor ethnicity data collection need to be 
addressed, both in policy and in further research. 
10.1 Data collection 
10.1.1Recording 
There needs to be better completed, validated, self-reported ethnicity data in order 
to estimate the representativeness of ethnic minorities in clinical trials. One of my 
key findings was the inadequate completion of ethnicity data and the high 
proportion of missing data. Data collection has improved over recent years but 
there is still considerable room for improvement given the large number of patients 
with missing codes (not stated, not known and not specified) recorded in place of 
ethnicity. Analyses of local HES data revealed inpatient data to be better completed 
than outpatient data. This may be on account of outpatients’ clinics being busier 
and therefore reception staff having less time in which to obtain data from patients. 
It may also be due to the advantage of having more time in which to obtain the 
information or perhaps needing to be more thorough when a patient is admitted.  
Providing ethnicity monitoring training and promoting awareness of the importance 
of ethnicity data and its uses are essential. Collecting ethnicity data in primary care 
and linking through to other services would be the most efficient method of 
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collecting these data once resources are put in place. Success stories include the 
achievements by Lambeth and Central Liverpool NHS Primary Care Trusts where 
ethnicity data were pursued with vigour (Adebayo and Mitchell, 2004; Race for 
Health, 2006). Lambeth Primary Care Trust introduced the ‘Individual Patient 
Registration Profile’ programme which provided funding and training to GP 
practices as an incentive to collect patient profiling data. Patients who were already 
registered with the practice were posted a patient profiling questionnaire with free 
return envelopes and data entry was funded by the programme. Templates were 
provided to capture patient profiling data prospectively for all new registrations.  
10.1.2 Use of existing ethnicity data 
Ethnicity data have been used in reports by the NCIN since 2009 through use of 
data collated from cancer registries, HES and ONS held in the National Cancer Data 
Repository. Cancer incidence data by ethnicity highlighted the flaws in the data and 
the large proportion of missing ethnicity (NCIN, 2009). However, the data have 
been used in the second All Breast Cancer Report which found women of Black 
origin to be younger at diagnosis compared to White women (median age at 
diagnosis 50 and 62 years respectively) (Lawrence et al, 2011).  In addition, fewer 
Black and Asian women of routine screening age of 50-70 years were reported to 
have had their cancer detected through this method compared to White women in 
the same age group (44.6%, 52.1% and 56.3% respectively).  Further to this, 56% of 
Black women were reported to be more likely to have poorer grade 3 tumours and 
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64% had lymph node involvement compared to White Women with 36% and 38% 
respectively. 
Ethnicity data collected by Lambeth Primary Care Trust have been used in a health 
equity audit of Stop Smoking Services and a needs assessment exercise of the 
Portuguese community (Race for Health, 2006). Ethnicity data have also been used 
to investigate the poor uptake of screening services in detail within ethnic minority 
populations which may partly explain the lower rates of cancer observed in this 
thesis (Chapter Eight). Szczepura et al (2008) reported uptake patterns for breast 
and bowel cancer screening in UK South Asians vs non-South Asians over a 15 year 
period, and reported an improvement in screening rates as a result of targeting 
single GP practices. Breast cancer screening rates were generally found to be lower 
in South Asians than non-South Asians (61% and 75% respectively).  However, an 
improvement in overall breast cancer screening was observed during the course of 
the study to 67% in South Asians and 78% in non-South Asians. Bowel cancer 
screening rates were found to be significantly lower in South Asians vs non-South 
Asians (33% vs 61% respectively).  Bowel screening rates were reported to be 
particularly low in the Muslim population (26%).  
In a study of attitudes to colorectal cancer screening in UK ethnic minorities, Robb 
et al (2008) reported less knowledge of the causes of colorectal cancer in ethnic 
minority participants when compared to White British participants. Feelings of 
‘embarrassment’ and ‘shame’ were the most cited barriers to screening in the 
ethnic minority communities. 
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10.1.3 Perceptions and experiences of ethnicity data collection 
Focus group participants did not have many issues with regards to providing their 
data for healthcare purposes, on condition that an acceptable rationale was given.  
By contrast, one third of healthcare professionals did not attempt to collect any 
data because either they or their organisations did not believe it to be of 
importance. Several respondents said they did not understand why such data were 
required, possibly due to a lack of training. This lack of understanding could explain 
why some Healthcare professionals (HCP) chose not to ask the patient to provide 
these data, and instead opted for assessment by observation or an alternative 
method whereby they would not need to offer an explanation to the patient. One 
HCP survey respondent thought staff may not be aware they needed to ask the 
patient. HCPs recording ethnicity by observation method in one US report believed 
the data to be accurate as they felt they knew the local population (Regenstein and 
Sickler, 2006). Others may have simply seized the opportunity for a less 
confrontational route.  
Reluctance to collect ethnicity data was encountered first hand during the course of 
the ethnicity data collection exercise I conducted at the CRN (reported in Chapter 
Nine). Research nurses felt uncomfortable asking the patients for ethnicity 
information believing it to be too sensitive and because they believed the patients 
were too fragile and already overwhelmed having received a cancer diagnosis 
coupled with treatment and trial information.  
267 
 
Fear of causing the patients offence or of being challenged by a patient was a worry 
for some staff as demonstrated in my survey of healthcare professional’s 
perspectives of ethnicity data collection reported in Chapter Six. One healthcare 
professional felt it would be particularly offensive to ask younger ethnic minorities 
who were more likely to be British born for ethnicity information. A hospital in the 
USA, identified by the ethnicity data collection literature review (Chapter Four), 
addressed the problem of staff recording large numbers of ‘Not known’ codes 
through quality monitoring and provided extra training as needed (Regenstein and 
Sickler, 2006). 
10.1.4 Methods currently used by researchers due to poor 
ethnicity data  
The absence of complete ethnicity data has meant researchers have had to adopt 
other methodologies such as 1) using proxy indicators where available e.g. Country 
of Birth, 2) use of name recognition software such as Nam Pehchan and SANGRA 
where use is limited to South Asians, 3) data linkage, 4) sensitivity analyses and 5) 
use of multiple imputation or 6) conduct studies targeting specific populations 
(Wild et al, 2007; Cummins et al, 1999; Nanchahal et al, 2001; Ali et al, 2010; 
Fischbacher et al, 2007; Downing et al, 2011).  
In a report of cancer incidence by ethnic group (2009) several permutations of 
sensitivity analyses were performed to assign ethnicity to the 24% of patients with 
missing ethnicity, but crude techniques like this can lead to results that are 
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problematic to interpret. Ryan et al (2012), reported inadequacies in name 
recognition software and the use of census data when performing analyses of 
cancer registry data. Downing et al (2011) opted for the more complex multiple 
imputation in their exploration of the relationship between ethnicity, breast cancer 
incidence and survival. This method was also used by the Office for National 
Statistics in a study of infant mortality by ethnic group. However, multiple 
imputation is based upon untestable assumptions, in cases where ethnicity is not 
missing at random (e.g. concentrated in particular ethnic groups) multiple 
imputation is deemed inappropriate (Marshall et al, 2010). 
10.1.5 Training and highlighting the usefulness of ethnicity data 
Use of the data to identify health needs and improve services is needed to 
showcase the utility of these data to patients and HCP alike as both parties felt 
collected data were not being used.  The problem is that the data are not used in 
routine reports because it is so poor, and it is not collected because its value has 
not being sufficiently demonstrated. Staff training and promoting awareness of the 
importance of ethnicity data and its uses are essential in order to improve ethnicity 
data collection in healthcare. Training packages should promote the use of 
standardised ethnicity questions and provide standardised explanations to the 
questions frequently asked by patients, such as the purpose of collection. As 
reported in the literature review of ethnicity data collection in Chapter Four, both 
the USA and Scotland have toolkits which are freely available and provide 
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downloadable training materials (Health Research and Education Trust, 2007 and 
Health Scotland, 2005).  
In the long run, using the ethnicity data we have in healthcare and government 
reports will highlight the flaws and may be the incentive required to improve 
ethnicity data collection. 
10.2 Participation in RCTs 
The systematic review of interventions to increase ethnic minority participation into 
RCTs highlighted the lack of research in this area from the UK (Chapter Seven). The 
USA literature revealed awarding grants to sites, the use of financial incentives and 
community representatives to be the most effective in recruiting ethnic minority 
participants. Financial incentives were also shown to aid retention, particularly 
where payments were staggered across the duration of the trial as demonstrated in 
the study reported by Germino et al (2011). The issues faced in the USA are very 
different to the UK with much of the literature focused upon addressing the lack of 
trust in researchers that African Americans feel following the infamous Tuskegee 
experiment.  
There are important differences between the UK and USA healthcare systems. Care 
in the UK National Health Service is freely available, meaning that patients have 
access to treatment even when they are not in a clinical trial. Conversely, in the USA 
health insurance is usually provided by employers. Individuals out of work or those 
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in low paid jobs with either low or no medical cover may have very limited access to 
treatment.  
 The offer of free healthcare and/or the provision of financial incentives were found 
to be useful in increasing minority recruitment to clinical trials in the USA. In the 
UK, ethics committees only allow patients to receive payment for participating in 
research limited to costs incurred as a result of participation e.g. travel, food, loss of 
earnings, or childcare. Any additional payments are deemed to be ‘inducement’ and 
thought to lead to patients not considering the risks of the trial sufficiently or 
withholding information from health care professionals that would prevent them 
from taking part (Beckford and Broome, 2007). Australia has a similar policy, where 
payment above and beyond costs incurred or a fixed amount felt to be a reasonable 
estimate of out-of-pocket expenses is not allowed. The Australia Ethics National 
Statement states: 
‘Those who are economically disadvantaged might be exploited if payment 
were such that it provided what, in effect, would be a perverse incentive to 
take risks that they would otherwise not take, for example, payment that is 
greater than the current minimum wage’ (Australian Health Ethics Committee, 
2009).  
Interventions reported to be effective in improving the recruitment of ethnic 
minority participants identified by my review (Chapter Seven) included government 
grants to sites serving ethnic rich populations which allowed sites to invest in 
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additional resources. Community health workers and ethnicity matched researchers 
successfully overcame lack of trust issues in African American communities. 
Targeted mailshots to addresses in ethnic rich areas were reported to be the most 
cost effective method. Least successful strategies were found to be recruiting 
through health insurance companies, church events and health fairs. 
10.3 Implications for the UK 
Cancer clinical trials are now starting to routinely collect ethnicity data. Ethnicity 
questions were prospectively included in six trials currently being conducted at 
Warwick Clinical Trials Unit (three breast cancer, two head and neck, and one 
multiple myeloma trial). Initial results indicate that the majority of participants 
entering these trials are White. Ethnicity data from trials when teamed with Cancer 
Registry data and HES data will allow an assessment of the representation of ethnic 
minorities in clinical trials in the future.  
Recruiting ethnic minorities into clinical trials also requires additional resources as 
demonstrated in the article by Cook et al (2010) where selected sites were awarded 
grants in order to facilitate the recruitment of African Americans. The funding was 
used in a variety of ways, the most successful methods included extra staffing 
permitting out of hours screening, transportation and parking payments, 
development of recruitment materials, refreshments, use of media advertising and 
mailshots targeting ethnic minority specific media channels, stores or areas of 
residence. 
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Additional barriers to participation, such as raising awareness of the need for 
research, the potential benefits of participating in a trial, the need for validated 
questionnaires in languages other than English and opportunities to request same 
sex healthcare professionals at assessments have been reported and may need to 
be considered when planning future interventions (Ford et al, 2005, Hussain-
Gambles et al, 2004). Non-drug trials may also need to consider cultural issues and 
beliefs, such as modest dress and mixing of genders, i.e. in a study including 
physical exercise or group therapy.  
However, the issue of participation and access to clinical trials is not restricted to 
ethnic minorities, other minority groups who don’t speak English or don’t 
understand, cannot read or write, who aren’t educated and aren’t aware of 
research and how research can be used to improve treatment/outcomes will 
experience similar inequities. Collecting data to monitor inequities in access to 
clinical trials for groups such as these is also a challenge. Indeed, the USA NIH 
revitalization Act 1993 is not restricted to ethnic minorities but instead mandates 
the inclusion of women and members of all minority groups and their 
subpopulations (NIH, 1993). 
10.3.1 Examples from practice (insights from colleagues) 
Experiences with inappropriate interpreters 
Interpreters have been used in many hospitals within the NHS in the UK. However, 
difficulties experienced whilst using independent interpreters include age and 
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gender conflicts, such as a young Polish female patient with breast cancer allocated 
an elderly Ukrainian male interpreter.  
However, there are issues surrounding the acceptability of relatives as interpreters. 
Clinicians are encouraged not to use relatives if avoidable, however, this can lead to 
problems when it is the patients wish to have a family member to interpret, and do 
not want the services/presence of a stranger. In South Asian communities, 
healthcare professional found most patients preferred to use relatives and were 
accompanied to appointments by an English speaking relative.  
There are advantage of using interpreters over relatives because healthcare 
professionals have much more control of interpreters and can tell them exactly 
what to tell the patient, clinicians have much less power over relatives.  
In one hospital, I learned they had stopped using interpreters due to cost issues and 
instead used a telephone service which cut costs but wasn’t effective.  Prior to this, 
the hospital would request an interpreter and he or she would be on standby until 
the patient was called. However, there are often long waits during busy clinics and 
the meter would be running for the entire duration. As it would be unethical to 
prioritise patients needing an interpreter to be seen first, interpreters were 
replaced by a dedicated telephone interpretation service. However, there were 
many problems with language mismatches, such as a Portuguese speaking patient 
from Brazil who was connected to a Portuguese speaking interpreter from Portugal 
which is different. The call was abandoned. 
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Time constraints 
One clinician explained that it takes approximately 30 minutes to explain diagnosis 
and treatment information to a new cancer patient when the patient speaks English 
but has no medical knowledge. This time increased when discussing a trial as it may 
involve explaining what a trial is and why it needs to be conducted.  A clinician may 
need to explain concepts such as equipoise, randomisation and possible treatment 
options as well as what treatments are available if they choose not to participate in 
the trial. This process is much more time-consuming with non-English speaking 
patients where awareness of research and trials is much lower.  
Consent issues 
A lead research nurse from Dorset described the complexities of taking consent 
from potential cancer trial participants and the need for the person taking consent 
to be reassured that the person giving the consent had understood the information. 
She described how particularly difficult this was when considering non-English 
speaking ethnic minorities. At times she wasn’t sure if they could read the 
information leaflet and therefore didn't feel they were giving informed consent or 
that the consent process was what it should be. On several occasions she was asked 
by consultants to consent patients and refused because she didn't feel sure that 
consent could be given in a really informed way. 
One consultant felt the most daunting thing about recruiting ethnic minorities was 
the clinician feeling that he or she cannot explain the study to the patient correctly, 
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and the difficulties of doing this through an interpreter. Most patient information 
leaflets are not available in languages other than English and there are so few 
ethnic minority research nurses. The consultant went onto to say “I think it’s effort, 
it’s effort, it’s effort, that’s why” stating that he/she believed ethnic minorities to 
be under-represented in clinical trials because they were much harder to recruit at 
every step.  
Use of translated patient information sheets and consent forms  
A chief investigator of a national phase III cancer trial reported translating patient 
information sheets and consent forms into the two most common non-English 
ethnic minority languages within the catchment areas for the centres recruiting into 
the study (Urdu and Gujarati). These were sent to all participating centres in the UK, 
irrespective of ethnic minority population composition. However, the use of the 
translated patient information sheets was very low.  The research nurses and 
doctors were not trained to be culturally sensitive and did not try to identify 
suitable patients or use the patient information sheets. An estimated eight eligible 
patients who were literate in Urdu or Gujarati were identified from a total of 68 UK 
centres and only two of these patients consented to participate in the trial. The 
initial cost of translating the information was large and increased each time an 
amendment was made, but the resulting recruitment was small.   More recently, 
the same Chief Investigator has adopted a ‘translate on demand’ approach, 
providing patient information sheets and consent forms in any language required 
upon request. However, the ‘translate on demand’ approach has not proved to be 
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affective in practice so far (i.e. no requests) possibly due to the ‘bother’ factor, 
literacy levels in older ethnic minority groups and a lack of awareness of the 
initiative. 
There is some evidence to suggest acculturation of cancer rates is occurring. This is 
the process where the risk of ethnic minorities developing disease changes to 
become similar to that of the host population. It has already been reported to be 
happening in breast cancer rates in the UK South Asian population (Farooq and 
Coleman, 2005). Migration studies have also shown this. A study of South Asians 
from India, Singapore, UK and the USA found the lowest rates of cancer in India and 
higher rates in Indian immigrants in Singapore, UK and the USA (Rastogi et al, 
2008).   
10.4 Recommendations  
To address the poor quality of ethnicity data collection, the collection of self-
reported ethnicity data should be mandated the first time a patient comes into 
contact with the NHS, preferably in primary care and such data should then be 
linked through to secondary care and verified at subsequent appointments where 
needed. Providing healthcare professionals with training and access to ethnicity 
monitoring toolkits with standardised questions and rationale would help combat 
barriers to ethnicity data collection at the healthcare professional level. 
Demonstrating the value of the collected data in reports and using it to improve 
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services would also encourage ethnicity data collection and provision and would 
highlight the deficiencies in the data.  
Recruitment of ethnic minority groups in clinical trials could be improved by 
mandating the inclusion of a representative sample of ethnic minorities 
(representative of the population and/or incidence of the condition of interest) in 
clinical trials, similar to the model demonstrated by the USA’s NIH Revitalization Act 
1993 and the successful NCRN who were established with the aim of doubling the 
recruiting of all cancer patients into clinical trials from 3.75% to 7.5% of incident 
cases (NCRN, 2006). Research in the USA has shown the effectiveness of patient 
navigators, cultural brokers or link workers to facilitate the recruitment of ethnic 
minority patients into clinical trials. The role would involve using a member of the 
same community as the target group of patients to minimise cultural and language 
barriers. The facilitators should have knowledge of clinical trials in general and of 
the clinical trials available and be able to give patients the fullest information 
possible enabling them to make an informed decision.  
Patients who are not proficient in English were encouraged by research staff at the 
CRN to attend appointments with an English speaking relative or friend (Chapter 
Nine). Continuation of this recommendation would overcome the difficulty of some 
patients not even being approached to enter an RCT and help minimise problems 
related to matching languages and dialects of patients to interpreters.  However, 
independent interpreters may need to be available as it is not certain that a relative 
could provide all the necessary information for ‘fully informed consent’.   
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10.5 Conclusions 
A change in local and national policy to mandate the collection of ethnicity data in 
primary care and linked through to other healthcare service providers is needed.  
Healthcare professionals should be familiarised with the Equality Act 2010 in 
training exercises or at induction to raise awareness of the need for ethnicity data 
collection and how this data will be used to improve services. Unused data were 
reported to be a disincentive to both healthcare professionals and patients alike 
(Iqbal et al, 2012, Fulton, 2010). Training should also emphasise the importance of 
self-reported ethnicity as well as providing standardised:  1) rationale, 2) wording of 
questions, 3) response categories offered and 4) answers and explanations to 
frequently asked questions. Only when we have better ethnicity data will we be 
able to assess the true extent of inequities in access to healthcare and clinical trials. 
Investigations of barriers to ethnic minority participation in clinical trials are needed 
before we identify appropriate strategies to combat them.  
Reducing health inequalities, improving access to clinical trials and tailoring current 
services to meet the needs of the UK’s ethnic minority population is dependent on 
having accurate ethnicity data. Patients need to feel confident that their data will 
be handled confidentially and used to improve services (Johnson 2012, Fulton 
2010). Without improvement in the recording and use of this information we will 
continue to remain blind to the size of the problem. Collecting ethnicity data is of 
no use if the data are not used to target resources and reduce inequalities (Raleigh, 
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2008). In the words of Fulton (2010) ‘health equality is not possible without ethnic 
monitoring’. 
There has been a noticeable change in ethnicity data being collected since the start 
of this thesis in 2006, the CanEth report in 2009 and the papers I have published. 
Through data linkage with HES and ethnicity data collection on new registrations, 
ethnicity data of cancer patients are now becoming available through the National 
Cancer Data Repository (NCIN et al, 2010). Researchers using the data will identify 
the flaws in the ethnicity data collected and drive improvement and change. 
The outcomes from each of the research components in this thesis highlight 
challenges and solutions to the collection and use of ethnicity data in the UK, 
completing the research cycle from initial empirical observation to implementation 
in practice. 
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